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Biofilms are the primary cause of clinical bacterial infections and are impervious 
to typical amounts of antibiotics, necessitating very high doses for treatment. 
Therefore, it is highly desirable to develop new alternate methods of treatment that 
can complement or replace existing approaches using significantly lower doses of 
antibiotics. Current standards for studying biofilms are based on end-point studies 
that are invasive and destroy the biofilm during characterization. This dissertation 
presents the development of a novel real-time sensing and treatment technology to aid 
in the non-invasive characterization, monitoring and treatment of bacterial biofilms. 
  
The technology is demonstrated through the use of a high-throughput bifurcation-
based microfluidic reactor that enables simulation of flow conditions similar to 
indwelling medical devices. The integrated microsystem developed in this work 
incorporates the advantages of previous in vitro platforms while attempting to 
overcome some of their limitations.  
Biofilm formation is extremely sensitive to various growth parameters that cause 
large variability in biofilms between repeated experiments. In this work we 
investigate the use of microfluidic bifurcations for the reduction in biofilm growth 
variance. The microfluidic flow cell designed here spatially sections a single biofilm 
into multiple channels using microfluidic flow bifurcation. Biofilms grown in the 
bifurcated device were evaluated and verified for reduced biofilm growth variance 
using standard techniques like confocal microscopy. This uniformity in biofilm 
growth allows for reliable comparison and evaluation of new treatments with 
integrated controls on a single device.  
Biofilm partitioning was demonstrated using the bifurcation device by exposing 
three of the four channels to various treatments. We studied a novel bacterial biofilm 
treatment independent of traditional antibiotics using only small molecule inhibitors 
of bacterial quorum sensing (analogs) in combination with low electric fields. Studies 
using the bifurcation-based microfluidic flow cell integrated with real-time 
transduction methods and macro-scale end-point testing of the combination treatment 
showed a significant decrease in biomass compared to the untreated controls and 
well-known treatments such as antibiotics.  
  
To understand the possible mechanism of action of electric field-based treatments, 
fundamental treatment efficacy studies focusing on the effect of the energy of the 
applied electrical signal were performed. It was shown that the total energy and not 
the type of the applied electrical signal affects the effectiveness of the treatment. The 
linear dependence of the treatment efficacy on the applied electrical energy was also 
demonstrated.  
The integrated bifurcation-based microfluidic platform is the first microsystem 
that enables biofilm growth with reduced variance, as well as continuous real-time 
threshold-activated feedback monitoring and treatment using low electric fields. The 
sensors detect biofilm growth by monitoring the change in impedance across the 
interdigitated electrodes. Using the measured impedance change and user inputs 
provided through a convenient and simple graphical interface, a custom-built 
MATLAB control module intelligently switches the system into and out of treatment 
mode. Using this self-governing microsystem, in situ biofilm treatment based on the 
principles of the bioelectric effect was demonstrated by exposing two of the channels 
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1. Investigation of the use of microfluidic bifurcations for the reduction in biofilm 
growth variance. 
2. Investigation of the effect of electrical energy on the treatment efficacy of the 
bioelectric effect. 
3. Investigation of the synergistic effects of a combination therapy using AI-2 
analog and electric fields. 
4. Development of an impedimetric sensor with feedback for self-governing biofilm 
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Chapter 1. Introduction 
1.1 Background and Motivation 
Bacterial biofilms are a major cause of concern in the clinical field. They are the 
primary cause of clinical infections, commonly forming on medical devices like 
implants and catheters and also on respiratory tract surfaces and teeth [1,2]. It is 
estimated that 65% of all bacterial infections involve biofilms [3]. The high mutation 
rates and horizontal exchange of genetic material in biofilms promote antibiotic 
tolerance mechanism and result in high resistance to antibiotics [1,4-7]. It is estimated 
that biofilms require 500 – 5000× higher doses of antibiotics for treatment as 
compared to freely floating planktonic bacteria [1,6,8]. The use of such high doses of 
antibiotics has led to the emergence of antibiotic resistant strains [7]. Hence, there is 
an urgent need to develop alternate treatment methodologies that eliminate the need 
for such high doses of antibiotics. 
While biofilms have been studied for decades [9,10], much is still unknown. Over 
the years, a number of in vitro models have been developed to not only understand 
the biology of biofilms but also to study the effect and biofilm response to external 
stimuli such as change in pH or exposure to antimicrobials [7,11-15]. However, no 
standard procedures have been identified for the characterization and study of 
biofilms. Moreover, the variability inherent to biological systems warrants the need 
for multiple experimental repeats in order to ensure reliability. Hence, biofilms grown 





platforms [16,17]. This prevents reliable comparison of treated biofilms to their 
controls.  
Additionally, biofilm characterization and evaluation often rely on bulky external 
quantification equipment or laborious protocols that label components of the biofilm 
and destroy the biofilm itself [18,19]. Furthermore, maintaining the consistency of 
macroscale protocols is a challenge that adds to the variability of biofilms. Therefore, 
there is an urgent need to develop scalable and reliable systems that can quantify and 
characterize biofilms noninvasively. Microfluidic lab-on-a-chip (LOC) sensing 
platforms are an ideal solution to address this multi-faceted problem. Microfluidics 
provides several advantages including ease of fabrication, low reagent volumes and 
cost, and high throughput. Additionally, they can be readily integrated with sensing 
technologies that can be used to evaluate the biofilms in real time for label-free, 
continuous and noninvasive characterization of biofilm properties [20-52]. This 
doctoral research aims at developing a scalable microfluidic platform with integrated 
sensor-treatment modules for biofilm testing and treatment evaluation. It is 
anticipated that this integrated system will lay the foundation for rapid and reliable 
testing of clinically effective biofilm therapies.  
 
1.2 Summary of Accomplishments 
In this work we leverage the advantages of microfluidic LOC systems to develop 
a novel, high-throughput microfluidic platform for the rapid investigation of new 
alternative biofilm treatment methods that are independent of high doses of 





microfluidic biofilm impedimetric sensor-treatment microsystem that can be used for 
biofilm evaluation and new treatment testing. Using this platform, a new 
combinatorial biofilm treatment that combines small molecule inhibitors, 
autoinducer-2 analog (AI-2 analog), with electric fields was evaluated. We envision 
that successful development of this sensor-treatment system will enable future 
technologies for active treatment for biofilm infections right at the onset of biofilm 
growth. For example, a prospective application of this technology would be 
integrating the sensor-treatment system into a simple indwelling medical device like a 
catheter. As a first step to enable this research four key objectives were investigated: 
development of high-throughput microfluidics, the investigation of the proposed 
combinatorial therapy using small molecule inhibitors and electric fields, 
investigation of the role of electric energy on the efficacy of the bioelectric effect 
(BE), and the development of the impedimetric sensor-treatment module. Each of 
these objectives is discussed in the following sub-sections.  
 
1.2.1 Investigation of Biofilm Growth Variance in Bifurcation Microfluidics  
For this work, an easy-to-fabricate, high-throughput PDMS based microfluidic 
device was developed. A PDMS mold using negative photoresist was fabricated and 
used to cast a simple PDMS device. The PDMS-based flow cell aided in mimicking 
clinical conditions, for example the flow rates observed in a urinary catheter. The 
microfluidics was tested for reduced biofilm growth variance, and flow rates and 
dimensions similar to in vivo models were used to allow for reliable testing of new 





to single channel microfluidics, was analyzed using traditional confocal microscopy. 
Biofilms grown in this platform exhibit only an 7.1% variation in thickness as 
compared to previously reported 68% variation in single channel microfluidics. 
 
1.2.2 Investigation of the Effect of Electrical Energy on the Efficacy of the 
Bioelectric Effect  
The second goal of this dissertation is to examine the effect of electrical energy on 
the efficacy of the bioelectric effect. The use of electric fields in combination with 
small doses of antibiotics for enhanced treatment of biofilms is termed the bioelectric 
effect (BE). Different mechanisms of action for the alternating current (AC) and 
direct current (DC) fields have been reported in the literature over the last two 
decades. In this work, we conduct the first study on the correlation between the 
electrical energy and the treatment efficacy of the BE on Escherichia coli K-12 
W3110 biofilms. Our results demonstrate that the energy of the electrical signal, and 
not the type of electrical signal (AC or DC or SP), is the key to determine the efficacy 
of the BE treatment. We anticipate that this observation will pave the way for further 
understanding of the mechanism of action of the BE treatment method and open new 
doors to the use of electric fields in the treatment of bacterial biofilms. 
 
1.2.3 Investigation of a Novel Combinatorial Therapy Using Small Molecule 
Inhibitors and Electric Fields 
The third accomplishment of this work is to investigate a novel combinatorial 





analogs, were combined with electric fields. The efficacy of this treatment to treat 
mature biofilms was studied. Mature biofilms treated with this combination therapy 
showed a 46% decrease in biomass using a static macro-scale system and a 78% 
decrease in biofilm thickness using the dynamic microfluidic system, in comparison 
to the untreated control. Additional characterization and investigation of this therapy 
could lead to the development of a new bacterial biofilm treatment method that is 
independent of traditional antibiotics. 
 
1.2.4 Development of an Impedimetric Sensor-Treatment System  
The final objective of this research is the development of a noninvasive label-free 
sensing technology that allows for sensitive real-time monitoring of bacterial 
biofilms. An impedance sensor suitable for monitoring surface attachment events was 
used as the transducer in this LOC system. This impedimetric sensor was designed to 
operate in two modes: 1. Sensing mode (lower frequencies and volatges), and 2. 
Treatment mode (higher frequencies and voltages). The electrodes of the impedance 
sensor were used in the sensor mode to sense biofilm growth and in the treatment 
mode to apply electric fields in combination with antibiotics or small molecule 
inhibitors (analogs) to treat bacterial biofilms. A flowchart showing the feedback 
system is shown in Figure 1-1. The successful development of this sensor-treatment 
system will lay the foundation for integration of electric field-based biofilm sensors 









1.3 Literature Review 
This section provides the necessary background and literature review as 
applicable to the presented work. First, a discussion of bacterial biofilms is presented 
with a focus on quorum sensing and the factors contributing to the increased severity 
of biofilm infections. Second, current treatment methods and new alternative methods 
of treatment under research are reviewed. Third, traditional methods of studying 
biofilms along with their advantages and disadvantages are discussed. Finally, LOC 
platforms with emphasis on microfluidic systems for biofilm studies are presented.  
 
1.3.1 Bacterial Biofilms  
Bacterial biofilms are complex communities of bacteria enveloped in a self-
produced matrix of polysaccharides, proteins and extracellular DNA (eDNA), known 
as the extracellular matrix (ECM). Biofilm formation is initiated by the attachment of 
freely floating (otherwise known as planktonic) bacteria to surfaces. The adhesion, 
while initially reversible, is strengthened through the secretion of the ECM which 





















biofilm as shown in Figure 1-2. The ECM provides the biofilm with structural 
stability and also protects the bacteria from attack from the host’s immune system 
[4,54]. It also plays a role in restricting the molecular diffusion of typical treatments 
like antibiotics, thereby necessitating higher doses of antibiotics for treatment [1,6]. 
The various stages of biofilm growth include reversible attachment (stage I), followed 
by irreversible attachment to the substrate (stage II). Following this, microcolonies 
are formed (stage III) and three-dimensional structures known as stalks and towers 
form as the biofilm matures (stage IV) The final stage involves the release of motile 
bacteria through rupture of the ECM or detachment of larger pieces of encased 







Bacterial biofilms are known to exhibit higher resistance to antibiotic treatment 
than planktonic (freely suspended) bacteria. There are a number of hypotheses 
concerning what mechanisms enable biofilm resistance to antibiotics [5,55]. First, the 
ECM itself can reduce the potency of antibiotics applied to biofilms. Antibiotics that 
interact with the ECM are often prevented from completely penetrating thick biofilm 
layers [56-58]. However, other studies have shown that slow diffusion of antibiotics 
through the ECM may not be a function of its composition, but rather of other factors 
secreted by the bacteria in the biofilm or of the type of antibiotic and bacterial species 
[59,60]. Second, horizontal gene transfer between the bacteria in the biofilm often 
promotes biofilm survival, as genes that regulate antibiotic and metal resistance are 
carried on plasmids that can be easily transferred between cells [61,62]. Third, the 
chemical environment within biofilms is believed to promote antibiotic tolerance by 
altering bacterial rates of metabolism and growth, thereby removing antibiotic targets 
[63]. Traditional antibiotics are known to target vital processes in actively growing 
bacteria, such as metabolism or cell wall production. Removal of these vital processes 
in bacteria in biofilms is thought to add to the antibiotic tolerance of biofilms. Finally, 
the differences in nutrient concentrations and deep anaerobic niches of the biofilm 
can lead to the formation of persister cells, which are inactive, dormant cells that can 
persist even on prolonged exposure to high doses of antibiotics. Persister cells can 
revert back to active cells under favorable conditions and restart the biofilm formation 
process [64,65]. 
The high antibiotic resistance of bacterial biofilms precludes the use of small 





antibiotics (500 – 5000× in comparison to planktonic bacteria) for treatment [1,6]. 
Hence, there is an urgent need for alternate methods of treatment that can effectively 
and efficiently remove existing biofilms and prevent the onset of biofilm formation. 
  
Quorum Sensing 
Biofilm formation is triggered through a cell-to-cell communication mechanism 
known as quorum sensing (QS) [66-68]. QS molecules or autoinducers are secreted 
into the extracellular environment by the bacteria. Bacteria can detect the 
concentration of the autoinducers in the extracellular environment through 
nonspecific uptake of the molecule or through specific autoinducer binding receptors 
[69]. Once a threshold concentration of autoinducer molecules is attained, a genetic 
cascade regulating a number of QS genes is triggered. This is illustrated in Figure 1-3.  
 
 







QS is known to regulate numerous genes, and many of these genes control 
phenotypes associated with bacterial biofilm pathogenicity including toxin production 
and biofilm formation [69,70].  
While different bacteria have different QS systems, the class of autoinducers 
known as autoinducer-2 or AI-2 is referred to as “universal” since its synthase, LuxS, 
is found in more than 70 species of bacteria [71]. AI-2 is believed to regulate the 
interspecies communication in many bacteria including Vibrio harveyi, Salmonella 
typhimirium, Pseudomonas aeruginosa and Escherichia coli [72-74]. AI-2 is 
synthesized intracellularly in a multi-step process. In E. coli, multiple enzymes are 
used to convert S-adenosyl-L-homocysteine (SAH) to 4,5-dihydroxy-2,3-
pentanedione (DPD). DPD is then cyclized and undergoes further processing to form 
AI-2, which is then secreted. Once secreted, the extracellular AI-2 is imported into 
the cells through interactions with the AI-2 transporter as well as non-specific uptake 
[75]. Inside the cell, the AI-2 molecule is phosphorylated by LsrK, after which it 
interacts with the repressor LsrR, allowing for the transcription of the lsr operon, 
including genes regulating AI-2 uptake and processing [76].  
Much work has been conducted to understand QS, as it controls a number of 
processes contributing to the formation of biofilms and toxin production by bacteria. 
E. coli strains that lack the AI-2 signaling regulators lsrK and lsrR have been 
observed to form thinner biofilms than the wild type [77]. Furthermore, addition of 
AI-2 to E. coli biofilms resulted in a 30-fold increase in biomass of the biofilm [78]. 





While AI-2 is primarily used for interspecies communication, another class of 
autoinducers, called autoinducer-1 (AI-1) is used for intraspecies communication. P. 
aeruginosa uses QS extensively to modulate both biofilm formation and maturation, 
using acyl-homoserine lactone (AHL) molecules in autoinducer-1 (AI-1) signaling. It 
has been shown that P. aeruginosa deficient in producing AHLs formed thinner 
biofilms that were more sensitive to detergents compared to wild-type biofilms [81]. 
Although P. aeruginosa primarily uses the AI-1 QS system and does not produce AI-
2, gene expression in this species can still be regulated by extracellular AI-2 present 
in the surrounding environment [82]. The genes regulated by AI-2 include virulence 
genes implying that AI-2 is capable of altering the P. aeruginosa gene expression and 
pathogenicity [82].  
An additional contributor to chronic biofilm infections are persister cells. 
Persisters, as discussed earlier are dormant variants of regular cells that form 
stochastically in microbial populations and are highly tolerant to antibiotics. 
Interestingly, QS does not appear to have an effect on the formation of these cells. 
Initial evidence suggests that presence of AI-2 does not increase or decrease the 
incidence of persister cells [65]. 
While QS in itself is not required for the growth and survival of bacteria, it is the 
key mechanism responsible for the severity and pathogenicity of infections. Hence, 
understanding this mechanism has been a key focus over the past two decades. 
Additionally, research involving development of methods to inhibit QS has been 
pursued as an alternative treatment method [83-85]. QS inhibition and other methods 





1.3.2 Biofilm Treatments 
The high resistance to antibiotics renders traditional antibiotic therapy ineffective 
in treating biofilm infections. Hence alternate methods of treatment for both 
preventing and treating biofilms are being pursued by the scientific community at 
large. Some of these alternative treatment methods are discussed in this section. 
 
Antimicrobial Coatings  
In the pathogenesis of biofilm infection around implants, initial adhesion of 
bacteria onto biomaterial surfaces is believed to be a critical event [86]. For example, 
titanium, a biomedical implant material of choice due to its biocompatibility, is 
known to be susceptible to bacterial colonization and biofilm infections because of a 
surface protein layer that is formed under physiological conditions [87-90]. Since 
antibiotic treatments are ineffective in treating implant related biofilm infections, one 
of the major biofilm treatment methods under research is the use of antimicrobial 
surface coatings or surface modifications to prevent biofilm formation.  
Antibiotic loaded coatings for implants have been tested in both in vitro and in 
vivo models as a method for preventing implant related biofilm infections. 
Specifically, antibiotics have been loaded into porous hydroxyapatite (HA) or sol-gel 
coatings on titanium implants [91,92]. The antibiotic-HA coatings show an improved 
prevention of infections compared to standard HA coatings in in vivo models, 
although fabrication of these coatings with clinical relevant doses of antibiotics and 
timely release of the antibiotics are a challenge [93-98]. Besides antibiotic-releasing 





realize long lasting antibacterial ability. Unlike non-covalent coatings, covalently 
bonded antibiotics are not released from the surface during bacterial infections. This 
method has shown some promise as these modified surfaces exhibit prolonged 
prevention of biofilm formation when tested using in vitro models. However, a 
protein layer is formed on the surface under physiological conditions and the efficacy 
of the covalently bonded antibiotics in preventing biofilm formation in vivo is still 
under doubt [87]. Although antibiotic coatings (covalent and non-covalent) seem 
promising there are many outstanding issues. Apart from the challenges of fabrication 
and the timely release of the drug, the use of antibiotics could potentially lead to the 
emergence of many more antibiotic-resistant strains. Furthermore, it has been 
reported that some drug carriers release the antibiotics at levels below the minimum 
inhibitory concentration (MIC) for long after the implantation (~ 6 years) [99]. Such 
prolonged exposure could lead to toxic side effects including damage to DNA, 
proteins and lipids in human cells that may harm regular cellular functions [100,101]. 
To avoid the risk of emergence of antibiotic resistance strains as a result of use of 
antibiotic coated surfaces to treat biofilms, non-antibiotic coatings like chlorhexidine, 
chloroxylenol, and poly(hexamethylenebiguanide) have been investigated [102,103]. 
However, several studies have suggested that use of these non-antibiotic 
antimicrobials may cause cell damage [100]. Furthermore, effective ways to fabricate 
these antimicrobials and controlled elution still remain a challenge.  
One of the inorganic antimicrobial agents that has shown some promise as an 
infection-preventing surface modification in the recent past is silver. Some of the 





broad antibacterial spectrum to both Gram-positive and Gram-negative bacteria and 
most importantly is believed to be less prone to resistance development [104-107]. 
Initial in vitro studies show that silver has excellent biocompatibility without 
genotoxicity or cytotoxicity and in vivo studies have indicated that silver coatings 
have no local or systemic side-effects [108-110]. Additionally, fabrication of silver 
doped materials is easy due to the stability of the element. While other inorganic 
antimicrobial agents like zinc, copper, calcium, fluorine, and nitrogen have been 
studied, none have been as widely investigated as silver [111]. However the 
mechanism of antimicrobial activity of silver is still not well understood and further 
clarification of its bactericidal properties is much need to broaden its clinical 
applications. Also some research suggests that use of silver compounds can not only 
lead to development of bacterial resistance but also toxicity in rats [112-115]. Hence, 
further investigation into the potential side effects of silver as a biofilm inhibiting 
agent is required. 
 
Surface Modifications 
The surface characteristics like surface chemistry, surface energy, roughness, 
hydrophobicity, and surface potential play a crucial role in the initial adhesion of and 
growth of bacteria on the surface. Hence a bacterial adhesion-resistant surface can be 
fabricated by modifying these surface properties.  
Various studies implementing different surface modifications including 
modification of the physical and chemical properties of the surface through UV 





conducted [116,117]. Anti-adhesive surface polymers have also been developed and 
their anti-adhesion properties were tested in both in vitro and in vivo models [118-
120]. In in vivo systems, although the adsorption of plasma proteins encourages 
biofilm formation, microbial growth is strongly delayed on the coated surfaces [120]. 
Biofunctionalization with antibacterial bioactive polymers like chitosan and 
hyaluronic acid have also been performed. These polymers possess the ability to 
inhibit bacterial adhesion and/or kill the bacteria [121-123]. Chitosan is noted for 
various biological properties including biocompatibility, biodegradability into 
harmless products, nontoxicity, physiological inertness, remarkable affinity to 
proteins, and antibacterial, hemostatic, fungistatic, antitumoral, and anticholesteremic 
properties [124]. However, the binding affinity and bonding strength of chitosan to 
various materials is smaller than that reported for other coatings. Also, further in vivo 
studies to understand its performance are necessary for the widespread use of chitosan 
as an antimicrobial surface coating. 
Surface microtopography has also been shown to play a crucial role in bacterial 
adhesion and biofilm formation. It has been observed that some unique patterns or 
certain surface microtopographies prevent microorganisms from settling and growing 
on the patterned surface. For example, SharkletTM, an ordered, microscopic surface 
pattern, inspired by the skin of sharks, is micropatterned as an anti-adhesion surface 
treatment [125,126]. The skin of sharks was chosen as the ideal surface topography, 
as the shark is the only mobile marine creature whose skin does not foul. It is 







Figure	 1-4	 Sharklet™	 topography	with	 2	 μm	 feature	 width	 and	 spacing	 and	 3	 μm	 feature	 height.	 (A)	 Light	
micrograph	of	 sharklet	 topography	on	PDMS.	 (B)	and	 (C)	Scanning	electron	micrographs	 (SEMs)	 captured	at	
different	angles.	Reproduced	with	permission	from	[127].	
 
prevents the adhesion and growth of microorganisms on it. The SharkletTM 
micropattern, fabricated using PDMS shown in Figure 1-4, was observed to delay the 
onset of bacterial colonization. The smooth PDMS surface exhibited early-stage 
biofilm colonies at 7 days and mature biofilms at 14 days, while the topographically 
modified surface did not show evidence of early biofilm colonization until day 21. 
[127]. Other microtopographies for biofilm prevention are currently under 
investigation, as is optimization of the dimensions of the topographies [128,129].  
 
Bioelectric Effect 
Application of electric fields in combination with antibiotics has been observed to 
enhance the biocidal effect of the antibiotics in a phenomenon termed the bioelectric 
effect [130,131]. A number of hypotheses for the mechanism of action of the 
enhanced biocidal effect have been proposed. One of these suggests that the 
application of electric fields promotes the penetration of the antibiotic into the biofilm 
either through the application of an electrophoretic force or due to an increase in the 





inside the biofilm results in an improved treatment efficacy of the antibiotic. It has 
also been suggested that the electrochemical generation of various oxidant species 
due to the application of electric fields may play a significant role in the increased 
efficacy of this treatment method. Also, the delivery of increased oxygen to the 
biofilm due to electrolysis may be the cause for this enhanced treatment efficacy 
[130,132,134]. Yet other research postulates that the biofilm may expand and contract 
depending on the polarity of an applied alternating current electric field, and thereby 
enhance convective transport of antibiotics into the biofilm [132]. 
The BE throughout literature, has been implemented by application of either an 
AC or DC field in combination with antibiotics. In our group, a super-imposed 
electrical signal was applied in combination with near-MIC levels of antibiotics 
[135,136]. The use of different modes of electrical energy (AC and DC) allowed for 
the application of higher electrical energies, at which significant inhibition was 
observed, using lower voltages that were below the limit for water electrolysis (0.82 
V). This is an important advancement in the field of biofilm treatment, as this allowed 
for the application of higher energy BE without the generation of gaseous species 
within the solution. Previous work in our group conducted by Kim et al. further 
demonstrates the efficacy of the BE without any significant bulk electrolysis. While 
localized hydrolysis may be a contributing factor to the biofilm removal by the BE, 
the exact mechanism of action is still unknown. Furthermore, characterization and 
optimization of the electrical parameters and the antibiotic concentration needs to be 





damage the surrounding microflora or host cells near the biofilm when an electric 
field is applied. 
 
Quorum Sensing Inhibition 
QS inhibition is considered an ideal biofilm treatment method as QS does not 
influence cell growth or viability. Consequently, many research groups have 
developed new QS inhibitors and many studies have been performed on QS inhibitors 
with the hypothesis that development of resistance to these inhibitors will either not 
occur or will be delayed. Much work has been performed in developing such 
inhibitors, analogs of AHLs and AI-2 [83-85]. The effect of these analogs on QS and 
biofilm formation has been studied and verified [137,138]. In vitro and in vivo studies 
show that these small molecule inhibitors or analogs prevent biofilm formation and 
work synergistically with antibiotics [139-141].  
Since AI-2-based QS is found in over 70 species of bacteria, AI-2 analog 
development may have significant impact in controlling and treating biofilm 
infections [83]. Many AI-2 analogs have been shown to be effective QS inhibitors 
[73,142,143]. In previous work conducted by our collaborators, C-1 alkyl analogs of 
AI-2, including isobutyl-DPD, were developed and demonstrated to be highly 
effective broad species QS inhibitors in E. coli, S. typhimurium and V. harveyi 
[141,144]. An illustration of the mechanism of action of AI-2 analogs in E. coli is 
shown in Figure 1-5. Isobutyl-DPD is phosphorylated by LsrK in E. coli and inhibits 





Gamby et al. also showed that phenyl-DPD, a different C-1 alkyl analog, inhibits QS-




DPD	binds	 to	 the	 repressor	 LsrR	derepressing	 the	 lsr	operon	and	 switching	on	 the	expression	of	 related	QS	
genes.	 Phospho	 iso-butyl-DPD	 binds	 to	 the	 repressor	 LsrR	 repressing	 the	 lsr	 operon	 and	 turning	 off	 the	
expression	of	related	QS	genes.	Reproduced	with	permission	from	[141].	
 
While AI-2 analogs that can inhibit QS in several types of bacteria have been 
developed, no studies have been performed to date to investigate the efficacy of the 
combinatorial treatment of AI-2 analogs used in conjunction with electric fields. Such 
studies could lead to the development of a novel treatment for biofilm infections that 
is independent of traditional antibiotic therapy. 
 
1.3.3 Evaluation of Biofilms 
In developing the field of biofilm science, various new techniques and formats to 
evaluate biofilms have been employed by researchers through the years. This section 







Macroscale Biofilm Reactors 
Broadly, biofilm reactors can be divided into static biofilm reactors and flow 
cells. Static biofilm reactors allow for the growth of biofilms in a static environment 
where the media is replenished only periodically. The most common format for 
growing biofilms in a static environment is using microwell plates. Microwell plate 
readers are a staple to every microbiology and biotechnology laboratory. 
Furthermore, automated systems for filling and mixing reagents in microwells exist 
that allow for easy handling and experimentation of biofilms.  
As opposed to static biofilm reactors, biofilms can also be grown under flow, 
which provides a continuous supply of nutrients to the biofilm in addition to aiding in 
continuous removal of planktonic cells, separate from the biofilm, from the system; 
an added advantage over static systems. Flow cells typically have one inlet, one 
outlet, and one channel throughout which biofilms are grown. The biofilms grown in 
these devices can be monitored continuously using a microscope, however this 
requires that the device be mounted on a transparent substrate. Some of the 
commonly used flow reactors are presented below. 
The modified Robbin’s device is a commonly used method for evaluation of 
biofilms. The device, shown in Figure 1-6, consists of a main channel that contains 
multiple specimen plugs on which biofilms can be grown. After biofilm growth, these 
plugs can be removed and the biofilm grown on the plugs can be subject to various 
experiments [15]. Although the biofilms are grown in parallel, their analysis remains 







Figure	 1-6	 A	 Schematic	 of	 two	 parallel	 modified	 Robbin’s	 devices	 showing	 the	 specimen	 plugs	 and	 the	
apparatus	required	to	provide	continuous	flow	of	media.	Reproduced	with	permission	from	[15].	
 
The Calgary biofilm device combines the microwell plate with the ability to apply 
shear stress through flow as provided by the modified Robbin’s device [11]. The 
device has two components, a pegged lid and a bottom with channels, shown in 
Figure 1-7. The pegs on the lid can be positioned over the channels or fitted into a 
traditional 96 well plate. The flow of the liquid in the channels can be directed around 
the pegs by placing the device on a rocking table. The biofilms grown on the pegs 
experience a constant amount of shear due to the flow of the fluid. They can be 
removed and analyzed individually as in the case of the Robbin’s device or the 
pegged lid can be inserted in a microwell plate filled with different antibiotics or new 
treatments that needs to be tested. A major drawback of this device is that imaging of 
the biofilms on the pegs using either confocal microscopy or scanning electron 












The CDC biofilm reactor (CBR) allows for the growth of biofilms under moderate 
to high fluid shear stress [146]. The reactor, shown in Figure 1-8, incorporates 24 
removable biofilm growth surfaces (coupons) for sampling and analyzing the biofilm. 
It consists of a 1 liter glass vessel with an outlet positioned to provide about 350 ml of 
working fluid capacity. The polyethylene lid supports eight independent removable 
rods that can each house 3 coupons, an inlet port, and a gas exchange port. The entire 
device is usually placed on a digitally controlled stir plate to provide constant rotation 
of the baffled stir bar at a designated speed that controls the amount of applied fluid 
shear. The CBR is used as a flow cell i.e. a continuous-flow stirred-tank reactor, by 
constantly pumping fresh media into and out of the reactor. The primary disadvantage 












Microscale systems are able to address many of the disadvantages and 
measurement challenges of their macroscale counterparts. The use of microfluidics 
allows for greater ease in controlling the fluidic environment and integration of 
microfabricated sensors or micropatterned growth substrates [147,148]. Additionally, 





systems require smaller sample and reagent volumes on the order of nanoliters. While 
larger samples of bacterial cultures are easy to obtain, it is often difficult to obtain 
larger volumes of reagents, antibiotics, or new drugs under research. In the recent 
past, several standard macroscale methods routinely used for the analysis of 
biomolecules, like electrophoresis and PCR have been successfully miniaturized into 
microscale systems [149,150]. 
While the simplest microfluidic systems, single channels or chambers, are 
miniatures of existing macroscale platforms such as microwell plates or flow cells, 
complex fluid handling architectures can be integrated with arrays of channels or 
chambers. On-chip pumps can provide tunable flow of solutions throughout a device 
whereas integrated valves can direct this flow to designated locations on demand. 
Integrating microfluidic valves into PDMS and using a pressurized gas to control the 
valve orientation, also known as Quake valves, is a popular valving scheme used in 
much of today’s microfluidic work [151-153]. 
Another significant advantage of using microfluidic systems is that they can be 
integrated with microfabricated sensors. These microfluidic LOC systems provide 
numerous advantages in biomedical research and clinical diagnostics and can be a 
valuable tool in the investigation of novel therapies. They enable functional 
integration with other technologies, leading to portability, and high-throughput usage. 
These translational technologies hold the potential to improve the resolution, 
regulation, sensitivity, and flexibility over more traditional approaches. Summarily, 
microfluidic LOC devices can provide a dense array of microfluidic channels and 





along with flow conditions similar to in vivo systems, and can include integrated 
sensors, all critical elements to new drug discovery [20-52,154]. 
 
End-Point Measurement Methods  
The most common method of quantifying biofilms is using the crystal violet stain 
[155,156]. In this method, crystal violet is applied to a biofilm, where it binds to 
negatively charged exopolysaccharides and molecules on bacterial cell surfaces. The 
excess unbound dye is rinsed out, following which the stain bound to the biofilm is 
solubilized into a second solution. The optical density of this solution of released dye 
is measured at 590 nm and directly corresponds to the biomass of the biofilm. While 
this is a standard method of biofilm measurement, the method suffers from 
variability. This is primarily due to the differences in stain penetration into the 
biofilm and variable binding of the dye to the cell wall. 
The most common high resolution methods used for imaging biofilms are 
confocal microscopy and scanning electron microscopy (SEM) [18,19,157,158]. 
Confocal microscopy allows for the imaging of biofilms that are comprised of 
fluorescent bacterial cells. Fluorescence can be obtained either by using a cell line 
that is engineered to produce a fluorescent protein like the green fluorescent protein 
(GFP) or by staining the biofilms using commercially available kits like the 
Filmtracer™ LIVE/DEAD® Biofilm Viability Kit (Invitrogen Corp.). Given a 
fluorescent biofilm, confocal microscopy can generate a series of images along the z-
axis, called a Z-stack. By concatenating the various images of the Z-stack using 





three-dimensional representation of the biofilm can be obtained. Quantitative analyses 
of the biofilm can be performed using software packages like COMSTAT, developed 
by Heydorn et al. [159]. This provides morphological data like average thickness, 
maximum thickness, surface coverage, roughness etc., which allow for measureable 
characterization and comparison of different biofilms. However, a major drawback of 
this method of measurement is that it necessitates the use of bulky and expensive 
equipment and also requires pre-treatment of the biofilms with stains.  
SEM provides more detailed topographical information than confocal microscopy 
by virtue of its high resolution and independence of specific fluorescent markers. This 
technique can be used to evaluate the quality of the ECM and the interaction of the 
ECM with the cells in the biofilm [18]. Typically, biofilms are super-critically dried 
and coated with a metal and imaged under high vacuum conditions, thereby 
dehydrating the biofilm and preventing further growth. Environmental SEM or ESEM 
can be used to image the biofilm in a hydrated state, however imaging using ESEM 
requires low temperatures close to freezing and continuous interaction with the 
electron beam, preventing imaging through an enclosed biofilm reactor.  
 
Noninvasive Measurement Methods 
It is evident from the end-point measurement methods discussed in the previous 
section that the primary challenge in studying biofilms is observing the properties of 
the biofilm in a non-destructive manner. Although these methods are not used as 
commonly as the end-point measurement techniques discussed previously, a number 





have been developed [160]. Some of the common methods of non-invasive biofilm 
evaluation are discussed below. 
A common method of biofilm evaluation is using their electrical properties. Both 
cells and the ECM within the biofilm serve as a dielectric material and thereby 
provide an electrical impedance that varies with time or with composition of the 
biofilm. The electrical impedance of the biofilm can be measured using techniques 
like electrochemical impedance spectroscopy (EIS) or capacitive measurement 
techniques [161-163]. A detailed review of the concepts of impedance based sensing 
of biological samples especially biofilms is provided in Chapter 2. 
Another method of evaluating biofilm growth is using fiber optic sensors [160]. 
The biofilm can be quantified by observing its turbidity in the biofilm reactor. This 
can be implemented as a differential measurement system wherein one turbidity 
measurement is obtained from the biofilm and the other is obtained from a blank at a 
location where no biofilm exists [164].  
The Optical density (OD) measurement technique uses the same principle as 
above to characterize bacterial biofilms. OD measurements have been used for 
detecting the cell count in bacterial suspensions for decades. Similar to OD 
measurements for cell suspension, the OD of biofilms can be measured at a particular 
wavelength at various instances in time. This can be compared to a baseline or blank 
measurement obtained before biofilm growth or formation [165]. This change in OD 
from the baseline was compared to the optical thickness. While the two were not 
directly correlated it was observed that as the biofilm grows the optical density 





within the biofilm, similar to the OD measurements performed on bacterial 
suspensions using a spectrophotometer. Previous work by our group has 
demonstrated the viability of biofilm monitoring via the use of optical absorbance. 
Continuous optical sensing was achieved by integrating microscale flow cells with 
inexpensive off-the-shelf optical components like a broad band light source and a 
photodetector [136,166,167]. 
 
1.3.4 Microsystems for Biofilm Characterization, Sensing and Treatment 
Biofilm studies have been performed for decades using macroscale setups like the 
modified Robbin’s device and the microwell plate. However, more recently the study 
of biofilms using microfluidics has spawned research providing new insight on the 
various properties of biofilms including development of antibiotic resistance, biofilm 
growth characterization and the role of intercellular communication 
[141,157,166,168-170]. Furthermore, it has been suggested that small devices based 
on microfluidics will reduce the analysis time from days to the order of 2 to 4 hours 
with a more accurate specific recognition of the biological targets [171,172]. 
Biofilms grown in microfluidic devices have been observed to exhibit device-to-
device variability [16]. Due to this variability, many biofilm studies are conducted to 
only understand the trends of growth and treatment and rarely report more than three 
repetitions. One solution to this problem is to perform multiple biofilm 
characterization experiments in parallel on the same device with an integrated control 
[173]. This reduces inter-device variability, along with the advantages of high 





Although a majority of the biofilm studies performed in microfluidics utilize 
direct measurement of biofilm thickness using microscopy and image analysis, very 
few studies performed demonstrate real-time microsystem-based monitoring of 
bacterial biofilm during growth and treatment. Previous work conducted by our group 
demonstrated the sensitive real-time detection of biofilm growth using a surface 
acoustic wave (SAW) sensor and treatment system [154,174,175]. A schematic of the 
SAW sensor integrated with electrodes for BE treatment application is shown in 
Figure 1-9. Real-time detection of biofilms is achieved by measuring the resonant 
frequency of the SAW system, which is a function of the total biomass adhered to the 
surface of the sensor. As both biofilm growth and BE treatment cause a change in the 
adhered biomass, they can be measured in real-time by monitoring the resonant 
frequency of the system. Moreover, other studies that employ microfluidic platforms 
with interdigitated or parallel electrodes for impedance spectroscopy to detect biofilm 
formation have been performed [161,163,176]. However, the use of such a system has 










While microsystems have leveraged the properties of microfluidics to create 
environments more difficult to obtain with traditional biofilm reactors, very few real-
time integrated monitoring and treatment microsystems have been developed for 
biofilm sensing, treatment and characterization. The development and validation of 
such microsystems against traditional methods of biofilm sensing and 
characterization will allow for easy detection of biofilm formation and evaluation of 
new treatments for biofilm prevention and removal in real-time. 
 
1.4 Structure of Dissertation 
The preceding chapter presented the motivation behind this research along with a 
brief literature review to establish context for the performed research. Chapter 2 
discusses the theory and design of the microfluidic LOC system and its components. 
Chapters 3, 4 and 5 present the key results of this dissertation. Specifically, chapter 3 
presents the design and characterization results obtained for the valveless bifurcation-
based microfluidic biofilm sectioning device. Chapter 4 introduces alternate treatment 
therapies like the BE and its variations, alongside the results that show that the 
electrical energy is a key factor in determining the efficacy of the BE. Chapter 5 
presents the sensing and treatment results using the designed impedimetric 
microfluidic LOC system and its components. Lastly, chapter 7 summarizes the 
research work of the dissertation and concludes with a discussion of potential future 






Chapter 2. A Microfluidic Impedance Sensor-Treatment 
Platform: Theory and Design 
This chapter covers the design of the microfluidic impedance sensor platform. 
First, the theory and design of the valve-less microfluidic device is described. This is 
followed by a brief review of the basics of impedance sensing followed by a 
description of the design and operation of the impedance sensor. The final section 
describes the integration of the microfluidic device with the sensor.  
 
2.1 Bifurcation-based Microfluidic Platform  
2.1.1 Principle of Bifurcation 
Microfluidic systems offer significant advantages over macroscale systems 
including precise control and flow of fluid and particles. These particles can be rigid, 
immiscible liquid drops, vesicles, or biological cells. For this work, we developed a 
simple scheme based on the principle of bifurcation that allows for the equal 
distribution of the biological cells suspended in the media across all the microfluidic 
channels of the device. This will ensure reduced biofilm variability across the 
multiple channels of the device, thereby allowing more reliable comparison of the 
different treatment therapies within the same device. 
A bifurcation is a point where a channel splits into two channels. Bifurcation 
based devices have been used to direct particles or fluid along preferred paths in 
microfluidic devices or prevent them from entering certain microchannels. In a 





suspended particles are determined completely by the channel geometry and the way 
in which the channels are connected to each other [177]. Thus, it may be possible to 
control the direction of particle flow by controlling these device parameters. Since, 
this method of controlling suspended particles is solely dependent on the design of 
the channel, it is amenable to scale-up as compared to other methods of controlling 
particle flow, such as changing local flow rates or pressures.  
Roberts and Olbricht conducted experiments to examine the effects of 
microchannel cross-sectional shape and the angles between the bifurcation branches 
[177]. Figure 2-1 shows the schematics of the two different bifurcations studied by 
Roberts and Olbricht. Specifically, Figure 2-1a illustrates the schematics of a Y-
shaped bifurcation where the angles between the branches of the bifurcation  
 
 
Figure	 2-1	 Schematic	 of	 the	 two	 bifurcations	 studied	 by	 Roberts	 and	 Olbricht	 [177].	 The	 arrows	 indicate	
direction	of	fluid	flow.	(a)	A	Y-shaped	bifurcation	with	Ɵ1	=	Ɵ2	=	45°.	 (b)	An	oblique	bifurcation	with	Ɵ1	=	0°	







are equal (Ɵ1 = Ɵ2 = 45°) and Figure 2-1b shows the schematic of an oblique 
bifurcation with Ɵ1 = 0° and Ɵ2 = 135°. All the branches of the bifurcation (one inlet 
and two outlets) lie in the same plane, so that the overall geometry is determined only 
by the angles of the two outlet branches with respect to the inlet branch.  
Figure 2-2 plots the fractions of particles entering branch 1 (N1/NT) as a function 
of the fractional volumetric flow rate in branch 1 (Q1/QT), for both the Y-shaped 













cross-sections. As seen from Figure 2-2, equal distribution of the suspended particles 
(N1/NT=0.5) occurs only when the bifurcation is symmetric, as in the case of a Y-
shaped bifurcation with equal flow rates across both the outlet branches (Q1/QT=0.5). 
Furthermore comparison of the Figure 2-2aA (top) with Figure 2-2aB (bottom), 
suggests that for Y-shaped bifurcations the channel-cross-sectional shape does not 
strongly affect particle portioning. On the other hand, comparison of Figure 2-2a and 
Figure 2-2b, suggests that the bifurcation angles strongly affect particle portioning. 
Hence, a symmetric Y-shaped bifurcation device operating with equal flow rates 
through the outlet branches was chosen to ensure equal distribution of freely 
suspended bacteria and media between the outlet branches.  
 
2.1.2 Bifurcation Device Design 
Bacterial biofilms are the primary cause of infections in medical implants and 
catheters. The widespread use of antibiotics to treat biofilms is leading to the 
emergence of antibiotic-resistant bacterial strains, necessitating the development of 
alternative methods of treatment. However, the experimental evaluation of new 
treatment techniques is strongly hindered by the stochastic nature of biofilm growth 
[166]. Therefore, it is required to develop microsystems that can facilitate multi-
experiment studies for new treatment evaluation and also enable the growth of 








growth	 in	 the	 open	 center	 horizontal	 channel	 and	 sectioning	 of	 the	 uniform	 biofilms	 (valves	 actuated),	 (c)	










Figure 2-3 shows the schematics of different microfluidic channel configurations 
used for biofilm studies. While single channels (Figure 2-3a) provide an easy 
solution, the growth variance between the single channel devices was observed to be 
as high as 68% [166,178]. However, the growth variation within a single channel was 
observed to be less than 10% [178]. In previous work, we demonstrated an integrated 
microfluidic system with valve actuators to section a biofilm grown in a single 
horizontal channel (Figure 2-3b) [167,173]. Other complex, branched microfluidic 
platforms with valves have also been used for biofilm studies, but the uniformity of 
biofilms between channels has never been demonstrated [170]. A key challenge with 
these devices is the integration and fabrication of multiple microfluidic valves, which 
limits device scalability. Figure 2-3c shows the schematic of a valve-less device that 
enables biofilm sectioning using the principle of bifurcation. The device consists of a 
single inlet that bifurcates at ‘n’ levels or stages to 2n channels. The distribution of 
bacteria and media between the channels is ensured to be symmetric by controlling 
the bifurcation angles and the flow rates as discussed in the previous section [177]. 
Figure 2-4 shows a simple 2-level bifurcation device that bifurcates into 4 
daughter channels. During the growth phase the bacterial suspension and the media 
are introduced from the common source and the flow is directed from the single 
common inlet to the 4 outlets as shown in Figure 2-4a. Since the biofilms are grown 
simultaneously on the same device from the same source of bacterial suspension, the 
variability between the biofilms grown in the different channels of the bifurcation 
device is expected to be significantly lower than the variability in biofilms grown in 





be tested in the different channels of the same device. During treatment, the direction 
of flow is reversed as shown in Figure 2-4b. Different treatments can be flowed 
through each channel of the bifurcation device. By using one of the channels as a 
reference (control), we can ensure that the results of the various experiments 
performed on the same device are compared to a common control. This allows for 
streamlined parallel experiments to be performed on one biofilm grown in the same 
device under uniform growth conditions using a microfluidic design that allows for an 








2.2 Impedance Sensing  
Impedance based techniques have been used as a method of transduction for 
detecting and/or quantifying bacteria. Specifically, impedance microbiology (IM) has 





food industry, environment, health care etc. IM is based on the measurement of the 
change in impedance of the media or culture solution as a result of bacterial growth. 
However, so far the use of IM for the real-time sensing and treatment of bacterial 
biofilms in microfluidics has not been demonstrated. Also, the development of such a 
sensor with self-governing treatment capability will enable its use as a bench top 
platform for biofilm characterization and new treatment testing, as well as a novel 
technology for use in medical implants and catheters for effective biofilm 
management. In this section, the basic principles of impedance based sensing and the 
design of the impedance sensor are discussed. 
 
2.2.1 Impedance Microbiology (IM) 
A common method of evaluation of biological samples is using their electrical 
properties. In IM, the change in impedance is measured using a pair of electrodes that 
is submerged in the culture medium. This can be performed as either (i) a direct 
measurement, or (ii) an indirect measurement. In the direct measurement technique, 
the electrodes measure the change in bulk impedance of the solution with time as the 
bacteria grows. The impedance change is caused by the bacterial metabolism or due 
to ion release by the live bacteria in the medium. The ion release by the bacteria 
changes the ionic composition of the medium that changes its conductivity resulting 
in a change in the impedance. In the indirect measurement technique, the electrodes 
are not immersed in the growth media and hence do not directly measure the change 





potassium hydroxide (KOH), which absorbs the gases produced by the bacteria, that 
decreases the conductance of the KOH solution. 
To detect bacterial growth in real-time, the relative or absolute change in 
conductance, impedance or capacitance of the solution are measured at a given 
temperature. Figure 2-5a plots a typical impedance curve. At the detection time td, the 
decrease in impedance value exceeds the threshold value. This generally occurs at a 
bacterial count of approximately 106-107 cfu/ml [179]. Finally, the impedance growth 
curve plateaus when the bacteria have grown to a very high concentration. The 
detection time td is linearly related to the logarithm of the initial cell concentration 
(C0) as shown in Figure 2-5b. The slope and intercept of this line depends on the type 







While classical impedance microbiology uses either direct or indirect 





studies have found that the total impedance change during bacterial growth consists 
of two impedance change components that can be measured at different frequency 
ranges: (i) impedance change contributed by the media and (ii) impedance change 
contributed by the electrode/electrolyte interface, also known as electrode, or 
interface, or double layer impedance. The electrode impedance is dominant at lower 
frequencies (typically < 10 kHz) while the medium impedance is dominant at 
frequencies above 10 kHz. A simple equivalent circuit model can be used to 
understand the frequency dependence of both impedances on the total impedance. 
Figure 2-6b shows a simple equivalent circuit for the impedance between two 
electrodes of Figure 2-6a. The impedance of the circuit can be mathematically 
expressed as equation (2.1) below. 
 
𝑧 =  𝑅!! +  (
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)!     (2.1) 
 
where Rs is the solution resistance and Cdl is the double layer capacitance at the 
electrodes. The equation explains the impedance growth curve observed (Figure 2-6c) 
in which the impedance always decreases as bacteria grow as a result of the decrease 
in the solution resistance Rs and an increase in Cdl. As previously discussed, Rs 
decreases due to the bacterial metabolism, in which large uncharged molecules are 
metabolized into small charged molecules. On the other hand Cdl increases due to the 








(c)	 Plot	of	 observed	and	 fitted	 impedance	 versus	 frequency	 curve	 for	Salmonella	 typhimurium.	 Reproduced	
with	permission	from	[181].	
 
Similarly, interdigitated microelectrodes (IDEs) have been used for sensing of 
biological samples. The equivalent circuit model (Figure 2-6b) is still valid for the 
case of the interdigitated electrodes. However, the frequency ranges over which the 
double layer capacitance and the medium capacitance are dominant may change with 
the size of the electrode spacing and width. Yang et al. demonstrated the use of IDEs 
for sensing growth of bacteria. Specifically, in response to bacterial growth, a 30% 
change in the double layer capacitance and almost no change in the medium 
capacitance (-0.58%) was observed [182]. In this respect, IDE based systems are 
different from conventional electrode systems, in that the IDE measures the change in 
the double layer capacitance to monitor bacterial growth. The advantages of using 
IDE based impedance systems include a reduction in sample volume, low resistance, 





Impedance biosensors have been developed for the detection of bacteria in a 
sample, in which an antibody specific to the target bacteria are immobilized on the 
IDE surface. The IDEs probe the attachment of the bacteria to the antibody. The 
current through the system or the sensor signal is determined by the presence of an 
intact cell membrane bound to the antibodies. The impedance measurement can be 
performed in the presence or absence of a redox probe, and is referred to as Faradaic 
and non-Faradaic impedance measurements, respectively. The absence of a redox 








S. epidermidis 1 × 106 10 Hz Rs 32 % [169] 
S. typhimurium 7.6 × 101 1 MHz Rs 30 % [181] 
S. typhimurium 4.8 × 100 10 Hz Cdl 30 % [182] 
E. coli O157:H7 8 × 100 1 MHz Cdl 46.5 % [183] 
P. aeruginosa 1 × 106 1 – 100 Hz Cdl 15 % [184] 
P. aeruginosa 1 × 108 100 Hz  Cdl 10 % [185] 
 
on the electrode surface, primarily owing to the cell membrane that acts as an 
insulating layer (conductivity of the cell membrane is 10-7 S/m). Hence, the 
impedance measured is affected by changes in number, morphology and growth of 





sensor measures the change in impedance due to biological events like antigen-
antibody binding, oligonucleotide-DNA interaction etc. that occur on the electrode 
surface. Table 2-1 compares some of the current literature on pathogen detection 
using impedance spectroscopy techniques. Furthermore, the parameter analyzed and 
the relative change measured are also compared for both Faradaic and non-Faradaic 
measurement methods.  
 
2.2.2 Impedance Sensing of Biofilms 
In biofilms, both the cells and the ECM within the biofilm serve as a dielectric 
material and thereby provide the biofilm with an electrical impedance that varies with 
time, or composition, or metabolic state of the biofilm. Hence bacterial biofilms 
grown on the surface of microelectrodes can be modeled as an electrical circuit. One 
such equivalent electrical model is presented in Figure 2-7. Figure 2-7a presents the 
electrical model of a sterile culturing media that does not contain any bacteria. Figure 
2-7b-c presents the series and equivalent parallel electrical models when the biofilm 
and ECM grows between the two electrodes. In the circuit, the parameters represent 
the following: Cdl is the double layer capacitance, Rsol is the resistance of the media 
without bacterial cells, and Cbio and Rbio are the capacitance and resistance of the 
biofilm, respectively. When the bacterial metabolism causes a change in the first two 









(IDE).	 (a)	Circuit	model	 for	 sterile	culture	media	before	 inoculation	with	bacterial	 cells.	 (b)	Equivalent	 series	
and	(c)	parallel	circuit	models	after	biofilm	and	ECM	formation.		
 
The magnitude of the impedance of the three electrical circuits shown in Figure 
2-7 can be calculated using equations (2.2), (2.3) and (2.4) listed below. Paredes et 
al., calculated the numerical values of the various parameters by fitting these 
equations to the experimental data obtained for Staphylococcus epidermis biofilms 
[169]. 
  
𝑍 !  =  𝑅!"# +  
!
!"#!"
       (2.2) 
𝑍 !  =  𝑅!"# +  𝑅!"# +  
!
!"#!"
 +  !
!"!!"#
   (2.3) 
𝑍 !  =   
!!"# !!"#
!!"# ! !"!!"#!!"#!!"! !!"#
 +  !
!"!!"



















By fitting these or other equivalent models to the experimental data, specific 
electrical parameters of the system can be tracked and used to accurately sense the 
onset of biofilm growth.  
 
2.2.3 Impedance Sensor Design 
Literature review in the field of IM suggests IDEs as the preferred electrode 
configuration for the accurate sensing of biological samples. As the sensitivity of the 
impedance sensor is dependent on the electrode surface area that is exposed to the 
culture media and bacteria, IDEs provide an easy way to increase the surface area 
while keeping the size of the device in check. IDEs provide several other advantages 
including higher signal to noise ratio, low resistance and faster attainment of steady 
state.  
The distribution of the electric field or current over the electrodes is dependent 
primarily on the width and spacing of the fingers of the IDEs. Typically, the majority 
of the electric field is concentrated within a height of one-electrode spacing from the 
surface of the electrode. Since the designed microfluidic channels are 100 µm tall and 
the average thicknesses of biofilms grown in these channels are in the range of 5-30 
µm, initial electrode spacings and widths of 25 µm, 50 µm and 100 µm were chosen 
for the IDEs. These are similar to or in the order of the widths and spacings of IDEs 
used previously for biofilm sensing [169,176]. However, further optimization of the 
electrode width and spacing needs to be performed in order to achieve higher 






2.3 Integrated Sensor-Treatment Platform 
2.3.1 Operation of LOC Device 
The goal of this research is to develop a high-throughput microfluidic 
platform that can reduce growth variance of in vitro biofilms and closely mimic the 
conditions encountered in a clinical indwelling device. New treatment studies are 
severely hampered because of the stochastic nature of biofilm growth. This platform 
will enable multi-experiment studies simultaneously on uniform biofilms, thus 
facilitating reliable comparison between different experiments performed on the same  
 
 
















microfluidic device. The microfluidic LOC will be integrated with impedimetric 
sensor-treatment modules to accurately detect the onset of biofilm formation and 
perform biofilm treatment through the application of electric fields. A schematic of 
the proposed sensor-treatment LOC device is shown in Figure 2-8. As shown in the 
schematic, each channel has its individual integrated sensor-treatment module for 
real-time sensing and treatment within the channel. 
In our previous work, we used a valved microfluidic biofilm reactor to section 
uniformly grown biofilms. The microfluidic device was integrated with arrays of 
charge coupled devices (CCDs) as optical sensors to detect long-term biofilm growth 
by measuring the change in optical density (OD) [167]. While the signal obtained 
from the CCDs does not saturate with time, this method is not sufficiently sensitive to 
detect the small changes in OD during onset of biofilm formation. Impedimetric 
sensing using interdigitated electrodes provides an efficient method for detecting the 
early stages of biofilm formation based on the capacitance and resistance changes 
between the fingers of the sensor. This method has been recently employed in our lab 
to conduct on-chip ELISA as well as particle counting, demonstrating the capability 
to accurately measure small impedance signal changes due to particle/molecule 
presence in the space between the sensor electrodes [186-188]. In this dissertation, we 
integrate an impedimetric sensing and treatment modality with high-throughput 
bifurcation-based microfluidics into a microsystem and demonstrate reliable, real-
time, non-invasive, continuous sensing of the onset of biofilm formation. More 
importantly, we show for the first time, the use of the same IDEs to provide the 





time impedance monitoring was used to provide feedback to the IDEs so as to switch 
the electrodes from the low frequency-low voltage sensing mode to the high 
frequency-high voltage treatment mode that uses the principles of the BE.  
 
2.3.2 Expected Results and Challenges 
The microfluidic LOC is designed to reduce growth variance of in vitro biofilms 
by growing biofilms in multiple channels on the same device using the same bacterial 
suspension. Hence it is expected that the variance in biofilm thickness between the 
channels of the bifurcation device is lower compared to single channel microfluidics. 
The integrated impedimetric sensors allow for the real-time monitoring of the biofilm 
growth in each channel of the device. The total impedance and the interfacial 
capacitance in particular are expected to increase at lower frequencies as the biofilm 
grows with time. This is primarily due to an increase in surface coverage by the 
insulating bacterial cells on the surface of the sensor. However, the ionic conductivity 
of the bulk solution increases, thereby decreasing the impedance at higher frequencies 
as a result of the change in ionic composition at the electrode surface due to the 
metabolically active bacteria. By measuring the change in impedance between the 
channels of a device and multiple devices the onset of biofilm growth can be 
monitored and compared.  
To detect the onset of biofilm formation, a highly sensitive sensor that is capable 
of accurately measuring the attachment of a few cells onto the surface is required. 
However, increasing the sensitivity of the device could result in an increase in the 





be investigated. Furthermore, the sensitivity of the device depends on the active 
surface area of the electrodes that is exposed to the growth media. Since the proposed 
LOC is a microfluidic device, the active electrode area is significantly smaller when 
compared to macro or mm scale devices. In microfluidics, increased sensitivity is 
usually achieved by passivation of the IDEs using a stable dielectric; however such 
passivation would prevent the application of electric fields and currents through the 
biofilm during treatment [148]. Consequently, it is a challenge to increase the 
sensitivity of the system while ensuring easy and reliable application of electric field 
based treatment.  
Some methods of improving the sensitivity of the device without the use of a 
dielectric include designing fine IDEs with smaller electrode widths and spacings or 
using three-dimensional electrodes. Both these methods increase the active area of the 
electrode, thereby increasing measurement sensitivity. While the use of smaller 
electrode width and spacing will increase the sensitivity of the device, it will 
adversely result in a smaller linear range of operation of the sensor. This is due to the 
reduced electric field strength at heights greater than one electrode spacing distance 
above the IDEs. A way to mitigate this problem is by using a staggered IDE scheme 
that has multiple electrode widths and spacings. Such a configuration is expected to 
provide a larger linear range of operation and increased sensitivity. 
Treatment with AI-2 analogs has been previously demonstrated to reduce growth 
of bacterial biofilms [143,167]. Furthermore, application of novel combination 
therapies, including application of AI-2 analogs with small doses of antibiotics, and 





have both been previously demonstrated to significantly enhance biofilm treatment 
[141,189]. In this work, AI-2 analogs were combined with electric fields for the 
treatment and prevention of mature bacterial biofilm growth. The uptake of AI-2 
analog by the bacterial biofilm is currently a diffusion-limited process. It is 
hypothesized that the application of electric fields will provide the charged AI-2 
analog molecule with the required drift component that will allow for increased 
penetration of the QS inhibitor by the biofilm, enhancing treatment efficacy. 
Furthermore, application of this combination therapy as a preventative treatment is 
expected to result in greatly reduced biofilm formation due to QS inhibition of the 
planktonic bacteria.  
 
2.4  Chapter Summary 
This chapter covers the theory and design of the components of the microfluidic 
LOC sensor-treatment system. The basics of microfluidic bifurcations were 
discussed, following which an introduction to IM was presented. Specifically, IM as 
applied to bacterial sensing was discussed, and the advantages and disadvantages of 
IM-based sensing of biofilms were presented. The design of the microfluidic LOC 
was introduced and the expected results and challenges were examined. The 
experiments and results of biofilm characterization, sensing and treatment using the 
designed microfluidic LOC system, as well as the characterization of the effect of 






Chapter 3. A Bifurcation-based Valveless Microfluidic 
Biofilm Sectioning Device 
The ultimate goal of this dissertation is the development of a threshold-activated 
feedback biofilm sensing-treatment microfluidic system for effective treatment of 
biofilms right at the onset of formation. To achieve this, four individual goals 
introduced in chapter 1 viz., 1. Investigation of biofilm growth variance in bifurcation 
microfluidics, 2. Investigation of the effect of the electrical energy on the efficacy of 
the BE, 3. Study of a new combination treatment of AI-2 analogs with electric fields, 
and 4. Sensing and treatment of bacterial biofilms using the IDE-based impedance 
sensor were studied. The results of the first aim are presented in detail in this chapter. 
Here we present the results of biofilm growth and treatment using a simple 
microfluidic device that was designed based on the principle of bifurcation introduced 
in Chapter 2. I would like to acknowledge my mentor Dr. Mariana Meyer for her 
critical feedback and guidance without which this research would not have been 
possible. 
 
3.1 Comparison with Other Microfluidic Devices 
To highlight the importance of an integrated control and to assess the biofilm 
variability of the microfluidic bifurcation device, biofilm variability studies were 
performed in other microfluidic devices. Specifically, biofilm growth experiments 
were performed in both simple single channel microfluidics and the valved biofilm 





variability in biofilm growth between these microfluidic devices and the bifurcation 
device is presented below. 
 
3.1.1 Single Channel Microfluidics 
Biofilm growth experiments were performed in four simple single microfluidic 
channels. Each device was sterilized by flowing 70 % ethanol followed by DI at a 
flow rate of 100 µl/min. A culture of E. coli W3110, grown overnight at 37 °C at 250 
rpm, was diluted to an OD600 of 0.25 in LB media and introduced into the channel at a 
flow rate of 100 µl/min. This suspension is incubated in four devices under static 
conditions for 2 hours at 37 °C following which, sterile LB media was introduced at a 
rate of 10 µl/hr for 48 hours for biofilm growth. Fresh LB media is replenished every 
24 hours. Results from four devices are shown in Figure 3-1. The biofilm thicknesses 
obtained using the three confocal images taken for each of the four single channel 
devices are listed in Table 3-1.  
The results of Figure 3-1 show that the variation in biofilm thickness between the 
four single channel devices. Confocal images were obtained at the inlet, center and 
the outlet of each channel. The variation in biofilm thickness within a single channel 
device is observed to be 15.77 % at most and 9.05 % on average. However, the 
average biofilm thickness of the four devices is 19.78 µm with an average variation of 
13.58 µm or 68.62 %. This high inter-channel variability further illustrates the need 
for multiple experiments to be performed on the sections of the same biofilm grown 






















Biofilm Thickness (µm) 
Image 1 Image 2 Image 3 Average 
1 5.33 5.95 6.13 5.80 ± 0.42 
2 22.13 24.95 23.17 23.41 ± 1.43 
3 9.28 10.30 12.58 10.72 ± 1.69 
4 37.22 37.95 42.20 39.19 ± 2.81 
 
 
3.1.2 Microfluidic Valved Biofilm Segmentation Device 
As a solution to the biofilm variation problem, a multi-depth valved microfluidic 
device for biofilm segmentation was designed and fabricated in our group. The device 
consists of hydraulic actuated microfluidic valves (push-up and push-down 
configurations) that are used to section a mature biofilm into multiple (usually three 
or four) segments [167,173,178]. Figure 3-2a shows the schematic of a push-down 
three-segment valved device and its various modes of operation. It has also been 
previously demonstrated in our group that the total biomass of the biofilm can be 
indirectly measured by monitoring the change in optical density (OD) [136,166]. In 
order to measure biofilm growth in the sections of a four-segment valved biofilm 
segmentation device in real-time, a linear arrayed charge coupled device (CCD) was 





coli biofilm growth in each of the four sections of the device with respect to the 
baseline OD measured at time t=0 hours. The error bars represent the spatial variation 
of the biofilm across the length of the microfluidic section (N = 162 pixels along 
length of channel). After 24 hours of growth, the change in OD in each section is 
observed to converge to a single point. 
 
 





Statistical correlation was demonstrated between the OD measurements obtained 







the growth of a uniform biofilm across the center channel. After 24 hours of growth, 
the variation in biomass between the four sections was calculated to be only 9%, as 
compared to the 69% biomass variation seen in our previous work conducted in 
separate microfluidic channels. Although a sharp increase in OD, corresponding to an 
increase in biomass is observed around t=18 hours in some sections of the device 
during the biofilm growth, the OD then rapidly decreases and converges to a single 
point. We hypothesize that this reduction in biomass and therefore the convergence of 
the OD of the four sections of the device to a single point at t=24 hours is possibly a 
result of a self-leveling effect due to the increased shear experienced by the thick 
biofilms in the constricted microfluidic channels.  
A further comparison of the biofilm thicknesses was made using the confocal 
microscope images of the E. coli W3110 biofilms that were grown in the central 
channel of three different three-segment valved devices. The biofilms were grown for 
48 hours, following which they were stained and imaged using confocal microscopy 
following which they were analyzed using the COMSTAT software program [159]. 
Figure 3-3a plots the average thickness of biofilms in the three segments of the device 
for three different devices. The results show that the biofilms have a maximum of 2 
µm thickness variation within each device (13 % of the average thickness at most and 
7.2% of the average biofilm thickness on average). This is much smaller in 
comparison to the inter-device variability, which showed a 3.9 µm variation (23% of 
the average biofilm thickness). Figure 3-3b shows sample surface rendered confocal 
microscopy images using the Imaris software for each of the three segments of the 








average	 variability	 in	 biofilm	 thickness	 between	 sections/segments	 of	 the	 same	 device	 is	 observed	 to	 be	





Although, the average biofilm thickness variability between the sections of each 
of the segmentation devices (7.2 %) is very small as compared to the single channel 
microfluidics, a key challenge is the integration and fabrication of multiple PDMS 
valves for biofilm sectioning, thereby limiting scalability. However, the bifurcation 
device is a single-layer PDMS device that does not contain complex structures like 
microfluidic valves. Hence they are very easy to fabricate in comparison to the two-





not require hydraulic or pneumatic actuation to switch from biofilm growth mode to 
biofilm treatment mode, thus making the device more portable and easy to use. 
 
3.2 Fabrication of the Bifurcation Device 
The microfluidic bifurcation device can be fabricated using a simple two-step 
process. First, the mold for the device is patterned using traditional lithography 
techniques on a 4-inch silicon wafer using the negative photoresist KMPR 1050. 
PDMS (Sylgard 184, Dow Corning, USA) in the ratio of 10:1 silicone elastomer to 
curing agent is poured over the microfluidic mold, and cured at 60 ºC for 17 minutes. 
The devices are then peeled off the mold and the inlet ports are punched using a 
2 mm dermatological punch. They are then irreversibly plasma bonded to a number 1 
glass coverslip. Tygon tubing is connected to the inlets and outlets of the device using 
a tubing coupler, and the other end of the tubing is connected to a syringe pump 
(KDS-230, KD Scientific, USA). Figure 3-4 shows photographs of the single layer 2-
level bifurcation device with one port on the left end of the device and four ports on 
the right end of the device. Figure 3-4a shows a photograph of the PDMS 
microfluidic device when used in the biofilm growth phase. As shown, in this mode 
the media from the single inlet is distributed to all the channels of the device. In this 
mode, the 4 outlets of the device are connected to the syringe pump that is operating 
in withdrawal mode and the direction of the fluid flow is from the single inlet on the 
left to the multiple outlets on the right of the device. Figure 3-4b shows a photograph 
of the device when used in the treatment mode. As shown in the figure, the direction 





mode. Use of the syringe pumps in this mode ensures a constant flow rate through 
each of the four channels.  
Three bifurcation devices were tested for cross talk between the four channels of 
the device when operated in treatment mode. This was verified by flowing colored 
water (red and green) for three consecutive hours at a flow rate of 10 µl/hr through 
the four channels of the devices, as shown in Figure 3-4b. At the end of the three 
hours, the devices were observed to maintain laminar flow with no back-flow as 
evidenced by the unadulterated colored fluids in the channels. This demonstrates that 
the bifurcation device can be used at these flow rates or higher for testing multiple 




single	 inlet	 serves	 as	 the	 common	 source	 of	 bacterial	 suspension	 and	 growth	 media	 for	 all	 four	 channels	
during	the	growth	phase.	(b)	Photograph	of	bifurcation	device	during	the	treatment	phase.	Scale	bar	=	5	mm.	
 
3.3 Biofilm Growth 
In order to use the device for biofilm studies with integrated controls, biofilms 









the	 spatial	 variation	 of	 the	 biofilm	 (N	 =	 3	 images)	 in	 each	 channel	 of	 the	 bifurcation	 device.	 The	 average	
variability	 in	 biofilm	 thickness	 between	 the	 channels	 of	 the	 same	 device	 is	 observed	 to	 around	 7.1%.	 The	
















Channel 1 Channel 2 Channel 3 Channel 4 
1 12.65 ± 0.92 12.85 ± 1.93 13.48 ± 0.88 14.03 ± 2.14 13.25 ± 1.46 
2 9.95 ± 1.77 10.20 ± 1.71 12.35 ± 2.29 11.77 ± 1.41 11.07 ± 1.88 
3 9.27 ± 1.20 8.32 ± 1.14 9.53 ± 1.53 8.70 ± 0.09 8.96 ± 1.08 
 
channel can be compared to the experimental treatment channels as reliably as 
possible, knowing that prior to application of the treatment, all the channels were 
comparable. Uniformity of biofilms was verified by performing multiple growth 
experiments using E. coli W3110 biofilms in order to quantify the variation of biofilm 
growth between the channels of the microfluidic bifurcation device. The biofilms 
were grown for 72 hours, followed by staining, imaging and analyzing the biofilm for 
each channel of each device. 
Each device was sterilized by flowing 70 % ethanol followed by DI at a flow rate 
of 100 µl/min. A culture of E. coli W3110, grown overnight at 37 °C at 250 rpm, was 
diluted to an OD600 of 0.3 in Luria-Bertani (LB) media and introduced into the 
channels of the device set in the biofilm growth mode, at a flow rate of 100 µl/min. 
This suspension was incubated in the device under static conditions for 2 hours at 37 
°C to allow for bacterial adhesion to the channel floor. Following this, sterile LB 





media was replenished every 24 hours. Results from the three devices are shown in 
Figure 3-5a and samples of rendered confocal images are shown in Figure 3-5b-e. 
The colors in the image correspond to different components of the biofilm. The red 
represents dead cells, the green represents live cells and the blue represents the ECM 
of the biofilm. Specifically, the biofilm thicknesses in the various channels of three 
devices were compared. 
The results (Figure 3-5) show that the biofilms have very small thickness 
variation within each device (SD < 1.2 µm, 10 % of the average thickness at the 
maximum, as compared to the inter-device variability of 21%). Table 3-2 lists the 
average biofilm thickness of each channel of each device and the average biofilm 
thickness across each device. Three confocal microscopy images were obtained for 
each channel of each device. A comparison of the average thicknesses between 
devices suggests that the variation between devices is large enough so that the biofilm 
in a device is significantly different from the biofilm in the other device (ANOVA, P 
< 0.05). The smaller intra-device variability as compared to the inter-device 
variability between the three devices highlights the importance of an integrated 
control. These results confirm that biofilm thicknesses within each device are more 
uniform than biofilms grown between devices. The simple microfluidic platform 
developed herein will now be used to test new potential biofilm treatments. 
 
3.4 Discussion 
In this work, biofilm growth in various variations of microfluidic channels was 





variation within the channel while inter-device variability was measured to be as high 
as 68.62%. This device to device variability makes new treatment testing challenging 
in microfluidics, as comparison between channels becomes unreliable. Valved 
microfluidic devices provide a solution to this problem by using microfluidic valves 
to section a uniform biofilm grown within a single channel. Such sectioning allows 
for the introduction of multiple treatments into the different sections of the channel to 
enable true reliable comparison of the treatment efficacies.  
While microfluidic valves provide a true solution to significantly reduce 
variability of biofilm growth, the challenges of device fabrication and microfluidic 
valve integration need to be addressed. As a consequence, device yield is significantly 
lowered when the valved devices are scaled to perform tens of experiments in 
parallel. To address this issue, in this work a simple valve-less biofilm sectioning 
device was fabricated and tested. The device worked on the principle of bifurcation 
and spatially sections biofilms. Using confocal image analysis the variability between 
the channels of the same device was shown to be similar to the variability observed in 
the valved microfluidic devices. The lack of valves enables a simple fabrication 
process and also allows for easy scalability to tens to hundreds of channels, without 
loss in yield, thus emphasizing the suitability of this platform for high-throughput in 
vitro characterization of both biofilm growth and treatment. 
 
3.5 Chapter Summary 
Microfluidic systems provide an efficient and convenient method for investigation 





modules. A key challenge of using microfluidics for biofilm studies is the large 
variability between channels or devices. This issue was addressed through the use of a 
simple bifurcation-based microfluidic platform that enables spatial sectioning of the 
biofilms. The sectioned biofilms could then subjected to different treatments in 
parallel and by using one of the sections as a negative control, reliable comparison of 







Chapter 4. The Bioelectric Effect – An Alternate Biofilm 
Treatment  
A promising method to increase the efficacy of antibiotics on biofilms is a 
combinatorial treatment based on applying electrical signals in combination with low 
doses of antibiotic, also termed the ‘bioelectric effect’ [133,190,191]. Costerton et al. 
[130] demonstrated improved biofilm treatment through the application of either 
direct or alternating current (DC or AC) electric fields [131,132,134,192-197]. Details 
of the fundamental mechanisms of the BE are still under investigation, and divergent 
hypotheses have emerged based on the type of the applied field. In the case of a DC 
voltage, the generation of radicals owing to media electrolysis is suggested as a 
principal factor [132,134,198]. In addition, some reports describe enhanced efficacy 
owing to improved antibiotic binding to biofilms [191,199] and enhanced biofilm 
detachment [200] from an external DC electrostatic force. In the case of the AC 
treatment, results indicate increased permeability of the exopolysaccharide matrix 
because of locally charged molecular vibrations [197]. Other reports note augmented 
effects from thermal stimuli [192] as well as electrolysis of the medium [199]. In 
general, investigating the mechanisms that underlie the BE on biofilms is difficult 
owing to their complex structures and the diverse stimuli [199]. 
In this chapter, we study the effect of electrical signal energy on the efficacy of 
the BE. This work could not have been possible without the assistance of Dr. Young 
Wook Kim and Dr. Konstantinos Gerasopoulos. I would like to credit Dr. Kim for 
performing the CFU count experiment and the bulk electrolysis quantification using a 





4.1 Effect of Electrical Energy on Efficacy of BE Treatment 
Given the divergent nature of the reports on the attributable mechanisms of action 
for DC and AC fields independently, a hypothesis that was examined in this work is 
whether their superposition could result in a synergistic treatment effect, by 
combining the reported benefits of both DC and AC fields, namely increased 
permeability of the exopolysaccharide matrix, and media electrolysis, biofilm 
detachment and improved antibiotic binding, respectively. To test this hypothesis, we 
treated biofilms with antibiotics under the application of a superpositioned (SP) field 
containing both AC and DC components. Interestingly, we observed that the 
treatment efficacy of the SP-BE was the linear sum of the individual treatment 
efficacies of the AC-BE and DC-BE. As the total energy of the SP-BE was the linear 
sum of the AC-BE and DC-BE, we investigated the effect of total electrical energy on 
BE treatment efficacy and established that the energy provided to the BE was the 
governing factor that dictated the efficacy of the treatment. Despite the number of 
studies of both AC and DC fields and their apparent successes, to date, no studies on 
the effect of the total electrical energy have been conducted. 
We treated E. coli biofilms [201] with DC, AC and SP electric fields in 
combination with the antibiotic gentamicin [141]. We tested the effect of the 
electrical signal energy on the efficacy of the BE by applying either a DC field, an AC 
field or an SP field, in combination with the antibiotic gentamicin (10 µg/ml) to 24-
hour mature biofilms in a macro-scale cuvette setup (Figure 4-11). Three sets of 
experiments were performed and the efficacy of treatment was measured: (i) the 





that the magnitude of energy of the SP signal was the sum of the magnitudes of the 
DC and AC signal energies, (ii) the amplitudes of the AC, DC and SP potentials were 
chosen such that each signal had the same magnitude of energy when applied over a 
period of 24 hours and (iii) increasing energies of the AC electrical signal was applied 
over a period of 24 hours. The effectiveness of the BE treatment was quantified by the 
crystal violet (CV) staining method and the live bacterial density results as measured 
by the colony-forming unit (CFU) assay. As the voltages selected were less than or 
close to 0.82 V, we were able to avoid electrolysis of the surrounding medium. The 
concentration of gentamicin (10 µg/ml) used in our experiments is significantly lower 
than what is typically necessary for biofilm treatment (500–5000 times the 
concentration compared with the minimum inhibitory concentration (MIC) of 
suspended bacteria, MIC = 2–5 µg/ml) [130]. Our experiments resulted in two key 
conclusions. First, we observed that biofilm BE treatment with an SP signal of higher 
electrical energy that was the sum of two smaller AC and DC energies resulted in a 
net treatment efficacy that was equivalent to the sum of the individual AC and DC 
treatment efficacies. Second, the application of electrical signals (DC or AC or SP) of 
the same energy in combination with a fixed concentration of gentamicin resulted in 
equivalent treatment efficacies. These results reveal that the signal energy, and not the 
type of electrical signal (AC or DC or SP), is the primary parameter that governs the 
mechanism of action of the BE. These conclusions were further confirmed when 
varying the BE energy, by changing the amplitude of an AC potential, resulted in a 





The results presented in this work bring to light that the mechanism of action of 
the BE is not different for AC or DC or SP fields for potentials <1 V, as reported 
previously. We hypothesize that the electrical energy applied to the treatment in the 
form of the DC, AC or SP signals provides the charged antibiotic molecule with 
additional drift that results in the enhanced efficacy of this treatment. The linear 
dependence of the BE on the electrical energy, enables deterministic modification to 
the treatment. In addition, BE dependence on the energy and not the signal type 
allows for more efficient utilization of nearby electronic resources. For example, in an 
in vivo BE treatment system, generation of on-chip AC signals from nearby 
electronics can be achieved more easily with higher efficiency as compared with 
generation of a pure DC potential. It also opens up the opportunity to transmit 
wireless power in the form of an AC signal so that future designs of in vivo sensor-
treatment platforms can include electronics for inductive power transmission. True 
understanding of the mechanism of action of the BE will thus allow for more 
flexibility and ease of integration of the BE into various applications in both the 
clinical and environmental fields. 
 
4.1.1 Electrical Amplitude Calculation 
For Treatment with Equivalent Energies 
To compare the effect of different types of electrical energy signals on biofilm 
treatment using the bioelectric effect, DC, AC and superimposed DC and AC fields of 





hour biofilms. The average energy E of the signals were calculated using the equation 
below [202] 
 
𝐸𝑠𝑖𝑔𝑛𝑎𝑙 =  1𝑅  (𝐴+𝐵𝑠𝑖𝑛(𝜔𝑡))
2 𝑑𝑡𝑇0     (4.1) 
 
where A is the amplitude of the DC potential, B is the amplitude of the AC 
component of the signal, T is the duration of application of the electrical signal, R is 
the resistance of the system and ω is the frequency of the AC signal. 
Using equation (4.1), the energy of the SP-BE treatment (0.5 V DC and 0.5 V AC 
at 10 MHz) can be calculated as shown in equation (4.2) below. The resistance of the 
system is assumed to be primarily from the glass coupon. Using the resistivity of 
Pyrex glass as 4 MΩ-m, the resistance of a glass coupon is calculated to be 4,000 GΩ. 
 
𝐸𝑆𝑃−𝐵𝐸 =  1𝑅  (0.5+ 0.5𝑠𝑖𝑛 𝜔𝑡 )
2 𝑑𝑡𝑇0    (4.2) 
 
The amplitudes of the pure DC signal and pure AC signal at 10 MHz can then be 
calculated such that equation (4.3) below was satisfied. We assume that R is constant 
across all the experiments. 
 
𝐸𝑆𝑃−𝐵𝐸 =  𝐸𝐷𝐶−𝐵𝐸 =  𝐸𝐴𝐶−𝐵𝐸     (4.3) 
 
The amplitudes of the DC and AC signals were calculated to be 0.613 and 0.866 





0.82 V; however, the amplitude of the AC field was calculated to be slightly higher 
than that of 0.82 V. Nevertheless, application of an AC field of 0.866 V at 10 MHz 
did not result in significant electrolysis. 
 
For Treatment with Varying Energies 
To demonstrate the relationship between applied BE energy and the efficacy of 
treatment, increasing energies of the same type of electrical signal was applied in 
combination with 10 µg/ml of gentamicin to 24-hour mature biofilms. Varying 
amplitudes of a 10 MHz AC signal were used and the energy of the applied potential 
was calculated using equation (4.1). The potentials chosen were in the range of 0–0.9 
V, within the limit of electrolysis, to avoid bulk electrolysis of the media. 
Specifically, four amplitudes of the AC signal: 0 V (control), 0.3, 0.6 and 0.866 V 
were applied to 24-hour mature E. coli biofilms in combination with 10 µg/ml of the 
antibiotic for 24 hours. The total biomass quantified after treatment with the varying 
electrical energies is normalized to the control to successfully and reliably combine 
multiple runs of the experiment. A linear fit of the data was performed using Origin 
Pro software (OriginLab Corporation, Northampton, MA, USA). 
The data were inspected by an outlier checker programme (GraphPad Software, 
La Jolla, CA, USA, α = 0.05) to eliminate outliers from the raw data. With the data, 
we performed analysis of variance (ANOVA) to investigate the significance of each 






4.1.2 Effect of Varying Energies and Field Types 
Results for CFU Assay  
To test the efficacy of the BE treatment, 24-hour mature E. coli K-12 W3110 
biofilms were subjected to different fields. The concentration of the antibiotic was 
maintained at 10 µg/ml across all the treatments. The amplitudes of the different 
electrical signals—namely AC, DC and SP, used for the treatment are listed in Table 
4-1. The viable cell counts of the E. coli K-12 W3110 biofilms exposed to the BE 
treatments of different energies were analyzed using the CFU assay method. The 
reduction in viable cells (R) for each of the BE treatments was then calculated by 
subtracting the viable cell count of the untreated control biofilms. A plot of the 
reduction in viable cells is plotted for the different BE samples in Figure 4-1. 
It is interesting to note that the reductions in biomass as measured using the CFU 
count method are proportional to the net energy applied to the BE treatment. As 
 shown in the figure, the reduction in viable cells due to the AC-BE is the lowest 











1. AC-BE 10 µg/ml 0.5 V at 10 MHz 2.7 nJ 
2. DC-BE 10 µg/ml 0.5 V DC 5.4 nJ 
3. SP-BE 10 µg/ml 
0.5 V DC + 0.5 V 
















treatment. This is followed by the DC-BE, which shows a reduction of ~ 1.6 × 108 
CFU/ml (RDC-BE). Although the DC-BE has the same signal amplitude as the AC-BE 
(0.5 V), it provides twice the energy to the BE treatment, which results in twice the 
reduction in viable cells (Figure 4-1). The SP-BE, which is the superposition of the 
AC-BE and the DC-BE signals, results in the highest reduction in viable cells of 2.2 × 
108 CFU/ml (RSP-BE). Moreover, treatment with the SP-BE energy (ESP-BE = EAC-BE + 
EDC-BE) results in a reduction in viable cells (RSP-BE) that is not significantly different 
from the linear sum of the reduction in viable cells owing to the AC-BE (RAC-BE) and 





verified that the superposition of the AC and DC signals did not result in a synergistic 
treatment effect as hypothesized. However, the results suggest that the BE could 
depend on the energy provided to the treatment. Hence, further experiments to 
understand the effect of varying energy on the efficacy of the BE treatment were 
performed. 
 
Results for CV Staining Method  
After treatment with the different BEs for 24 hours, the biofilms were quantified 
using the CV staining method. Negative controls, i.e., treatment with only antibiotic 
(no electric field) and pure LB (no antibiotic or electric field) were also performed. 
The results of this experiment are shown in Figure 4-2. 
Figure 4-2a plots the total biomass of the biofilms for the various treatments applied. 
Treatment with only antibiotics at near MIC concentrations resulted in a very small, if 
negligible, reduction in biomass. This is expected as biofilms are known to have 
increased antibiotic resistance and require at least 500–5,000 times the MIC dosage of 
antibiotics for effective treatment [1,6,55,60]. Treatment with the AC-BE, DC-BE 
and the SP-BE resulted in significant reduction in bacterial biomass as compared with 
the controls (ANOVA P < 0.05). Approximately 50% reduction in total biomass is 
observed when biofilms are treated with the DC-BE, as compared with the untreated 
controls (ANOVA P < 0.05). Treatment with the SP-BE that has almost 1.5 times the 
energy as the DC-BE resulted in a significant decrease in total biomass (ANOVA P < 
0.05) of 50% over the DC-BE, or an overall decrease of almost 71% as compared 



















The total biomass, as measured using the CV staining method, is also plotted as a 
function of the total energy applied with the BE (Figure 4-2b). The biofilms treated 
with only 10 µg/ml of the antibiotic gentamicin is plotted as the control (treatment 
with no electrical energy). Again a strong linear dependence of the treatment efficacy 
on the applied BE energy is observed (r2 = 0.950). These results further demonstrate 
that the super-position of the two types of fields, AC and DC, during the BE treatment 
does not result in a synergistic effect. Rather, the energy of the electrical signal may 
have a key role in determining the efficacy of the treatment. 
 
4.1.3 Effect of Varying Field Types of Equal Energies 
Results for CV Staining Method  
To verify whether the electrical energy supplied to the BE treatments is the 
dominant factor affecting the efficacy of the BE treatment, AC-BE, DC-BE and SP-
BE treatments of the same energy were applied to 24-hour mature E. coli biofilms 
over 24 hours. The energies and potentials of the AC, DC and SP signals were 
established using equation (4.3), and are tabulated in Table 4-2. After treatment, the 
biofilms were stained using the CV staining method and the OD at 540 nm was 
recorded. A plot of the OD540 for the different BE treatments and the control is shown 
in Figure 4-3. 
As seen from Figure 4-3, the AC-BE, DC-BE and SP-BE treatments with 
equivalent energies result in a similar reduction in bacterial biomass (ANOVA P > 






Table	 4-2	 Table	 summarizing	 the	 magnitude	 of	 voltages	 used	 to	 test	 the	 effect	 of	 equivalent	 energies	 of	
different	signals	on	BE	treatment	efficacy	to	treat	mature	E.	coli	biofilms.	Reproduced	from	own	publication	
[203].	







1. AC-BE 10 µg/ml 0.866 V at 10 MHz 8.1 nJ 
2. DC-BE 10 µg/ml 0.613 V DC 8.1 nJ 
3. SP-BE 10 µg/ml 
0.5 V DC + 0.5 V 










resulted in an 82.55%decrease and the SP-BE resulted in an 88.15% decrease in total 





equivalent energies resulted in an 84.76 ± 5.32% average reduction of total biomass 
as compared with the control. This illustrates that the type of electrical signal used 
(AC, DC or SP) does not affect the efficacy of the BE treatment. Furthermore, these 














Results for Fluorescence Microscopy  
To visualize the effect of the BE treatments on the biofilms, the treated biofilms 
were stained using Filmtracer LIVE/DEAD Biofilm Viability Kit and imaged under 
the fluorescence microscope. The images for the control, DC-BE, AC-BE and SP-BE 
biofilms are shown in Figure 4-4. The control biofilm is the densest, whereas the BE-
treated samples result in almost complete removal of biofilm. Furthermore, the three 
BE-treated biofilms result in a similar reduction of biomass as observed from the 
images of Figure 4-4. This correlates very well with the end-point results obtained 
using the CV staining technique presented in Figure 4-3. 
 
4.1.4 Effect of Varying Energies of Equal Field Types  
To determine the relationship between the BE energy and the treatment efficacy of 
the BE, mature E. coli biofilms were treated to different electrical energies of a 
similar signal type. As observed from the results presented in Figure 4-3, biofilm 
reduction does not depend on the type of electrical signal used for the BE treatment, 
i.e., AC or DC or SP. Hence, for these experiments, we arbitrarily chose to use AC 
fields. Specifically, varying amplitudes of a 10 MHz AC signal was used in 
combination with 10 µg/ml of the antibiotic gentamicin. The magnitudes of the 
voltages used are tabulated in Table 4-3. The biofilms were then stained using the CV 










same	 type	 of	 signal	 on	 BE	 treatment	 efficacy	 to	 treat	 mature	 E.	 coli	 biofilms.	 Reproduced	 from	 own	
publication	[203].	
S. No Sample 
Amplitude of 10MHz 
AC voltage 
Energy applied 
1. Control 0 V 0 J 
2. E1 0.3 V 1 nJ 
3. E2 0.6 V 3.9 nJ 
4. E3 0.866 V 8.1 nJ 
 
Figure	4-5	Plot	showing	the	linear	relationship	between	the	total	biomass	of	the	biofilms	as	measured	using	CV	
staining	 method	 and	 the	 voltage	 or	 energy	 of	 the	 electrical	 signal	 applied.	 The	 error	 bars	 represent	 the	







The results of increasing energy on BE treatment efficacy as measured using the 
CV staining method is plotted in Figure 4-5. We observe a decrease in total biomass 
with increasing energy supplied to the BE treatment. Specifically, the application of 
energy E3 = 8.1 nJ, through the application of a 10 MHz AC voltage of 0.866 V, 
results in an 80 % reduction in bacterial biomass. This correlates very well with the 
results previously presented in Figure 4-3, wherein application of the same energy 
level E3 through the use of either an AC, DC or SP voltage results in a similar 
decrease in total biomass. These results when taken together validate our hypothesis 
that the energy of the electrical signal is the primary factor in determining the efficacy 
of the BE treatment. 
 
4.1.5 Discussion 
In this work, the efficacy of treating biofilms with an electric field applied 
concurrently with antibiotic treatment was evaluated as a function of energy and type 
of electric signal (AC, DC or SP). We hypothesized that the superposition of DC and 
AC fields would enable the simultaneous application of all mechanisms previously 
attributed to both DC and AC currents individually. That is, a DC electric field can 
create a non-uniform distribution of electrolytes [199,204] and an AC field can 
increase biofilm permeability [197]. However, the results obtained in this work 
support the conclusion that the biocidal effects of the antibiotic can be improved to a 
similar extent when different types of electrical fields of equivalent energies are 
applied. Overall, our data demonstrate that the enhancement of biofilm treatment 





additional energy provided to the treatment and not owing to the type of electric 
signal used. Furthermore, we believe that the additional energy provided to the 
treatment allows for a stronger directed flow of the charged antibiotic molecule into 
the biofilms that results in the enhanced treatment efficacy. Hence, when higher 
energy is provided to the treatment either in the form of increased electrical potential 
or in the form of longer durations of treatment we expect to observe larger reduction 
in biomass. 
The magnitude of the voltages applied in this work is lower than the threshold 
potential of biological electrolysis of the medium (0.82 V) [205]. This was done to 
avoid the generation of hazardous radicals [132]. Often, in previous work, the applied 
voltages for analyzing the BE have been above 0.82 V (typically in the range of 2–5 
V/cm) [130,198,199]. In the study performed by Costerton et al. [130],5.0 times the 
MIC of tobramycin was used in combination with an electric field of 5 V/cm for 48 
hour to treat Pseudomonas aeruginosa biofilms. Treatment with this high-energy 
combination therapy resulted in almost a complete kill of the viable cells (<102 viable 
cells per cm2; ~106 reduction in viable cells per cm2). In another detailed study [195], 
the electrical enhancement of different classes of antimicrobials (antimicrobial 
concentration range of 1.0–32.0 times the MIC) on various bacterial biofilms was 
studied. Treatment with 200 and 2,000 µA in combination with the antimicrobials 
resulted in ~ 102–104.5 CFU/cm2 mean reduction in viable cells. Correspondingly, 
media electrolysis owing to the high external electric fields used has often been cited 
as one of the major contributors to the enhanced biocidal effects observed under 





media decomposition. These factors make the direct attribution of specific 
mechanisms of action difficult [190,199]. Furthermore, they make integration of such 
high voltage treatments in in vivo systems impossible. In comparison, in our work, we 
applied only 2.0 times the MIC of gentamicin in combination with low SP fields over 
24 hours and observed a decrease of 2 × 108 CFU/ml. 
In this work, we present effective treatment using voltages below those needed for 
electrolysis. We tested for bulk pH changes owing to electrolysis, using a pH 
indicator (#36828, Fluka Analytical) which changes color in the pH range of 4–10, 
after application of the SP-BE field to unbuffered LB media for 24 hours; results 
reveal no statistical difference relative to the control (no applied potential). This is in 
contrast to significant bulk pH change measured when the electrolysis threshold 
voltage of 0.82 V DC was applied (Figure 4-6, ANOVA P < 0.05). Samples subjected 
to AC or DC fields used here also exhibited no visible signs of bulk electrolysis 
relative to the control. We thus conclude that the application of electric fields used in 
this work does not induce any significant fluidic electrolysis. 
We also note that thermal effects can be induced by applying external fields, 
which might lead to misinterpretation of data. Temperatures greater than 45 °C result 
in biocidal effects as enzymes and proteins essential to biofilm growth processes are 
denatured [206]. Several studies, however, have reported that local heating from 
applied AC signals with field intensities of 2 V/cm was less than 1 °C for a 24-hour 
treatment. This temperature change did not affect bacterial growth [192,197]. As the 
applied field intensity in this work was lower than previous reports (2 V/cm), we did 








mL	of	 fresh	unbuffered	LB	growth	media	was	placed	 in	 the	cuvette	and	electrical	potentials	 (no	antibiotics)	
were	applied	for	24	hours.	The	potentials	applied	are:	AC:	0.5	V	at	10	MHz;	DC:	0.5	V;	SP:	0.5	V	DC	+	0.5	V	at	
10MHz;	 and	 the	 electrolysis	 threshold	 voltage	 of	 0.82	 V	 DC.	 No	 electrical	 potentials	 were	 applied	 to	 the	
controls	(pure	LB	media	or	pH	8	phosphate	buffer).	Since	electrolysis	induces	the	production	of	hydrogen	gas,	
the	solution	is	expected	to	become	more	basic18,	26,	34.	This	increase	in	pH	is	used	to	indirectly	quantify	the	
bulk	 electrolysis	 of	 the	 media	 due	 to	 application	 of	 electrical	 potentials.	 Following	 24	 hours	 of	 electrical	
potential	 application,	 two	drops	 of	 the	 pH	 indicator	were	 added	 to	 the	 solution	 and	 the	OD	 spectrum	was	
measured	by	the	spectrophotometer.	Since	the	peak	value	of	the	pH	8	buffer	solution	using	the	pH	indicator	
was	observed	at	616	nm	wavelength,	OD616	was	selected	to	quantify	the	electrolysis	effect.	As	observed,	only	
the	 samples	 to	which	 0.82	V	was	 applied	 and	 the	pH8	buffer	 positive	 control	 samples	 showed	 significantly	
higher	OD	 compared	 to	other	 treatments.	We	 thus	 conclude	 that	 application	of	 low	energy	electrical	 fields	
does	not	induce	significant	bulk	electrolysis.	Reproduced	from	own	publication	[203].	
 
Finally, we note that the BE is applicable to a broad range of microorganisms; 
hence, it cannot be generalized. Previous studies demonstrate that the BE can be 
extended to different species of bacteria and various antibiotics [195,207,208]. The 
enhancement in efficacy of the antibiotics through the use of electrical potentials is 





multiple parameters like the type of antibiotic, the antibiotic concentration and the 
electrical energy applied [195,196,209]. However, we suggest that when all other 
experimental parameters (bacterial species, antibiotic and antibiotic concentration) 
are kept constant, for the same magnitude of electrical energy applied, irrespective of 
the type of electrical signal, a similar increase in efficacy of treatment is expected to 
be observed. 
In summary, significantly improved treatment of biofilms was demonstrated by 
using electric fields in conjunction with the antibiotic gentamicin. It was observed 
that the BE supplied with higher electrical energy induced greater biofilm reduction 
than the BE with lower electrical energy for applied voltages less than the media 
electrolysis voltage. We further note that the type of electrical signal did not appear to 
affect the efficacy of the treatment indicating that the mechanism of action is not 
different for DC versus AC signals in this range of potentials (applied voltages less 
than 1 V). We suggest that the enhanced treatment efficacy of any BE treatment (AC, 
DC or SP) is primarily owing to the energy provided to the treatment that allows for 
either increased permeability of the membranes or the apparent improved diffusion of 
the charged antibiotics or both. We highlight that the intensity of the fields utilized 
here was below the electrolysis potential of the biological fluid. Hence, applications 
of this technique would minimize generating harmful radicals due to media 






4.2 Efficacy of Alternative Treatment Therapies 
Traditional treatments for biofilms include the use of high doses of antibiotics or 
surgical removal of the implant. However, in previous work performed in our group 
other alternative combinatorial treatments have been studied for the treatment of 
mature biofilms. The key results of these alternative therapies are presented below 
along with the results obtained for the new combination therapy that combines AI-2 
analog with electric fields. 
 
4.2.1 AI-2 Analog 
Small molecule QS inhibitors or AI-2 analogs are of particular interest as a 
method of treatment for bacterial biofilms as they aid in biofilm prevention by 
inhibiting QS. Analogs can be tailored to target different bacteria by modifying the 
alkyl group attached to the DPD backbone [143]. For example, iso-butyl DPD, an AI-
2 analog variant can be used to target E. coli biofilms. This was verified in both static 
and flow conditions by using a 96-well plate and a simple microfluidic flow cell. 
Figure 4-7 presents the results of E. coli W3110 and MDAI2 biofilm exposure to 
various concentrations of iso-butyl DPD in a microliter plate setup. The biofilms were 
grown in the wells of the plate for 24 hours at 37 °C, followed by treatment with 
various concentrations for an additional 48 hours. The AI-2 analog was diluted in LB 
and refreshed every 24 hours. The biofilms were stained using ECM matrix stain, 
Dimethyl methylene blue (DMMB), and a viable cell stain, Resazurin, as per the 










for	 AI-2-producing	 E.	 coli	W3110	 biofilms,	 and	 (b)	 non-AI-2-producing	 E.	 coli	MDAI2	 biofilms.	 The	 OD	 was	









polysaccharide intercellular adhesion (PIA) present in the ECM. Hence by measuring 
the amount of DMMB trapped in the ECM is directly proportional to the amount of 
ECM present in the sample. The redox dye resazurin, widely used for cellular 
viability testing, is a deep blue dye that is reduced to the pink resorufin proportionally 
to the amount of metabolically active cells present in the sample. Figure 4-7a plots 
the OD as a function of AI-2 analog concentration for E. coli W3110 biofilms. As 
seen from the figure, there is a significant decrease in the ECM produced and viable 
cell count with increased concentration of AI-2 analog. In contrast, Figure 4-7b plots 
the results for E. coli MDAI2 biofilms, a genetically engineered E. coli strain 
designed to not synthesize AI-2 that is critical to biofilm formation. As expected 
application of increased concentrations of AI-2 analog does not affect the viable cell 
count or the sparse ECM produced. 
Varying concentrations of iso-butyl DPD were also tested on E. coli W3110 
biofilms using a simple microfluidic flow cell (3 cm x 500 µm x 100 µm). E. coli 
biofilms were grown in the microfluidic channel for 24 hours at 37 °C, following 
which varying concentrations of AI-2 analog diluted in LB media was introduced at a 
flow rate of 10 µl/hr for 48 hours. The biofilms were then stained using Filmtracer™ 
LIVE/DEAD® Biofilm Viability Kit (Invitrogen Corp.) and imaged using an LSM 
710 Zeiss confocal microscope. The Z-stacks obtained were then analyzed using 
COMSTAT computer program [159]. Figure 4-8 plots the biofilm thickness (µm) and 
biomass (µm3/ µm2) of the imaged Z-stacks for varying concentrations of iso-butyl 







Figure	 4-8	 (a)	 Plot	 of	 biofilm	 thickness	 for	 various	 AI-2	 analog	 concentration	 as	 tested	 in	 single	 channel	
microfluidics	on	E.	 coli	W3110	biofilms.	 Treatment	with	 increasing	 concentration	of	AI-2	 analog	 results	 in	 a	
decrease	 in	average	biofilm	 thickness	as	measured	using	confocal	microscopy	and	analyzed	using	COMSTAT	







biomass across three confocal images. As seen in the figure below, there is a decrease 
in both biofilm thickness and biomass with increasing concentration of AI-2 analog. 
A comparison of the results show that a reduction in biofilm thickness and biomass is 
observed at an analog concentration of 50 µM in the flow cell as opposed to 500 µM 
in the static well plate setup. The better treatment efficiency in the flow cell is 
attributed to the continuous replenishment of nutrients and analog. 
The treatment efficacy of the AI-2 analog, iso-butyl DPD was also verified using 
a continuous monitoring CCD platform. E. coli W3110 biofilms were grown for 24 
hours at 37 °C in a microfluidic biofilm sectioning device. Following the growth, the 
center channel was sectioned into four segments by actuating the sectioning valves. 
Different treatments – control (LB media, section 1), antibiotic (gentamicin, 
10 µg/mL, section 2), a small molecule biofilm growth inhibitor, (AI-2 analog, iso-
butyl DPD, 100 µM, section 3), and a detergent (sodium dodecyl sulfate (SDS), 0.2%, 
section 4) – were introduced into the four sections of the device for an additional 24 
hours at the rate of 10 µl/hr. The control biofilm section was provided with LB media 
at the same flow rate as the other sections in order to provide a reference, thereby 
ensuring that the results of the treatments are compared to an integrated control. OD 
measurements were recorded every 8 minutes, across the length of the microfluidic 
channel, for each section of the device. These measurements enabled the monitoring 
of the spatio-temporal development of the bacterial biofilms in each section of the 
microfluidic device during treatment.  
Figure 4-9a plots the change in OD during the 24-hour biofilm treatment. The 





growth inhibitor, (AI-2 analog, 100 µM), and detergent (sodium dodecyl sulfate 
(SDS), 0.2%) applied to sections 2, 3, and 4 respectively – showed a reduction in 
biofilm growth compared to the control section (pure LB media, section 1). As seen 




length	of	 channel	 section)	 at	 representative	 time	points,	 during	biofilm	 treatment	 in	 the	 four	 sections.	 The	
section	 treated	with	 AI-2	 analog	 shows	 the	 least	 increase	 in	 biomass.	 The	 error	 bars	 represent	 the	 spatial	
variation	of	the	biofilm	in	each	section	of	the	microfluidic	channel.	(b)	Relative	percentage	change	in	average	
biomass	 calculated	 using	 the	 OD	measured	 after	 the	 biofilm	 treatment	 in	 each	 of	 the	 four	 sections	 of	 the	
microfluidic	optical	platform.	
(b)
=				abs	ODtreatment at	48	hrs – abs	ODtreatment at	24	hrs x	100____________________________________








slowest growth. This correlates with previously obtained results which demonstrate 
the efficacy of analogs to interrupt the bacterial communication in biofilms that is 
required for biofilm growth, thereby reducing increase of total biomass. The 
percentage relative change in average biomass was also calculated for each section of 
the device after the 24-hour treatment. It is calculated as the ratio of the increase in 
biomass after treatment to the total biomass formed at the end of the initial 24-hour 
biofilm growth. The equation used to calculate the percentage relative change in 
average biomass and the calculated values for each section are plotted in Figure 4-9b. 
As expected, the control shows the most significant increase in biomass, with a 166% 
relative increase in average biomass. Treatment with gentamicin resulted in a small 
decrease in biomass in comparison to the control and showed a 114% increase in 
average biomass. The AI-2 analog and the detergent (SDS) resulted in a similar 
reduction in biomass growth with relative change in average biomass of 68% and 
66% respectively. Specifically, the analog reduced the average biomass 88% more 
than the antibiotic. This further verifies the efficacy of AI-2 analogs to inhibit biofilm 
growth in comparison to the traditional antibiotic therapy. 
 
4.2.2 AI-2 Analog and Antibiotics 
The reliability of using the bifurcation platform as a test bed for biofilm treatment 
characterization and evaluation was verified by analyzing biofilms that were 
subjected to previously reported therapies using the protocols listed above. Presented 








Figure	 4-10	 Verification	 of	 biofilm	 treatment	 testing	 using	 the	 bifurcation	 device.	 (a)	 End-point	 confocal	
microscopy	of	the	combination	treatment	of	the	antibiotic	gentamicin	and	AI-2	analog	as	applied	to	24-hour	
E.coli	W3110	biofilms,	resulted	in	a	50.7	±	2.2%	decrease	in	biofilm	thickness	as	compared	to	the	control.	This	








antibiotic (gentamicin, 10 µl/ml), AI-2 analog (isobutyl DPD, 100 µM), and the 
combination of AI-2 analogs and antibiotics. As observed, the antibiotic treatment 
resulted in almost no change compared to the control (ANOVA, p = 0.1), as measured 
by biofilm thickness calculations using COMSTAT [159]. Treatment with 100 µM 
isobutyl DPD showed a slightly higher reduction of 17.4 ± 2.6% with respect to the 
untreated control and antibiotic treatment (ANOVA, p = 0.0014). However, treatment 
with the combination of near MIC levels gentamicin and 100 µM isobutyl DPD 
significantly enhanced the treatment and results in a decrease of 50.7 ± 2.2% 
(ANOVA, p < 0.0001). These correlate with previously published results [141], 
thereby validating the use of the bifurcation device based platform for treatment 
testing of biofilms. 
 
4.2.3 AI-2 Analog and Electric Fields 
Macro-scale Cuvette Test Setup  
A macro-scale test setup for easy testing of electric field-based biofilm treatments 
was assembled as shown in Figure 4-11. Figure 4-11a presents a schematic of the 
macro-scale test setup. It consists of a cuvette with metal electrodes exposed to both 
inside and outside the cuvette for easy application of electrical voltage. A Pyrex chip 
4 cm x 0.8 cm in size is placed in the center of the cuvette such that it is parallel to the 
electrodes. This surface provides a constant area for biofilm growth. Figure 4-11b 
shows a photograph of the cuvette with a Pyrex chip placed in the center. The gap 





Using the test setup shown in Figure 4-11, experiments to test the efficacy of the 
new combination therapy combining AI-2 analogs with electric fields was performed. 
E. coli W3110 cells were cultured overnight in LB media and diluted to an OD600 of 
~ 0.25. 1 ml of the diluted suspension was pipetted into each cuvette and a Pyrex chip 
was placed parallel to the electrodes. The cuvettes were placed in an incubator at 37 
°C for 24 hours to allow for biofilm growth on the Pyrex chip. After 24 hours, the 
glass chips were transferred to a new cuvette containing 1 ml of either fresh LB (for 
the control and electric field only cuvettes) or 100 µM of iso-butyl DPD in LB (for 
the AI-2 analog and combination treatment cuvettes). This concentration of AI-2 
analog was chosen in order to clearly visualize if the combination treatment increased 
treatment efficacy, as the previous results (Figure 4-7a) showed that in a static 











growth. An electric voltage of 0.5 V DC super-imposed on 0.5 V AC at 10 MHz was 
applied to the electric field only and the combination treatment cuvettes. This strength 
of electric field was chosen as a starting point as it was used in our previous study of 
BE using antibiotics [189]. After treatment for 24 hours, the glass chip from each 
cuvette was immersed in 1 ml of 0.1% crystal violet (CV) stain for 15 minutes. 
Following this the Pyrex chips were carefully rinsed in DI four times to remove any 
excess unbound stain. The chips were then immersed in 2 ml of the decomplexation 
solution (80% ethanol and 20 % acetone) for 30 minutes to allow for the absorbed CV 
stain to be released. The OD of this solution was then obtained at 540 nm. The results 
of the experiment are shown in Figure 4-12. The error bars represent the standard  
 
 
Figure	 4-12	 Results	 plotting	 the	 average	 total	 biomass	 after	 treatment	with	 the	 electric	 field	 only,	 the	AI-2	
analog	 and	 the	 combination	 treatment	 of	 AI-2	 analog	 and	 electric	 fields.	 The	 total	 biomass	was	 quantified	
using	the	crystal	violet	staining	method	and	the	final	OD	was	measured	at	540	nm.	The	error	bars	represent	






deviation across three experimental repeats (N = 3). The OD540 of the combination 
treatment of AI-2 analog with electric fields shows a 46.5% decrease in total biomass 
as compared to the control (ANOVA P < 0.0001), whereas the AI-2 analog treatment 
by itself results in only a 6.76% decrease in total biomass, which correlates with the 
previous AI-2 analog results obtained in the microwell plate Figure 4-7a.  
This is the first demonstration of an enhanced biofilm treatment without the use of 
any antibiotics. Further experiments to understand the effect of concentration of the 
analog and the effect of different types of electric fields (AC, DC and super-imposed 
fields) need to be performed. Additionally, the new combination treatment will also 
be tested as a potential method to not only treat but also prevent biofilm growth in 
both the macro-scale cuvette setup and in microfluidics.  
 
Micro-scale Bifurcation Device Test Setup 
E. coli biofilms were grown in the channels of the bifurcation device for 24 hours, 
and subsequently exposed to the four experimental conditions – control, electric fields 
only, AI-2 analog isobutyl DPD, and the combination of AI-2 analogs and electric 
fields. The respective solutions were introduced into the four channels of the device 
over an additional 24 hours. Both end point confocal microscopy images, and CCD-
based real-time monitoring of biofilm growth and treatment were performed. These 
results are discussed below. 
The electric field intensity used for treatment of biofilms was chosen such that no 
bulk electrolysis of the media occurs. Experiments previously performed on E. coli 





V/cm can be used without inducing bulk electrolysis of the media [203]. The 
electrical potential used in this work was 0.125 V AC at 10 MHz offset by 0.125 V 
DC, significantly lower than the bulk hydrolysis potential of 0.82 V. This corresponds 
to an electric field of 1.25 V/cm DC field with a 1.25 V/cm AC field at 10 MHz. The 
frequency of the AC electric field (10 MHz) was chosen based on previous work that 
was shown to be effective [192,197].  
 
End-Point Confocal Microscopy: To test the efficacy of the antibiotic-free 
combination therapy (AI-2 analogs and electric fields), E. coli biofilms were grown in 
the bifurcation device for 24 hours and exposed to the four treatments for an 
additional 24 hours. The biofilms were then stained and imaged using confocal 
microscopy. Figure 4-13a plots the average thickness of the biofilm after treatment. 
As shown, application of only an electric field results in no significant decrease in 
biofilm thickness (ANOVA, p = 0.36). Treatment with 100 µM AI-2 analog isobutyl 
DPD results in a 31.1 ± 10.1% decrease in average biofilm thickness as compared to 
the control (ANOVA, p = 0.023). This correlates with previously obtained data using 
single channel microfluidics (Figure 4-8). Treatment with the combination therapy 
results in a significant decrease in biofilm as measured by the 77.8 ± 6.3% (ANOVA 
p = 0.0001) decrease in average thickness as compared to the control. The larger 
percentage decrease in biomass following treatment using the microfluidic platform 
(77.8%), in contrast to the cuvette test setup (46.4%), can be attributed to the flow in 


















fresh AI-2 analog molecules at the biofilm site. In contrast, the cuvette setup limits 
AI-2 analog availability at the biofilm surface to purely diffusion. Also, the better 
efficacy in the microfluidic device could be attributed to the shear in the channel that 
could add to the increased penetration of the treatment into the biofilm as well as 
easier removal of the biofilm. 
 
Real-time Biofilm Monitoring: Optical density monitoring of biofilms using CCDs 
has been previously demonstrated [136,167] and discussed in earlier sections of the 
dissertation. The same CCD platform is used in conjunction with the bifurcation 
device to study the real-time change in OD during the treatment of mature E. coli 
biofilms with AI-2 analogs and electric fields. A schematic and photograph of 
bifurcation device and the platform are shown in Figure 4-14.  
Figure 4-15 depicts the change in OD during the growth and treatment of E. coli 
biofilms. The high change in OD during the first few hours of growth is due to the 
seeding of the bacterial suspension. The OD then gradually decreases as pure LB 
media is pumped through the channels. Following this, small variations in OD are 
observed during biofilm growth and removal. We hypothesize that this is a result of 
the self-leveling effect experienced by thick biofilms possibly due to the increased 
shear observed in the microfluidic channel. Statistical correlation between the 
biomass in the four channels after the growth phase, as measured using the OD 
measurement setup was demonstrated (ANOVA, p < 0.0001), thus validating the 
















the variation in biomass was observed to be 8.5% as compared to the 68% that was 
previously measured in single channel microfluidics [166]. This reduced biomass 
variance at the end of the biofilm growth period, enables reliable comparison of the 
various treatments. The treatments, LB, AI-2 analog, electric fields and a combination 
of the AI-2 analog and electric fields were applied to the channels of the device. 
Treatment with electric fields (pink line) resulted in no variation in total biomass in 
comparison to the control (black line). The AI-2 analog treatment (blue line) showed 




channel)	 at	 representative	 time	 points	 during	 biofilm	 growth	 and	 treatment.	 The	 error	 bars	 represent	 the	







resulted in the most significant decrease in biomass as compared to the control. This 
correlates well with the end point results obtained using both the CV assay and 
confocal microscopy.  
 
4.2.4 Discussion 
We suggest that the AI-2 analog, when combined with electric fields permeates 
the biofilm more rapidly, similar to the antibiotic molecule during application of the 
BE. We suspect that increased permeation into the biofilm makes available more AI-2 
analog molecules in the bulk of the biofilm. The rise in concentration of AI-2 analog 
in the biofilm, increases the probability that isobutyl DPD is imported into cells, 
phosphorylated by the QS kinase, LsrK, and then binds to the cognate transcriptional 
regulator, LsrR [143], thereby acting as a QS antagonist, quenching QS activities [68] 
and preventing further production of proteins necessary for biofilm ECM production. 
Such reduced ECM production may decrease the structural strength and stability of 
the biofilm, resulting in easier removal of the biofilm due to the shear experienced in 
the microfluidic channel. It is hypothesized that the increased shear experienced in 
the microfluidic channel is a contributing factor in the higher treatment efficacy 
observed in the microfluidic flow cell as opposed to the macro-scale cuvette setup. 
The biofilm treated with AI-2 analogs and electric fields resulted in the highest 
reduction in biofilm thickness. Figure 4-16a plots the macro-scale CV results and the 
biofilm thicknesses obtained using confocal microscopy for the various treatments 








Figure	4-16	 (a)	Measured	OD540	after	24	hours	 treatment	using	 the	CV	staining	method	(N	=	3	experimental	
repeats)	 and	 average	 biofilm	 thickness	 (N	 =	 3	 images)	 measured	 using	 end-point	 confocal	 microscopy	
measurements.	(b)	Measured	average	change	in	OD	(N	=	186	pixels)	as	measured	using	the	CCD	platform	and	







biomass are not detected with high sensitivity using the CV staining method, although 
the larger changes are easily measured. Due to the inherent lack in sensitivity of the 
CV staining method, the high resolution confocal measurements obtained using the 
microfluidic device do not show a very high correlation with the macro-scale 
measurement (r2 = 0.929). This, along with the relative ease of integrating real-time 
sensors into the microfluidic platform make microfluidics a better choice for biofilm 
studies. As observed from Figure 4-16b the correlation between the measurements 
obtained using the CCD setup and the end-point confocal microscope are statistically 
significant (r2 = 0.980). Even though the CCD set up cannot accurately measure very 
thin biofilms (<5 µm), the good correlation between the results obtained in the 
microfluidic device and the confocal microscopy data, combined with the low 
variability feature of the bifurcation design, highlight the suitability of this platform 
for rapid, highly paralleled in vitro characterization of novel biofilm treatment 
strategies. 
 
4.3 Chapter Summary 
To understand better the mechanism of BE, a thorough study was performed 
through the application of AC, DC and SP potentials on mature E. coli biofilms. 
Results showed that there is no statistical difference in treatment efficacy between the 
DC-, AC- and SP-based BE treatment of equivalent energies for voltages less than 1 
V. We also demonstrated that the efficacy of the BE treatment as measured by the 





electrical energy applied. We further verified that the treatment efficacy varies 
linearly with the energy of the BE treatment. Our results thus suggest that the energy 
of the electrical signal, and not the type of electrical signal (AC or DC or SP), is the 
primary factor in determining the efficacy of the BE treatment, at potentials less than 
the media electrolysis voltage. This suggests that at potentials below bulk media 
electrolysis, the mechanism of action of the BE treatment is not different for the 
various types of signals (AC, DC or SP), as reported previously in literature. We 
anticipate that this observation will pave the way for further understanding of the 
mechanism of action of the BE treatment method and may open new doors to the use 
of electric fields in the treatment of bacterial biofilms. Importantly, these findings 
suggest that this method is aptly suited for deployment in clinical biofilm treatment, 
as it enables more flexibility and ease of integration of the BE into various, especially 
in in vivo environments. 
Alternate treatments to biofilm infections were studied and presented. This 
included efficacy studies on AI-2 analogs, as both an independent treatment and when 
used in combination with antibiotics or electric fields. The results suggest that even at 
low concentrations AI2-analogs are effective at preventing further biofilm growth. 
This is achieved by turning off the genetic cascade required to synthesize key proteins 
necessary for biofilm existence and growth. The efficacy significantly improves when 
combined with other treatments like antibiotics and low electric fields. The results 
presented in this chapter demonstrate the increased efficacy of combination therapy 
using AI-2 analogs and electric fields that is completely independent of traditional 





viability. This new treatment was tested and verified using both macro-scale and 
micro-scale test platforms. By integrating a real-time OD measurement system with 
the microfluidic device, we demonstrated that the combination of AI-2 analogs and 
electric fields resulted in a significant decrease in biofilm thickness. We further 
confirmed these results by performing end-point confocal imaging. We suggest that 
the increase in treatment efficacy of the AI-2 analog when combined with electric 
fields is due to the increased permeation of the analog into the bulk of the biofilm. It 
is also hypothesized that the efficacy of the treatment when using a microfluidic 
device is larger due to the replenishment of the AI-2 analog molecules at the site of 
biofilm formation due to continuous flow in the device. Importantly, this finding 
suggests that this method of treatment is promising as a potential treatment and 
prevention method against antibiotic-resistant biofilm infection formation in both the 








Chapter 5. A Microfluidic Impedance Sensor-Treatment 
Platform: Characterization, Sensing and Treatment 
Results 
This chapter presents the experimental results for impedance sensing of bacterial 
biofilms in microfluidic channels. The results of both single channel and bifurcation-
based microfluidic devices integrated with impedance sensors are discussed. Finally 
the design and characterization of an impedimetric microsystem that integrates the 
real-time sensing and threshold-activated feedback based BE treatment of the 
biofilms is discussed and demonstrated. This work could not have been possible 
without the continuous efforts of Ms. Kathryn Schneider and Ms. Ekaterina Tolstaya. 
  
5.1 Impedance Sensing of Biofilms in Microfluidics 
In this section, we present a simple IDE-based impedance sensor that enables 
label-free real-time detection of bacterial biofilm growth and treatment. While 
impedance sensors for the detection of biofilm growth have been proposed in the past 
[169,176,211], they have been used to detect growth in static environments like 
microliter plates or petri dishes, or in macroscopic setups like the CDC reactor. The 
work presented here demonstrates the real-time detection of biofilm growth in 
microfluidic flow cells, as well as, monitoring of biofilm treatment with antibiotics. 
End-point fluorescence microscopy results correlate with the changes in impedance 






5.1.1 Finite Element Modeling of Bacterial Biofilms 
Effective medium approximations (EMAs) allow the theoretical modeling of the 
macroscopic properties of composite materials. These approximations calculate the 
macroscopic properties of a material by averaging the multiple values of the 
constituents that directly make up the composite material, although at the constituent 
level, these properties vary and are inhomogeneous. Given the multiple unknowns 
that increase the complexity of a composite medium like bacterial biofilm, precise 
calculation of the many constituent values is nearly impossible. However, theories 
have been developed that can produce acceptable approximations which in turn 
describe useful parameters and properties of the composite material as a whole. In 
this sense, EMAs are approximate descriptions of a medium (composite material) that 
are derived from calculations that are based on the properties and the relative 
fractions of its components. Presented in this section is a brief overview of one such 
EMA, Maxwell’s mixture theory (MMT), which is most frequently employed in the 
analysis of biological cell suspensions, and of the simulation setup using this model to 
theoretically calculate the electrical properties of the biofilm. 
 
Maxwell’s Mixture Theory: Spherical Single-Shelled Model 
A biological cell suspension can be modeled as a collection of differently shaped 
objects (the cytoplasm) covered by one or two shells (the cell membrane) and 
uniformly distributed in an aqueous phase (the extracellular medium). The overall 
dielectric properties of the suspension depend on the electrical parameters (the 





their volume fractions [212-214]. Although, E. coli are not spherical in shape, and 
refinements of the model, viz. ellipsoidal cells have been published, the spherical 
model presents a sufficient first-order approximation. Thus, in this work, we calculate 
the dielectric properties of the biofilm by assuming it to be a collection of spherically 
shaped objects (the bacterial cells), covered by a single shell (their cell membrane) 
and uniformly distributed in a medium (the ECM) as shown in Figure 5-1.  
For the single-shell spherical model, the complex dielectric constant ε*biofilm(ω) of 
the biofilm is given by [213] 
 
𝜀∗!"#$"%& 𝜔 =  𝜀∗!"# 𝜔  
! !! ! !∗!"# ! ! !! !! !∗!" !
!! ! !∗!"# ! ! !! ! !∗!" !
     (5.1) 
 
Where ε*eq(ω) is the equivalent complex dielectric constant of the dispersed 
particles (here bacterial cells) and can be written as 
 
𝜀∗!" 𝜔 =  𝜀∗!"! 𝜔  
! !! ! !∗!"! ! ! !! !! !∗!"# !
!! ! !∗!"! ! ! !! ! !∗!"# !
             (5.2) 
 
Where ε*mat(ω) = εmat +σmat/(iε0ω) is the complex permittivity of the ECM, 
ε*mem(ω) = εmem +σmem/(iε0ω) is the complex permittivity of the bacterial cell 
membrane, and ε*cyt(ω) = εcyt +σcyt/(iε0ω) is the complex permittivity of the cellular 
cytoplasm. ε0 is the dielectric constant of free space, ω is the frequency, φ is the 
fractional volume of the bacterial cells. Since the bacterial cell is modeled as a sphere, 





ϑ of equation (5.2) is calculated as ϑ = [R/(R+dmem)]3. The values of the various 
parameters used to theoretically estimate the electrical properties of the biofilm are 
listed in Table 5-1.  
Combining both equations (5.1) and (5.2) and separating the resultant complex 
equation into the real and imaginary part, we arrive at the permittivity εbiofilm and the 
conductivity σbiofilm of the biofilm. These calculations were performed using 
Mathematica (v10.2.0.0, Wolfram Research). The corresponding code is included in 
the appendix of this document (Appendix B). 
 
 
Figure	 5-1	 Effective	 medium	 approximation	 (EMA)	 of	 a	 bacterial	 cell	 as	 a	 single	 shelled	 sphere	 and	 the	
equivalent	circuit	of	the	experimental	setup.	The	part	of	the	equivalent	circuit	boxed	in	blue	corresponds	to	
the	Maxwell’s	mixture	 theory	 based	 approximation	 of	 the	 biofilm,	where	 Rcont	 	 and	 Ccont	 are	 the	 electrode	

















Cell cytoplasm 0.19 61 [215,216] 
Cell membrane 5 × 10-8 10.8 [215,216] 
ECM 0.68 60 [217] 
LB media 0.754 78 [218] 
 
COMSOL Simulation Setup  
To model the impedance system, a 3D electrodynamic simulation was setup in 
COMSOL Multiphysics (v4.4, COMSOL Inc.). The geometry was defined by a 
microfluidic channel of length 500 µm, width 50 µm and height 100 µm. Centered on 
the bottom of the channel is a pair of gold electrodes whose width and spacing can be 
varied. Three electrode widths and spacings, viz. 25 µm, 50 µm and 100 µm were 
simulated. For the ease of modeling it was assumed that a biofilm of uniform 
thickness (5 µm to 30 µm) grows along the entire length of the channel. The 
remaining channel volume was modeled to simulate LB growth media. Although the 
electrical characteristics of the LB media change with bacterial metabolism, for the 
case of this simulation it was assumed that the channel was filled with fresh LB 
media at all times. This represents the experimental condition in which the 
microfluidic flow rate is high enough to ensure that the media in the channel is 







Figure	 5-2	 COMSOL	 3D	 electrodynamic	 simulation	 setup	 plotting	 the	 current	 density	 between	 the	 two	




capacitance and resistance, as well as the double layer capacitance formed at the 
electrodes were also included as an additional electrical circuit in the simulation. The 
complete equivalent circuit of the experimental setup is shown in Figure 5-1. A 
snapshot of the COMSOL setup for both the control and the 30µm biofilm test cases 
are shown in Figure 5-2a-b, respectively.  
Additional simulations were performed for the test cases when the biofilm grew in 
only half the total surface area of the channel, namely, when a uniform biofilm grows 
along the entire width of the channel but only along half the length of the channel, 











The simulation results show that for IDEs with equal electrode width and spacing, 
the sensitivity of the sensors is inversely proportional to the width or spacing between 
the electrodes (Figure 5-3). Thus 25 µm IDE sensors are more sensitive than 50 µm 
IDE sensors, which are in turn more sensitive than the 100 µm sensors. Assuming the 
increase in simulated biofilm thickness is with growth time, the time to saturation of 
the signal is directly proportional to the electrode spacing. Thus, 100 µm IDE sensors 
demonstrate the largest linear range when compared to 50 µm or 25 µm IDEs. In 
order to balance both these aspects, 50 µm IDEs were predominantly used for 





5.1.2 Device Fabrication and Design 
The impedance sensor was fabricated by patterning evaporated Cr/Au 
(20nm/180nm) on a Borofloat 33 or oxidized silicon wafer to form the IDE pattern. 
Shipley 1813 photoresist was spun on the wafer following which it was exposed and 
developed (Masks #4 and #5, Appendix A). The Cr/Au was then wet etched to form 
the IDEs after which the excess resist was stripped using acetone. IDEs of two 
different widths and spacings, 50 µm and 100 µm, were fabricated. Figure 5-4 shows 
the fabrication process flow for the IDE sensors and Figure 5-5 presents a micrograph 









Following this, the devices were diced, cleaned by immersion in piranha solution 
for 1 minute, and rinsed with DI water and blow-dried. Single channel and 
bifurcation-based microfluidic devices were fabricated using traditional soft 
lithography techniques [141]. Briefly, the microfluidics is cast from 
polydimethylsiloxane (PDMS) (1:10 ratio of curing agent to polymer) molded by 
photo-patterned KMPR-1050. The microfluidic channels were 100 µm deep, 500 µm 
wide, and 2 cm long. Holes were punched at the inlet and outlet of each channel using 
a 2 mm dermatological punch. The channels were then aligned and placed over the 





The single channel microfluidic device contained three independent IDE sensors 
that were located near the inlet, center and outlet of the microfluidic channel, whereas 








Figure	 5-6	 (a)	 Photograph	of	 an	 impedimetric	 sensor	 device	 bonded	 to	 a	 simple	 single	microfluidic	 channel	
(scale	bar	=	5	mm).	Each	device	contains	three	IDE	sensors.	(b)	Test	setup	fabricated	for	parallel	testing	of	up	








channel. The PDMS microfluidic channels were plasma bonded to the device such 
that the fingers of the IDE sensor were perpendicular to the microfluidic channel 
(Figure 5-6a and c). To enable fluid flow, the microfluidic channels were interfaced 
to the external fluidic components using flexible Tygon tubing and barbed connectors 
(Figure 5-6). The tubing at the inlet of the single channel device was connected to a 
syringe pump (Cole Parmer 74901, Cole Parmer Instrument Company, LLC) 
operating in infusion mode at 20 µl/hr, and at the outlet, the end of the tubing is 
inserted into micro-centrifuge tube for waste collection. The bifurcation-based 
devices were operated in infusion or withdrawal mode depending on the phase of the 
experiment, as discussed previously. Prior to experiments, each device was sterilized 
by flowing 70 % ethanol for one minute and then rinsed using DI water. The entire 
apparatus was kept in an incubator held at 37 °C.  
 
5.1.3 Experimental Setup 
To ensure similar experimental conditions were applied to all devices at any given 
point in time, multiple experiments were performed in parallel. Two custom stages, 
shown in Figure 5-6b and d were machined, one for the single channel devices and 
the other for the bifurcation devices. These enabled interfacing up to twelve IDE 
sensors in four single channel microfluidic devices, or eight IDE sensors in two 2-
level bifurcation devices, to the potentiostat (Model 600D, CH instruments Inc.). Its 
multiplexing capabilities (CHI684 Multiplexer, CH instruments Inc.), were used to 
measure the AC impedance with an applied potential of 5-50 mV for a frequency 





minutes. Figure 5-7 plots the real and imaginary parts of impedance, the absolute 
impedance and the phase for the frequency range of 10 Hz to 1 MHz as measured 
using a 50 µm IDE sensor. The lines in the plots correspond to various time points 
during the 24-hour biofilm growth period with the solid red line corresponding to 
time t = 0 hrs of the biofilm growth period, followed by the solid blue, solid green, 
solid black, solid cyan, dashed red, dashed blue, dashed green and dashed black lines 
(t = 24 hrs). As observed from the plots, the impedance changes with time at any 
given frequency and can be used to monitor biofilm growth. On the other hand the 
 








phase remains almost constant with time at a given frequency, but changes over the 
frequency range as expected, with the phase being capacitive at lower frequencies and 
more resistive at higher frequencies.  
Investigation of the recorded data revealed that the frequency of 100 Hz resulted 
in accurate detection of biofilm growth while maintaining a high signal to noise ratio. 
Thus, impedance measurements at 100 Hz was used for to analyze the results of all 
the experiments. Due to hardware restrictions of the potentiostat’s multiplexer, only a 
maximum of three to four sensors could be tested in parallel. 
 
5.1.4 Results 
The results of biofilm growth and treatment in single channel microfluidics and in 
the bifurcation device as measured in real time using the impedance sensor are 
discussed in this section.  
 
Single Channel Microfluidics  
Device Pre-conditioning 
Device pre-conditioning was accomplished by flowing 1× phosphate buffered 
saline (PBS) through the sterilized channel at 20 µl/hr for 24 hours. Any air bubbles 
trapped in the channel are forced to the outlet by increasing the flow to 100 µl/hr for a 
short period of time. The primary goal of pre-conditioning is to allow for 
acclimatization of the device to the change in environment from air to liquid so as to 
achieve a stable signal. Also, we postulate that the application of the AC potential 





equilibrium due to electrochemical reactions occurring at the electrode surface. This 
process also enables removal of any excess ethanol present in the channel, tubing and 
connectors. Figure 5-8 shows the change in real, imaginary and absolute impedance at 
100 Hz with respect to their respective overall average values for a 50 µm impedance 
sensor. As observed from the plots, large variation in signal is observed during the 
first few hours of the pre-conditioning step after which the signal stabilizes over time. 
 
 
Figure	 5-8	 Representative	 plots	 showing	 the	 percentage	 relative	 change	 in	 (a)	 real	 part	 of	 impedance,	 (b)	
imaginary	part	of	impedance,	(c)	phase,	and	(d)	absolute	impedance	at	100	Hz	during	PBS	pre-conditioning	of	a	
50	μm	IDE	sensor.	A	large	change	in	impedance	observed	during	the	first	3-5	hours	of	buffer	introduction,	after	






This preliminary change in signal is in line with the initial hypothesis and is 
indicative of the process of electrochemical equilibrium achievement. As time 
progresses the electrodes acclimatize to the new liquid environment that leads to a 
stable signal over time. Furthermore, as observed from the graphs the absolute change 
in impedance at 100 Hz almost exactly equal to the change in the imaginary part of 
the impedance. We attribute this to the transduction mechanism of the impedance 
system, in which the change in double layer and biofilm capacitance, captured by the 
imaginary impedance, is dominant. Thus, the absolute impedance is strongly affected 
and follows the imaginary component of the impedance.  
 
Biofilm Growth 
A bacterial suspension of E. coli K-12 W3110 [201] was prepared from a stock 
solution stored at −80 °C. The suspension was prepared by transferring a frozen 
sample of bacteria into 5 ml of LB media in a cell culture tube. The tube was then 
placed in an incubator-shaker (Innova 4000, New Brunswick Scientific Co. Inc.) at 
250 rpm and 37°C for 18-20 hours to allow for bacterial growth. Subsequently, LB 
media was used to dilute the suspension to a final OD600 ≈ 0.25. Prior to cell seeding, 
the device was pre-filled with fresh LB growth media at a flow rate of 100 µl/min per 
channel. Once the device was primed with LB media the flow rate was reset to 20 
µl/hr per channel, and a few measurements were obtained to use as a baseline. The 
diluted bacterial suspension was then injected at a rate of 100 µl/min and was allowed 
to seed the channel for 2 hours without flow to facilitate bacterial attachment to the 





channel for 24 hours at the rate of 20 µl/hr. We previously characterized this flow rate 
and confirmed it to be sufficient to supply the needed nutrients for the formation of 
mature E. coli biofilms [136,154,166,167,175,219,220]. 
Figure 5-9 plots the percentage change in absolute impedance, its real and 
imaginary components and phase at 100 Hz during the 26 hour bacterial seeding and 
biofilm growth for a single 50 µm IDE sensor. It was observed that while the real and 
imaginary parts of impedance and the absolute impedance decreased by ~40% 
(Figure 5-9a, b, and d), the phase remained relatively constant (Figure 5-9c). This 
decrease in impedance is indicative of bacterial growth and gives a direct real-time 
measure of the bacterial attachment and biofilm growth on the sensor surface. The 
error bars plotted in the Figure 5-9 show the temporal variation of the signal (span = 
3) at representative time points. However, as the variation is very small, < 2 %, the 
error bars are not easily discernible in the plots.  
It is well documented that the low frequencies are affected by the capacitive 
behavior, while the higher frequencies are dominated by the resistive component 
[182]. Consequently, the decrease in the imaginary component of impedance at 100 
Hz plotted in Figure 5-9 is caused by the increase in double-layer and biofilm 
capacitance as a result of biofilm attachment and planktonic bacterial growth, 
respectively, at the electrodes. On the other hand, as the metabolic activity of the 
bacteria has a direct effect on the ionic concentration and therefore on the resistance 
of the media, the introduction of metabolites into surrounding medium over time 
results in a decrease in resistance as measured by the real component of impedance. 





lower than the imaginary component of impedance at low frequencies, biofilm growth 
results in a decrease in the absolute impedance.  
 
 
Figure	 5-9	 Representative	 plots	 showing	 the	 percentage	 relative	 change	 in	 (a)	 real	 part	 of	 impedance,	 (b)	
imaginary	part	of	impedance,	(c)	phase,	and	(d)	absolute	impedance	during	biofilm	growth	using	a	50	μm	IDE	




As each microfluidic channel is aligned over three similar IDE sensors, one each 
near the inlet, the center and the outlet of the channel, two additional impedance 
measurement data sets were obtained from the other two 50 µm IDE sensors aligned 





plotted in Figure 5-9. The average change in absolute impedance, real and imaginary 
parts of the impedance and the phase after the 26 hour bacterial seeding and biofilm 
growth phase for all three 50 µm IDE sensors is plotted in Figure 5-10. The error bars 
represent the standard deviation of the average end-point impedance values across the 
three sensors (N = 3 experimental repeats). It can be observed from the bar graph that 
the average absolute impedance change and the corresponding resistance and 
reactance components vary by comparable amounts (ANOVA P = 0.23; P > 0.05), 
thus indicating that they are statistically similar, whereas there was no significant 
change in the phase of the measured impedance. Hence, for all future impedance 
sensing experiments only the change in absolute impedance was monitored and used 
as a direct measure of bacterial attachment and biofilm growth. 
 
Figure	5-10	Average	relative	change	in	the	absolute	impedance,	real	impedance,	imaginary	impedance	and	the	
phase	 measured	 at	 100	 Hz	 across	 three	 50	 μm	 IDE	 sensors	 (N	 =	 3	 experimental	 repeats).	 Biofilm	 growth	






Comparison with 100 micron IDE Sensors 
Similar PBS pre-conditioning and biofilm growth experiments were conducted 
using 100 µm IDE sensors. Experiments were not conducted using 25 µm IDEs as the 
devices resulted in unstable impedance curves. The results of these experiments are 
shown in Figure 5-11, Figure 5-12, and Figure 5-13.  
 
 
Figure	 5-11	 Representative	 plots	 showing	 the	 percentage	 relative	 change	 in	 (a)	 real	 part	 of	 impedance,	 (b)	
imaginary	part	of	impedance,	(c)	phase,	and	(d)	absolute	impedance	at	100	Hz	during	PBS	pre-conditioning	of	a	
100	μm	 IDE	sensor.	A	 large	change	 in	 impedance	observed	during	 the	 first	3-5	hours	of	buffer	 introduction,	







The buffer pre-conditioning of the devices revealed a similar trend as with the 50 
µm sensors. While the impedance varies by ~20% in the first few hours (7-10 hours) 
of the conditioning, it stabilizes thereafter. The phase remains relatively constant 
through the entire period of time, with a maximum variation of 4 % during the first 
few hours of the buffer conditioning.  
 
 
Figure	 5-12	 Representative	 plots	 showing	 the	 percentage	 relative	 change	 in	 (a)	 real	 part	 of	 impedance,	 (b)	
imaginary	part	of	impedance,	(c)	phase,	and	(d)	absolute	impedance	at	100	Hz	during	biofilm	growth	using	a	








Figure 5-12 plots the change in resistance, reactance, phase and impedance during 
the 2-hour bacterial seeding and 24-hour biofilm growth process. As observed from 
the plots the change in impedance, resistance and reactance is negative indicating 
biofilm growth. However, a small increase in impedance is observed at the 5 hour 
time period. During the 5 to 15 hour time period, a shift in phase by negative 7 % is 
also observed. Such a change in phase was observed to occur only when small air 
bubble(s) were partially covering the surface of the electrode. However the general 
overall trend of decrease in impedance and near constant phase is observed. 
Moreover, we observe a saturation of the resistance signal at around the 15-hour time 
point. Saturation of the imaginary part of the impedance and the total impedance 
occurs at around t = 20 hours. Given that the 100 µm IDE sensors are theoretically 
known to be less sensitive to surface attachment than the 50 µm sensors, it follows 
that signal saturation can only occur in a 100 µm sensor when a much thicker biofilm 
is formed in the channel of this device as compared to the 50 µm device [178]. As 
discussed previously such variation in biofilms thickness is possible and very 
common as biofilms are extremely sensitive to environmental factors, and large 
variations in biofilm thickness (~68%) have been shown to occur between devices. 
Despite the thicker biofilm formed in the channel of the 100 µm device, the average 
change in impedance, resistance and reactance is comparable to the average change in 
these parameters measured using the 50 µm IDE sensor (Figure 5-9), proof of the 








phase	 measured	 at	 100	 Hz	 across	 two	 100	 μm	 IDE	 sensors	 (N	 =	 2	 experimental	 repeats).	 Biofilm	 growth	
experiments	 were	 performed	 in	 parallel.	 The	 two	 IDE	 sensors	 were	 placed	 along	 the	 length	 of	 a	 single	
microfluidic	channel.	
 
Figure 5-13 plots the average change in resistance, reactance, impedance and 
phase for two 100 µm IDE sensors. While the 100 µm devices appear to show near 
about the same average percentage change in these values as those measured for the 
three 50 µm sensors, the average variation between the 100 µm devices, measured by 
the error bars are significantly larger than those of the 50 µm sensors. Furthermore, 
the 50 µm finger width and spacing is theoretically known to have a higher sensitivity 
than the 100 µm sensors, as the sensitivity of an impedance sensor in inversely 
proportional to the finger spacing, while the time to saturation is directly proportional 
to the finger spacing. Thus, only the 50 µm IDE sensors were used for all future 







In this work, we present the first impedimetric microsystem for real-time 
monitoring and treatment of bacterial biofilms in a microfluidic bifurcation device. 
To reliably compare various treatment efficacies in parallel, each channel of the 
bifurcation device was integrated with an IDE sensor. Our approach successfully 
utilized IDEs for both BE treatment application and monitoring biofilms through real-
time impedance measurements. Our previous work with BE applied a 500 mV 
electrical signal during the entire treatment period [175,219], a long-term 
biocompatibility concern for medical devices as they on average require treatment 
over weeks. Additionally, the use of independent mechanical (or optical) and 
electrical domains for monitoring and treatment, respectively, made essential the use 
of auxiliary electrodes for BE application, increasing device footprint and 
necessitating additional bulky equipment [175,219]. Here, we demonstrate that 
biofilms can be accurately sensed in real-time by measuring the change in impedance 
across the IDEs. Treatment is performed by applying a 100 mV signal, for only 
~1/7th the 24-hour treatment period, across the same IDEs in combination with small 
doses of antibiotic [130]. End-point optical analysis of our BE treated biofilms shows 
~62% surface coverage reduction compared to the negative control, consistent with 
previous work [175,219]. Contrary to former systems, this integration of sensing and 
BE treatment capabilities into purely the electrical domain provides an elegant 






Device Pre-conditioning  
The four outlets of the bifurcation device were connected to the syringe pump 
while the single outlet at the other end of the channels was placed in a micro-
centrifuge tube that served either as a reservoir or a waste collection tube depending 
on the mode of operation of the device. Following the ethanol of DI rinse, PBS buffer 
was introduced into the channels of the device at 100 µl/min/channel (in withdrawal 
mode) to prime the channels. After the channels were filled with PBS and any large 
air bubbles in the channels were removed, the flow rate was set to 20 µl/hr/channel 
and the impedance of each channel of the device was obtained every 10 minutes for 
20 hours by applying a 5 mV AC signal across the IDEs.  
 
Figure	 5-14	 Plot	 showing	 the	 change	 in	 100Hz	 impedance	 for	 the	 PBS	 buffer	 baseline	 for	 each	 of	 the	 four	






Figure 5-14 plots the measured absolute impedance at 100 Hz during the PBS 
buffer flow for each of the four channels of the bifurcation device. As observed from 
the graph the buffer flow resulted in a steady signal over time in all four channels. 
The variation in measured impedance is calculated to be around 2 %. The error bars 
represent the temporal variation in absolute impedance at 100 Hz at representative 
time points.  
 
Biofilm Growth 
Following the PBS conditioning, an impedance measurement of pure LB media 
was acquired to establish a baseline. Subsequently, all the channels of the device were 
seeded using an overnight culture of E. coli W3110 (OD600 ≈ 0.25) without flow for 2 
hours, after which pure LB media was introduced at a flow rate of 20 µl/hr/channel in 
withdrawal mode. Figure 5-15 shows the measured relative decrease in impedance 
during 20 hours of biofilm growth in the four channels. Compared to the steady signal 
when flowing buffer only (Figure 5-14), the relative decrease in absolute impedance 
is indicative of the attachment of bacteria and of biofilm growth. Due to a self-
leveling effect in constricted channels, the variation in impedance at the end of the 
20-hour growth period was observed to be only 2.35%, thereby once again validating 











Biofilm Treatment  
After the growth phase, different treatments were applied to the biofilms grown in 
the channels for an additional 24 hours. The antibiotic gentamicin, which is 
commonly used for treating E. coli infections, was diluted in LB media to a final 
concentration of 10µg/ml. This diluted solution of the antibiotic was introduced into 
two of the channels (antibiotic only and BE) and pure LB media was introduced into 
the remaining two channels (control and electric field only) at a flow rate of 20µl/hr. 





channels treated with BE and electric field only treatment were subjected to a 100 mV 
electrical signal for about 5 minutes per channel once every 33 minutes. Table 5-2 
lists the various treatments applied to the four channels of the bifurcation device in 




Channel Treatment Experimental Conditions 
1 Control LB media only 
2 E-field only LB media + 100mV 
3 Antibiotic only 10 µg/ml gentamicin in LB media 
4 Bioelectric Effect (BE) 10 µg/ml gentamicin in LB media + 100mV 
 
Figure 5-16 plots the relative change in absolute impedance measured during the 
application of the various treatments. The antibiotic-only (magenta line) and BE 
treatment (blue line) showed a reduction in biomass as measured by the increase in 
impedance with respect to the 20-hour growth phase. Conversely, the negative control 
(green line) and electric field-only treatment (red line) resulted in a continued 
decrease in impedance, suggesting further biofilm growth. Previous work using a 
SAW sensor demonstrated that the negative control and electric field-only treatments 
resulted in a continued increase in biomass, whereas the antibiotic-only and BE 
treatment resulted in a decrease in total biomass. Moreover, the BE resulted in more 







Figure	 5-16	Measured	 change	 in	 100Hz	 impedance	during	biofilm	 treatment.	While	biofilm	growth	 shows	a	
decrease	 in	 impedance,	 biofilm	 treatments	 (BE	 and	 antibiotic-only)	 result	 in	 an	 increase	 in	 impedance	
suggestive	of	biofilm	removal.	The	error	bars	represent	the	temporal	variation	of	the	biofilm	(span	=	3).	
  
results of the untreated negative control and the electric field only treatment presented 
in Figure 5-16 are consistent with the aforementioned previous outcomes, the 
antibiotic-only treatment showed an efficacy that is equivalent to the BE. We 
postulate that this equivalence and the higher than expected efficacy of the antibiotic-
only treatment is a consequence of the periodic sensing voltage applied across the 
IDEs that also causes BE. 
After the completion of 24 hours, the biofilms in the channels were stained using 
the Filmtracer™ LIVE/DEAD® Biofilm Viability Kit (Life Technologies Inc.), using 





20 µl/hr. The biofilms were then washed with DI water at the same flow rate to 
remove any excess stains and imaged using a fluorescent microscope (Olympus 







an image-processing program (Image J 1.44), which supports background subtracted 
image analysis facilitating an independent quantitative measurement of the biofilm 
surface coverage. Representative end-point optical micrographs of the control and 
BE-treated biofilms are presented in Figure 5-17a-b. Corresponding ImageJ analysis 
shows that BE treatment reduced biofilm surface coverage by ~61.6 % compared to 







Figure	 5-18	 Correlation	 of	 measured	 average	 change	 in	 100Hz	 impedance	 (span	 =	 3)	 and	 average	 surface	
coverage	(N	=	2	images)	calculated	using	ImageJ	after	24-hour	treatment.	
 
Figure 5-18 plots the average change in impedance and the average biofilm 
surface coverage at the end of each of the four treatments. The change in impedance 
after 24 hours of treatment and the end-point biofilm surface coverage measurements 
correlate very well (R2 = 0.97). Even though the surface coverage analysis does not 
measure the third dimension or thickness of the biofilms, it is a good approximation 
for the measurement of total biomass assuming uniform biofilm thickness.  
This experiment thus demonstrates that the developed microsystem accurately 
detects biofilms in real-time, and also treats them using BE. The BE is applied only 
for a short period of the treatment cycle thus significantly lowering power utilization. 
The good correlation between the results obtained in the microfluidic device and the 





bifurcation design, highlight the suitability of our platform for rapid, highly paralleled 
in vitro characterization of novel biofilm treatment strategies. This would ultimately 
enable threshold-activated application of BE in response to biofilm growth for rapid 
and effective in situ infection management, thus preventing post-surgery infections 
and significantly improving the quality of life for millions of patients.  
 
5.1.5 Discussion 
In this section we presented a simple IDE-based impedance sensor and 
demonstrated its ability to function not only as a sensor but also as a treatment 
system. The results discussed in this section successfully demonstrate that the sensor 
can accurately and in real-time measure the growth of biofilms. Furthermore, we 
show that use of the IDEs to apply the electrical signal necessary to initiate the BE 
treatment. Our results suggest that even the small sporadic 5 mV AC signal used for 
probing the impedance between the IDEs results in enhanced treatment based on the 
principles of BE. Thus, true de-coupling of the BE treatment from the antibiotic-only 
treatment is not possible using this setup.  
One of the other major challenges of working with microfluidic systems is the 
introduction of air bubbles in the channel before or during the experiment. In the 
current impedance sensing microsystem removal of such air bubbles, although time 
consuming, is necessary in order to avoid large shifts in the measured impedance 
values. Thus, future generations of the microsystem will need to address this issue 
right at the design stage as it will avoid long periods of device priming and 





As with any real-time sensing system, depending on the rate of sensing, data 
analyses and storage can be a challenge. For the microsystem developed as part of 
this dissertation no optimizations were performed for efficient data handling. The data 
from each channel was collected once every 8-10 minutes, yielding hundreds of data 
files necessitating significant memory for storage. Moreover, analyses of such large 
data are time consuming and require substantial compute power. Multiple 
experiments resulted in failure due to the lack of system memory and other processor 
resources. Thus, in order to truly achieve the end goal of device miniaturization 
towards application in a medical device, future generations of the proposed 
microsystem will require to address the challenge of data storage, memory usage and 
allocation of processor resources for data analyses so that experiments of longer time 
durations that are clinically relevant can be performed. 
 
5.2 Threshold-activated Feedback Impedance Sensor-Treatment Microsystem 
In the previous section, we successfully demonstrated the use of the IDEs for not 
only impedance based sensing but also BE based treatment of biofilms. Such 
integration into a single domain facilitates rapid switching between sensing and 
treatment. In this section, we demonstrate the use of the real-time impedimetric 
sensing data to accomplish self-governing treatment of biofilms using BE. We 
developed a MATLAB control module that uses the measured impedance across the 
IDEs to identify biofilm growth and based on user-defined inputs makes the decision 
to either switch to BE treatment or continue impedimetric sensing of biofilms. This, 





sensing and self-directed treatment capabilities. We demonstrate the ability of the 
developed integrated microsystem using a bifurcation-based microfluidic flow cell 
setup. We believe that development of such threshold-activated feedback systems 
with sensing and self-directed treatment capabilities will pave the way towards rapid, 
real-time and truly autonomous management of in situ biofilms. Such management of 
biofilms on medical implants will allow for reduced revisional surgeries and greatly 
improve the quality of life of millions of patients.  
 
5.2.1 Experimental Setup 
We demonstrate impedimetric change-based self-governing treatment of biofilms 
with BE in a bifurcation device with 50 µm IDE sensors. The experimental setup to 
demonstrate the threshold-activated feedback sensing and treatment of biofilms is 
identical to the setup discussed in section 3.4.3 for the bifurcation device (Figure 
5-6c). However, instead of directly gathering impedance data using the CH 
Instruments (CHI) control software, the potentiostat and multiplexer were controlled 
by a custom-built MATLAB macro that enabled real-time impedance monitoring in 
all four channels and also the application of E-field based treatments in any of the 
channels of the device based on user-defined inputs. A block schematic of our micro-
total analysis system (µTAS) is shown in Figure 5-19. As shown in the schematic, the 
bifurcation based sensor and treatment system was placed in an incubator maintained 
at 37 °C. One end of the fluidics was connected to the syringe pump, while the other 





collector. The device was electrically connected to the CHI multiplexer, which was in 
turn connected to the potentiostat.  
 
 
Figure	 5-19	 Block	 schematic	 of	 our	 μTAS	 concept	 for	 threshold-activated	 feedback	 biofilm	 treatment.	
Photograph	of	bifurcation	based	IDE	sensor	and	treatment	system,	showing	the	components	of	the	sensor	and	
the	microfluidic	 channels.	Also	 shown	are	 the	 electrical	 and/or	 fluidic	 connections	 between	 the	device	 and	
other	equipment.	
 
5.2.2 MATLAB Control Macro Implementation 
A graphical user interface (GUI) was created using MATLAB for the user to 
provide the required inputs for performing the experiment. The control macro was 
implemented using the libec SDK for MATLAB provided by CH Instruments, the 
manufacturer of the potentiostat. Other platform libraries like LabVIEW are 
available, however MATLAB was chosen because of the relative ease in programing 
and its ubiquitous use in research. The library can be downloaded from the vendor’s 









Figure 5-20 presents a screenshot of the MATLAB control module GUI that 
appears on running the MATLAB file biofilm_gui2.m (Appendix C). On execution of 
the macro the library SDK is compiled using the inputs provided through the GUI to 
control the potentiostat. Two additional windows titled Figure 2 and Figure 3, shown 
in Figure 5-21, are also displayed alongside the GUI. These windows contain eight 
graphs in total and plot the absolute impedance and the relative change in impedance 
of each channel listed in List Channels field in real-time. A comprehensive 
explanation of each input to the GUI and the protocol used to successfully 
















User Inputs  
Table 5-3 lists all the inputs that are to be provided by the user using the 
MATLAB GUI along with a brief description of each field and their default values. A 




Field Name Description Default Value 
File name Prefix of the name of files that will be saved exp_data_ch_ 
List channels 
Array listing the physical potentiostat 
multiplexer channels in use 
4 5 6 7 
Sensing amplitude Sensing voltage in volts 0.005 V 
Sensing frequency Sensing frequency in Hz 100 Hz 
Treatment amplitude Treatment voltage in volts 0.1 V 
Treatment frequency Treatment frequency in Hz 1 MHz 
Quiet time 
(Control/Cond.) 
Quiet time in seconds after sensing all the 
channels listed in “List channels” during 




Quiet time in seconds after sensing all the 
channels listed in “List channels” during 




Quiet time in seconds after sensing all the 
channels listed in “List channels” during 








This field allows the user to enter a prefix that will be appended at the beginning 
of every file generated during the experiment. This includes the text files generated 
during the experiment and the final graphs generated at the end of the experiment. 
  
Treatment interval 
Array of whole numbers listing treatment 
mode of channels (0 – no treatment; n – 
treatment for 10n minutes) 
0 0 3 3 
Treatment threshold 
Upper threshold in % at which the system 
must switch from sensing to treatment  
20 % 
Sensing threshold 
Lower threshold in % at which the system 
must switch from treatment to sensing 
15 % 
Growth period before 
sensing 
Time in hours after switching “mode” to BE 
treatment during which mode of operation 




Threshold in % for outlier detection (used 
only in conditioning and control modes) 
100 % 
Mode 
List of experimental modes 
(radio button list) 
Conditioning 
Start/Pause button Button to start or pause data collection NA 
Generate graphs button 
Button to generate all graphs  







The multiplexer connected to the potentiostat can be programmed to serially 
address up to 12 channels (channel 1 to channel 12). The List channels field allows 
the user to manually enter the physical number of the various channels that needs to 
be addressed by the MATLAB program. The channels are listed in the order in which 
they are to be addressed with a space between two consecutive channels. The 
program is set by default to address only four channels at a time. If a different number 
of channels require to be addressed, the source code biofilm_gui2.m needs to be 
edited. 
 
Sensing Amplitude and Frequency 
The sensing amplitude and frequency refers to the AC voltage amplitude and 
frequency that is used to monitor the impedance across the IDEs during all modes of 
operation. Based on the previous experimental results presented in section 3.4, these 
were set to 0.001 V and 100 Hz respectively.  
 
Treatment Amplitude and Frequency 
The treatment amplitude and frequency refers to the AC voltage amplitude and 
frequency that will be used to apply the electric field component of the BE treatment. 
Since the efficacy of the BE treatment is directly proportional to the total energy 
applied to the treatment, a higher magnitude signal of 0.1 V at 1 MHz is set at the 







Quiet time refers to the wait time that the potentiostat is temporarily inactive i.e. 
no data collection or AC application occurs, immediately after a complete set of 
impedance measurements are obtained from all the channels listed in the List 
Channels field. Three separate Quiet Time fields are listed in the GUI corresponding 
to the different modes of operation. The first quiet time is set to 300 seconds and is 
used during the Conditioning or Control mode. The second quiet time, set to 600 
seconds, is used only in the Seeding or Growth mode. The wait times for the latter 
two modes is set to twice that of the former two modes in order to avoid electrical 
signal-based detachment of bacterial cells during seeding or growth. Thus, impedance 
data is obtained more sparsely for the Seeding and Growth modes. The final quiet 
time is used only during the BE Treatment mode. 
 
Treatment Interval 
This field allows the user to enter an array of positive whole numbers (0, 1, 2, 
3,…n) and represents the number of cycles for which the electric field based 
treatment needs to be applied to each channel. The length of the array should be the 
same as the List Channels field array and the numbers of the field must be entered 
with blank spaces in between them. The number of minutes of electric field 
application is equal to ten times the number of cycles entered in this field. For 
example an entry of 0 corresponds to no electric field application to the 





application of 10, 20, 30,…, 10n minutes, respectively, across the IDEs of the 
corresponding channel.  
 
Treatment and Sensing Threshold 
The treatment threshold is defined as the relative percentage change in absolute 
impedance beyond which electric field-based treatment is initiated. The sensing 
threshold is defined as the relative percentage change in absolute impedance below 
which treatment application is terminated. Two separate thresholds were defined in 
order to allow for user flexibility and to account for any impedance measurement 
noise, which in our experiments was generally about 2-3 %. 
 
Growth Period before Sensing 
As the media and antibiotics are introduced to the channels of the bifurcation 
device through fluidic tubing, a fixed amount of time exists before the treatment 
introduced at one end of the Tygon tubing reaches the microfluidic channel of the 
PDMS device. The Growth Period before Sensing field was designed to account for 
this 6-8 hour time period after the change of source from growth media to treatment, 
during which the growth media in the Tygon tubing flows through the PDMS 
channels. After the mode is switched from Growth to Growth/Sensing/BETreatment a 
timer is set for the number of hours entered in the Growth Period before Sensing field 
and countdown is initiated. The control module does not switch from the Growth 
mode till the counter counts down to zero after which the control module switches 







This user-defined parameter is used to remove any outliers measured during the 
device Conditioning and Control modes of operation. The outlier threshold is defined 
as the upper limit percentage change in impedance greater than which the data 
obtained is considered as an outlier. The number of such outliers for each of the 
channels for the two modes i.e., Conditioning and Control, is enumerated in a 
separate text file named <File name>_outliers.txt. 
 
Mode 
The GUI permits the user to select the mode of operation of the experiment from 
a radio-button list of five modes. The five modes are 1. Conditioning, 2. Control, 3. 
Seeding, 4. Growth, and 5. Growth/Sensing/BETreatment corresponding to the five 
different phases of the experimental protocol, viz., PBS conditioning, LB growth 
media control, bacterial seeding of the microfluidic channel, biofilm growth using 
growth media flow, and finally the treatment by flowing antibiotic diluted in growth 
media. As explained in the previous paragraph, the last mode includes a brief growth 
phase during which the growth media in the Tygon tubing is allowed to flow through 
the device channels. Following this the mode changes to the sensing and the electric-
field based treatment mode. The code directs the switching between these two modes 
based on the real-time impedance measurements collected and the sensing and 






Modes of Operation 
At the end of each experimental phase the user can pause the experiment using the 
Start/Pause button, select the mode of operation from the radio-button list under the 
Mode field in the GUI and continue the experiment by pressing the Start/Pause 
button again. This section details the various modes of operation of the control 
module. Additionally, a comprehensive explanation of the need for each mode and 
each mode’s functionality is discussed. 
 
Conditioning 
The Conditioning mode is used during the buffer conditioning of the device. This 
mode creates plots and data files that are independent of the other modes of operation. 
The data collected during this mode is plotted as black hollow circles in the Figure 2 
window (Raw |Z|) of Figure 5-21. Three plots are generated for this mode per channel 
when the Generate graphs button is used. They are the raw impedance plot, the raw 
impedance plot with outliers removed, and the change in absolute impedance plot. 




The Control mode is generally used during the growth media baseline data 
generation. This mode also plots the real time data in the Figure 2 window (Raw |Z|) 
of Figure 5-21 but as solid black circles. The data collected in this mode serves as the 
baseline for all the data collected in all other modes of operation (except the 





that are independent of the Conditioning mode data files. The modes discussed below 
append data to these plots. 
 
Seeding 
On switching modes from Control to Seeding, the change in absolute impedance 
is calculated and plotted in the Figure 3 window shown in Figure 5-21. The 
impedance values measured in this mode are plotted in real-time as absolute 
impedance and the change in impedance in both windows respectively. In this mode, 
the data points are plotted as solid magenta circles to distinguish them from the data 
measured in the preceding modes. 
 
Growth 
The Growth mode is used to during the growth phase of the experiment. Similar 
to the Seeding mode the Growth mode plots the data in real-time as absolute 
impedance and change in absolute impedance in both MATLAB figure windows. 
These are plotted as green solid spheres.  
 
Growth, Sensing and Treatment 
The final mode of operation is the Growth/Sensing/BETreatment mode and this is 
used to record impedance data once the syringe pump is switched to infuse treatment 
into the fluidic tubing. As the name suggests this mode is a grouping of three 
individual modes. The growth segment of this mode records data, in exactly the same 





before sensing input. This option exists to account for the growth media that has 
already been introduced into the Tygon tubing prior to the introduction of the 
treatment solutions. The Sensing/BETreatment modes go hand-in-hand. In the 
Sensing mode the system gathers impedance data in real-time and plots them as 
absolute impedance and change in impedance in both MATLAB figure windows in 
solid blue circles. If the average of five consecutive impedance change measurements 
is larger than the Treatment threshold set by the user, the system switches into 
BETreatment mode. During this mode the potentiostat applies the electric field-based 
treatment (set using the Treatment amplitude and Treatment frequency) to the 
appropriate channels. A red solid circle in the plots marks application of the electric 
field-based treatment followed by an impedance measurement at the Sensing 
amplitude and frequency. After a complete cycle of the application of electric field-
based treatment to all the channels, the potentiostat switches back to the Sensing 
mode and performs five cycles of sensing across all the channels. If, for a given 
channel, the average change in impedance of the five consecutive sensing 
measurements is greater than the Treatment threshold the system switches once again 
into the BETreatment mode. However, if the average is less than the Sensing 
threshold, the system continues to remain in the Sensing mode. The system thus 
systematically and regularly checks for the average change in impedance and 
switches the system into the appropriate state based on the user-defined threshold 
values. This mode thus allows for the self-governing treatment based on the real-time 






Control Module Verification  
To verify and validate the functionality of the MATLAB control module code, a 
simulated biofilm growth experiment was performed. Two channels (channel 
numbers 5 and 7) out of four channels (channel numbers 4, 5, 6, and 7) were set to 
switch to BE-based treatment by setting the Treatment Interval field to 0 3 0 3. The 
various settings of the MATLAB GUI are listed in Table 5-4.  
 
Table	 5-4	 List	 of	 parameters	 values	 used	 during	 simulated	 biofilm	 growth	 experiment.	 The	 parameters	 not	
listed	below	were	set	to	their	default	values.	
Parameter Name Parameter Value 
List channels 4 5 6 7 
Sensing amplitude 0.005 V 
Sensing frequency 100 Hz 
Treatment amplitude 0.1 V 
Treatment frequency 1 MHz 
Quiet time (Control/Cond.) 3 seconds 
Quiet time (Seeding/Growth) 6 seconds 
Quiet time (Sensing/BETreatment) 10 seconds 
Treatment interval 0 3 0 3 
Treatment threshold 20 %  
Sensing threshold 15 % 






With no device connected to the machined test stage, the first hour of 
measurements corresponding to the control, seeding and initial growth phases were 
obtained with an open circuit. Just before entering the sensing phase of the 
experiment, a 5 kΩ resistor was connected between the two electrodes so as to 












Figure 5-22 presents the results of this simulated experiment. The connected 
resistor resulted in a large decrease in measured impedance, which after five sensing 
cycles triggered the BE Treatment in the channels 5 and 7 (red circles). Channels 4 
and 6 continued in the Sensing mode, as indicated by the blue circles in the plots, 
despite a similar change in the absolute impedance. To simulate the removal of 
biofilm, the 5 kΩ resistor was removed from channels 6 and 7 yielding a return to the 
baseline in both these channels. As the now measured impedance change is less than 
the set Sensing Threshold, channel 7 returns to operate solely in Sensing mode (blue 
circles) without entering the BETreatment cycle. However, channel 5 continues to 
measure the impedance across the resistor, thus remaining above the Treatment 
Threshold and continuing to switch between the Sensing and BETreatment cycles. 
This simulated experiment thus validates the functionality of the macro to switch 
between Sensing and BETreatment modes based on the set thresholds and the real-
time impedance measurements obtained during the Sensing mode of operation. 
  
5.2.3 Results 
With the functionality of the control macro established by means of a simulated 
biofilm growth experiment, a bifurcation device integrated with IDE sensors was used 
to demonstrate real-time sensing and threshold-activated BE treatment of E. coli 
biofilms. The various settings of the MATLAB GUI used for this experiment are 
listed in Table 5-5. The results at the end of the buffer conditioning, growth and 







Table	 5-5	 List	 of	 parameters	 values	 used	 during	 simulated	 biofilm	 growth	 experiment.	 The	 parameters	 not	
listed	below	were	set	to	their	default	values.	
Parameter Name Parameter Value 
List channels 4 5 6 7 
Sensing amplitude 0.005 V 
Sensing frequency 100 Hz 
Treatment amplitude 0.1 V 
Treatment frequency 1 MHz 
Quiet time (Control/Cond.) 300 seconds 
Quiet time (Seeding/Growth) 600 seconds 
Quiet time (Sensing/BETreatment) 300 seconds 
Treatment interval 0 3 0 3 
Treatment threshold 20 %  
Sensing threshold 15 % 




Figure 5-23 plots the change in absolute impedance for the four channels of the 









The	 channel	 numbers	 in	 the	 title	 of	 the	 subplot	 correspond	 to	 the	 physical	 channel	 address	 of	 the	 CH	
Instruments	multiplexer.	
 
greater than a 100 % change is marked an outlier and removed from the plot. In order 
to observe the trend in data and to remove the effect of outliers that record less than 
the 100 % outlier threshold, a moving average of the data is calculated (relevant 
MATLAB code is in Appendix C). Figure 5-24 plots the same data along with the 
moving average line for the four channels of the device. As observed from the plots, 












conditioning phase but stabilizes to near zero with time. Small fluctuations in 
measurements, as observed by the increase in impedance, are recorded over time and 
it is hypothesized to be a result of either small air bubbles trapped within the 
microfluidic channels that are eventually removed with time, or due to the intrinsic 






Figure 5-25 plots the change in 100 Hz impedance and the moving average 
(span of moving average = 5) through the end of the biofilm growth phase of the 
experiment. Following the PBS buffer conditioning, pure growth media was 
introduced into the channels and the impedance data measured for six hours in 




the	 four	 channels	 of	 the	 bifurcation	 device.	 The	 three	 different	 colors	 represent	 the	 three	 phases	 of	 the	








an overnight culture of E. coli W3110 suspended in growth media to a final OD600 ≈ 
0.25 is introduced into the device to seed the microfluidic channels and allow for 
bacterial attachment (no flow). The data obtained during this phase of the experiment 
is plotted in magenta in the plots. Subsequently, growth media is introduced into the 
channels at 20 µl/hr to allow for biofilm growth. The real-time change in 100 Hz 








Since the plots in Figure 5-25 are plotted on different y-axis scales, the observed 
change in impedance between the four channels appear to be significantly different 





channels 5 and 7, during the LB media control or the bacterial seeding stages, 
possibly due to the introduction of an air bubble in the channel. However, if these 
huge shifts in impedance were set aside, an equivalent net change in impedance is 
observed across all four channels from the start of growth to the end of growth during 
which a continuous supply of growth media is introduced into the microfluidic 
channels (Figure 5-26). 
Figure 5-26 plots the relative change in impedance for each of the four channels 
of the device during the growth phase, from around the 9-hour time point to the 34 
hour time point, with respect to first data point measured in the Growth mode. This 
plot highlights the near similar shift in impedance across all four channels of the 
device, which is suggestive of uniform biofilm growth in all the channels of the 
device. Additionally, it is worth noting that the magnitude of the change in impedance 
observed in Figure 5-26 is similar to that obtained in Figure 5-15, thus highlighting 
the reproducibility of the impedance based sensing methodology to detect biofilm 
growth in real-time. 
 
Threshold-activated Biofilm Treatment 
Following the growth of biofilms in all four channels of the device, different 
solutions, namely LB media or antibiotic (gentamicin 10 µg/ml in LB media) were 
introduced into the microfluidic channels. The treatments applied to the channels of 
the device over 24 hours are listed in Table 5-6. The channels 5 and 7 received the 








Channel No. Treatment Name Treatment Applied 
4 Control LB media only 
5 E-field Only LB media + 0.1 V at 1MHz 
6 Antibiotic  10 µg/ml gentamicin in LB media 
7 Bioelectric Effect (BE) 
10 µg/ml gentamicin in LB media + 
0.1 V at 1MHz 
 
sensing voltage applied to all the channels. The plots presented in Figure 5-27 show  
the 100 Hz change in impedance for the various channels for all the experimental 
phases i.e. control (black), seeding (magenta), growth (green), sensing (blue), all at 5 
mV and BE treatment (red) at 100 mV. 
Figure 5-27 plots the real-time change in absolute impedance at 100 Hz after the 
24-hour treatment period. Even after the treatment phase the untreated control 
(channel 4) and the electric field-only treatment (channel 5) show a further decrease 
in impedance suggestive of an increase in total biomass or more biofilm growth. On 
the other hand, treatment with antibiotic (channel 6) and BE (channel 7) resulted in an 
increase in 100 Hz impedance that represents the removal or decrease in total 
biomass.  
The change in 100 Hz impedance observed only during the treatment phase is 
plotted in Figure 5-28. This plot enables clear visualization and comparison of the 








Figure	5-27	Plots	showing	 the	real-time	change	 in	absolute	 impedance	at	100Hz,	captured	at	 the	end	of	 the	
treatment	 phase	 for	 the	 four	 channels	 of	 the	 bifurcation	 device.	 The	 different	 colors	 represent	 the	 various	
phases	of	the	experiment,	namely	the	LB	growth	media	control	 (black),	bacterial	seeding	(magenta),	biofilm	
growth	(green),	biofilm	sensing	 (blue)	and	biofilm	treatment	using	BE	 (red).	The	 line	plots	show	the	moving	
average	(span	=	5)	for	each	of	these	experimental	phases	for	the	four	channels.	
 
channels of the device. As shown in the figure, the control (green line) and E-field 
only (red line) treatments continue to measure a decrease in impedance even during 
the treatment phase, correlating with continued biofilm growth. In contrast the 








at	 the	end	of	 the	 treatment	phase.	While,	 the	 controls	 (control	 and	E-field)	 show	a	decrease	 in	 impedance	




direction indicating a decrease in biomass. It is also worth noting that the antibiotic 
treatment (magenta line) appears to be as effective in treating the biofilm as the BE 
treatment. This is similar to previously obtained results (Figure 5-16) presented in the 
earlier sub-section of this chapter. As mentioned before, it is hypothesized that the 
similar efficacies between the antibiotic and BE treatments is due to the periodic 
sensing voltage applied to the antibiotic treatment (channel 6) that also causes 





a result of only the antibiotic therapy but rather due to regular and recurring BE 
treatment that results in effective removal of the biofilm in the channel. 
 
Optical Validation 
To independently validate the results obtained using the impedance microsystem, 
analogous to section 3.4.4, end-point fluorescent images obtained for each channel of 
the device were analyzed using the image-processing program. Representative end-
point optical micrographs of the control and BE-treated biofilms are presented in 
Figure 5-29a-b. ImageJ analysis shows that the antibiotic and the BE treatment 
reduced the average biofilm surface coverage by ~82.4 % and ~87.9 %, respectively, 













In this section we presented a novel integrated impedance-based sensing and 
treatment microsystem that allowed for accurate real-time sensing and treatment of 
bacterial biofilms. Development of such an integrated system was not without its 
challenges, with the primary challenge encountered during the development of the 
MATLAB macro. The control macro was developed using a CHI proprietary closed-
source library whose functions needed to be debugged to ensure accurate macro 
functionality. As the source code for the library was not openly available, efficient 
ways to circumvent the specific library function errors had to be implemented into the 
MATLAB macro using either other library functions that were experimentally 
determined as error-free or self-developed code. This was a time consuming process 
and so we envision that future designs of the microsystem will include a 
microprocessor coded with self-designed error-free functions to make the data 
acquisition control macro more efficient and if needed functionally more diverse.  
Currently, the results discussed in this section successfully demonstrate that the 
microsystem can accurately measure the real-time change in impedance during the 
growth and removal of biofilms. Moreover, we showed that using a control module 
the sensor’s IDEs can be used to perceptively apply the electrical signal necessary to 
initiate BE treatment. Such effective treatment, using low amplitude signals, 
highlights the efficiency of this microsystem to sense and treat in situ bacterial 
biofilms concurrently in time. Our results suggest that even the small periodic 5 mV 
AC signal used for probing the impedance between the IDEs results in enhanced 





treatment. The second level of threshold-activated treatment using the MATLAB 
control macro can be used to help treat thicker and more mature biofilms that require 
much stronger BE treatment. This is a substantial advantage over our previous work 
with BE that applied a 500 mV electrical signal during the entire treatment period 
causing a long-term biocompatibility concern for medical devices as they on average 
require treatment over weeks. Thus, in contrast to former systems, this integration of 
sensing and BE treatment capabilities into purely the electrical domain provides an 
elegant microsystem solution for accurate threshold-activated sensing and treatment 
of biofilms.  
 
5.3 Chapter Summary 
A novel integration of sensing and treatment modules into an impedance-based 
microsystem was presented. The developed platform is the first impedimetric 
microsystem for real-time threshold-activated monitoring and treatment of bacterial 
biofilms in a microfluidic bifurcation device. It allows for accurate real-time sensing 
and treatment of bacterial biofilms within a single domain, thus facilitating a 
significant decrease in device footprint and reduction in additional bulky equipment. 
The IDE sensors were demonstrated to detect biofilm growth in real-time. Using the 
measured impedance change and user inputs, provided through a convenient and 
simple graphical interface, the MATLAB control module intelligently switched the 
system into treatment mode. Treatment was performed by applying a 100 mV signal, 
for only a small fraction of the total treatment period, across the same IDEs in 





autonomy for treatment, by removing biofilms through periodic low energy BE 
treatment even while monitoring the biofilms through impedimetric measurements. 
Such application of BE, both during and in response to biofilm growth will ultimately 
enable effective rapid and autonomous in situ infection management, thus preventing 







Chapter 6. Conclusions 
6.1 Summary 
The use of high doses of antibiotics for treatment of chronic biofilm infections is 
resulting in the emergence of antibiotic-resistant bacterial strains, necessitating the 
development of new treatments that are not based on antibiotic therapies. In this 
work, a novel bacterial biofilm combination treatment independent of traditional 
antibiotics using only small molecule inhibitors of bacterial quorum sensing or AI-2 
analogs with low electric fields was studied using both macro and micro-scale 
devices. Crystal violet staining of the macro-scale biofilms and confocal imaging of 
microfluidic biofilms showed a significant decrease in biomass compared to the 
untreated control. The enhanced treatment efficacy of this combination therapy was 
also demonstrated using a high-throughput bifurcation-based microfluidic biofilm 
analysis platform combined with different real-time transduction methods, like a 
linear array of charge-coupled device for monitoring change in OD. The combination 
treatment showed almost twice the treatment efficacy compared to antibiotic therapy 
alone indicating it might provide an effective alternative to traditional antibiotic 
therapies against bacterial biofilm infections. The use of this treatment method in 
both the medical and environmental fields would alleviate the need for high-dosage 
antibiotic therapies, thus greatly reducing the rise of antibiotic-resistant bacteria. 
Secondly, this work tried to delve into the possible mechanism of action of the BE 
treatment. BE has been under investigation for about two decades, and researchers 
have shown the use of small doses of antibiotics with AC, DC and SP signals, 





dissertation tried to answer part of the complex mechanism by focusing on the energy 
of the electrical signal applied for potentials <1 V. We find that in this range of 
potentials, the type of signal does not affect the effectiveness of the treatment as once 
hypothesized, rather it is the total energy applied to the treatment, which could be 
through increased signal voltage or through extended durations of treatment time, that 
affects the BE treatment efficacy. We show that the success of this treatment, as 
measured using CFU count or biomass quantification, is linearly dependent on the 
energy applied, which will enable deterministic modification to the treatment. The 
results presented in this work, will allow for easier integration of the BE into 
microsystems developed for in vivo studies, as the dependence of BE on the energy 
will allow for efficient utilization of nearby electronics and to potentially transmit 
power wirelessly in the form of an AC signal. Consequently, true understanding of 
the mechanism of action of the BE will allow for more flexibility and ease of 
integration of the BE into various applications in both the clinical and environmental 
fields. 
Another key goal of this work is the development of a new sensing and treatment 
technology designed to aid in vitro microfluidic biofilm investigations and perform 
threshold-activated sensing and treatment of in situ infections. While many different 
platforms and evaluation methods for the characterization, sensing and treatment of 
bacterial biofilms exist, they each come with their own set of advantages and 
disadvantages. The microsystem developed in this work combines the advantages of 





The platform was designed to enable rapid, non-invasive, real-time biofilm 
monitoring and self-directed treatment. IDE impedance sensors such as previously 
used for macroscopic analysis of biofilms (in 96-well plates or CDC reactors), were 
integrated with a multi-experiment bifurcation-based microfluidic device that allowed 
precise control of the microenvironment within the channels. The microfluidic flow 
cell design addressed the high growth variation between biofilms grown in separate 
channels through spatially sectioning a single biofilm into separate channels using 
microfluidic flow bifurcation. This allowed for a more reliable comparison and 
evaluation of new biofilm treatments on a single device. Threshold-activated 
treatment, based on the principles of BE, was demonstrated using the microsystem, 
which will ultimately enable rapid and effective in situ biofilm management, 
preventing post-surgery infections or environmental contamination leading to 
significantly improved quality of life for millions.  
 
6.2 Future Work 
The research conducted as part of this dissertation raises additional questions that 
require further investigation. These questions fall into one of three categories – 1. 
technological improvements that will enhance the functionality, sensitivity or 
accuracy of the developed platform; 2. optimization-oriented, to develop better 
methods of biofilm prevention or treatment by perform optimizations of current 






For the developed µTAS platform, an immediate technological advancement 
would be the integration with bio-recognition elements like antibodies, for target 
specific recognition of different pathogenic biofilm forming bacteria. Such integration 
will provide real-time sensing of specific pathogenic bacteria of interest in a multi-
species environment.  
One of the major challenges with using IDEs is the interplay between the 
sensitivity of the system and the dynamic range of operation. Increasing one would 
require compromising on the other. One potential method to optimize for this is by 
using graded IDEs, i.e. IDEs with continuously varying widths and spacings. These 
can be tested and optimized for sensitivity, while extending the linear range of 
operation of the device. Detailed impedance information obtained through such an 
optimized system would provide information on the long-term dynamic growth 
behavior of mature biofilms. 
The combination treatment tested in this work used one concentration of the AI-2 
analog with a fixed strength of electric field. Optimization of the analog concentration 
and the field strength would reduce any adverse side effects that this treatment may 
induce. Such optimizations also assure that the best result is obtained while 
minimizing usage of resources like power. Moreover, this treatment needs to be tested 
on co-cultured bacterial and mammalian cells. To date, no detailed studies on the 
adverse side effects of AI-2 analogs on mammalian cells have been shown. For this 
system to be applicable in a clinical setting, such toxicity studies need to be 





This system also needs to be verified for different Gram positive and Gram 
negative bacteria and their corresponding AI-2 analogs, for efficacy and for optimized 
parameters. Specifically, experiments need to be conducted with clinically relevant 
bacterial strains and studies demonstrating the use of this treatment to prevent the 
formation and growth of these biofilms using the developed lab-on-a-chip platform 
need to be performed. Such studies will not only provide insight into new strategies 
for biofilm prevention but also expand our understanding of the biofilm formation 
process of different bacteria while still under treatment. 
 
 
Figure	6-1	 Schematic	of	possible	 future	designs	 for	 flexible	 sensor	 -treatment	devices	 that	 can	be	used	 in	a	
catheter.	
 
The work presented in this dissertation was carried out with the long-term end-
goal of miniaturization for application in a clinical setting in mind. The developed 
system can be easily modified and fabricated on a flexible substrate for sensing and 
treatment of biofilms in situ, for example in catheters and stents as shown in Figure 





sensitivity and other critical parameters. Additionally, multiple bacterial strains and 
bacteria-mammalian cell co-cultures would need to be tested.  
Finally, to make the system fully autonomous, it is necessary to integrate this 
system with self-powering abilities. Wireless power transfer through inductive 
coupling with high efficiency rates has already been achieved. Also, easy packaging 
methodology into medical devices needs to be developed. Such a system level 
integration of the developed microsystem will enable true testing in in vivo models 
and validate the efficacy of this system and the developed treatment. 
 
6.3 Conclusion 
The rise in super-bugs and antibiotic-resistant infections due to biofilms over the 
last few years has created a global health challenge. This has necessitated the need for 
efficient tools and methods to characterize and evaluate these organisms, as well as 
for trying to develop sensitive methods to detect these infections in situ and for 
conceiving new antibiotic-free therapies. This dissertation addresses these needs 
through the development of a sensing and treatment microsystem that can be used 
either in conjunction with the bifurcation microfluidics as a cheap, high-throughput 
platform for in vitro evaluation of biofilm growth and new treatment testing, or as a 
sensitive threshold-activated sensor-treatment solution for in situ biofilm infection 
management. Additionally, the initial results presented on the novel combination 
treatment show promise for it to be used as an antibiotic-free method for effective 
biofilm treatment. Lastly, we believe that insight gained into the mechanism of action 





of this organism and its treatment, and in so doing pave the way for the development 








Appendix A: Masks Used 














































Appendix C: MATLAB Code 
CH Instruments Data Analysis 
PBS Pre-Conditioning  
% THIS CODE IS FOR PBS CONTROL SAMPLES ONLY 
  
% Set MATLAB work path to folder with CHI data files 
  
%Manually enter values of N, start and end time and date, change the 
names 
%of filename and filename2 to files to be analysed 
filepath = '\'; % Enter your data folder path 
filepath_temp = 'Z:\MSAL User\Sowmya\Biofilm impedance sensing\CHI 
Data\Temp\'; %Enter filepath for temp files 
  
startPBS = 1; % start file number of PBS 
endPBS = 165; % end file number of PBS 
  
start_date = 5; %enter start date  
start_hour = 10; % enter starting hour in 24 hour format 
start_min = 36; % enter starting minute 
  
end_date = 6; %enter end date  
end_hour = 6; % enter end hour in 24-hour format 
end_min = 38; % enter end minute 
  
N= endPBS-startPBS+1; % N= number of txt files/runs of the CHI 
M = 60; % M = number of numeric lines in each CHI output text file 
  
Total_time =  (end_date - start_date) * 24 * 60 * 60 + (end_hour - 
start_hour)* 60 * 60 + (end_min - start_min) * 60 ; % Calculate 
total time in seconds 
  
Time_step = Total_time/(N-1); % average step time in seconds between 
two consecutive runs 
  
Time_s = 0: Time_step: Total_time; % create an array called time 
Time_h = Time_s/(60*60); % row array of time in hours 
Final_time = Time_h'; % column array of time in hours 
  
Final_data = zeros(M,5*N); %size of final data array 
Final_realZ = zeros(M,N); %size of final real Z data array 
Final_imZ = zeros(M,N); %size of final im Z data array 
Final_absZ = zeros(M,N); %size of final abs Z data array 
Final_phase = zeros(M,N); %size of final phase of Z data array 
  
j= 1; % counter 
column = 1; % counter for column of final arrays 





    filename = [filepath 'imp-PBS' num2str(i) '.txt']; %give path to 
files you want to analyse 
    fid = fopen(filename, 'r') ;  % Open source file. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    buffer = fread(fid, Inf) ;  % Read rest of the file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'imp-PBS' num2str(i) '_TRUNC.txt']; 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid) ; 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
    for x=1:M 
        Frequency(x,1) = Transpose_Temp(x,1);  
        x=x+1; 
    end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 





        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 
      column = column+1; 
end 
  
% plot figures   
  
% Real of Z versus frequency on a log log scale 
figure 
loglog(Frequency,Final_realZ(:,startPBS), 'r', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,25),'b', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,50),'g', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,75),'k', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,100),'c', 'LineWidth', 2.0) 
hold on 
% loglog(Frequency,Final_realZ(:,125),'r--', 'LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_realZ(:,150),'b--', 'LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_realZ(:,175),'g--', 'LineWidth', 2.0) 
% hold on 
loglog(Frequency,Final_realZ(:,N),'k--', 'LineWidth', 2.0) 
title('Re Z v. frequency', 'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('Re Z (ohms)', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ReZ_vs_Freq 
hold off 
  
% Im of Z versus frequency on a log log scale 
figure 










% loglog(Frequency,Final_imZ(:,125),'r--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_imZ(:,150),'b--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_imZ(:,175),'g--','LineWidth', 2.0) 






title('Im Z v. frequency', 'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('Im Z (ohms)', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ImZ_vs_Freq 
hold off 
  
% Abs Z versus frequency on a log log scale 
figure 










% loglog(Frequency,Final_absZ(:,125),'r--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_absZ(:,150),'b--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_absZ(:,175),'g--','LineWidth', 2.0) 
% hold on 
loglog(Frequency,Final_absZ(:,N),'k--','LineWidth', 2.0) 
title('|Z| v. frequency', 'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('|Z| (ohms)', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_vs_Freq 
hold off 
  
% Phase versus frequency on a log log scale 
figure 










% loglog(Frequency,Final_phase(:,125),'r--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_phase(:,150),'b--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_phase(:,175),'g--','LineWidth', 2.0) 
% hold on 
loglog(Frequency,Final_phase(:,N),'k--','LineWidth', 2.0) 
title('Phase of |Z| v. frequency', 
'FontSize',20,'FontWeight','bold') 







print -dpng -r300 Phase_vs_Freq 
hold off 
  
% Real of Z versus time  
figure 











title('Re Z v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time (hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Re Z (ohms)', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ReZ_vs_Time 
hold off 
  
% Im of Z versus time(hrs) 
figure 











title('Im Z v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Im Z (ohms)', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ImZ_vs_Time 
hold off 
  
% Abs Z versus time(hrs)  
figure 















title('|Z| v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('|Z| (ohms)', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_vs_Time 
hold off 
  
% Phase versus time(hrs)  
figure 











title('Phase v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Phase', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Phase_vs_Time 
hold off 
  





title('|Z| v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('|Z| (ohms)', 'FontSize',20,'FontWeight','bold') 
legend( '100 kHz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_100KHz_vs_Time 
hold off 
  





title('Phase v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Phase', 'FontSize',20,'FontWeight','bold') 
legend( '100 kHz') 
set(gca,'fontsize',16,'FontWeight','bold') 







% Change in Z with respect to baseline obtained using PBS 
  
baseline_absZ_PBS = mean(Final_absZ, 2); %  average baseline PBS 
absZ value for each frequency 
baseline_imZ_PBS = mean(Final_imZ,2); %  average baseline PBS imZ 
value for each frequency 
baseline_realZ_PBS = mean(Final_realZ,2); %  average baseline PBS 
realZ value for each frequency 
baseline_phase_PBS = mean(Final_phase,2); %  average baseline PBS 
phase value for each frequency 
  
  
for i =1:N 
    delta_absZ(:,i) = (Final_absZ(:,i) - 
baseline_absZ_PBS)./baseline_absZ_PBS ; 
    delta_imZ(:,i) = (Final_imZ(:,i) - 
baseline_imZ_PBS)./baseline_imZ_PBS ; 
    delta_realZ(:,i) = (Final_realZ(:,i) - 
baseline_realZ_PBS)./baseline_realZ_PBS ; 
    delta_phase(:,i) = (Final_phase(:,i) - 
baseline_phase_PBS)./baseline_phase_PBS ; 




plot(Time_h,delta_realZ) % plot the change in realZ with respect to 
time 
title ('Change in ReZ with time','FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ReZ-ReZ_{PBS Baseline}) / ReZ_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_realZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(60,:),'m', 'linewidth', 2.0) 
title ('Change in ReZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ReZ-ReZ_{PBS Baseline}) / ReZ_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  










plot(Time_h,delta_imZ) % plot the change in imZ with respect to  
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ImZ-ImZ_{PBS Baseline}) / ImZ_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_imZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(60,:),'m', 'linewidth', 2.0) 
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ImZ-ImZ_{PBS Baseline}) / ImZ_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 





plot(Time_h,delta_absZ) % plot the change in absZ with respect to  
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{PBS Baseline}) / |Z|_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_absZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(24,:),'g', 'linewidth', 2.0) 
hold on 






plot(Time_h,delta_absZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(60,:),'m', 'linewidth', 2.0) 
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{PBS Baseline}) / |Z|_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_phase) % plot the change in absZ with respect to  
title ('Change in phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(Phase-Phase_{PBS Baseline}) / Phase_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_phase(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(60,:),'m', 'linewidth', 2.0) 
title ('Change in phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(phase-phase_{PBS Baseline}) / phase_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Change_phase_vs_Time_2 
hold off 
  
%Plotting phase, real, imaginary and absolute relative change in Z 
for 100Hz 
figure 
plot(Time_h,delta_phase(48,:),'c', 'linewidth', 2.0) 
title ('Change in Phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 






legend( '100 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_realZ(48,:),'c', 'linewidth', 2.0) 
title ('Change in ReZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ReZ-ReZ_{PBS Baseline}) / ReZ_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_imZ(48,:),'c', 'linewidth', 2.0) 
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 








plot(Time_h,delta_absZ(48,:),'c', 'linewidth', 2.0) 
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{PBS Baseline}) / |Z|_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Change_absZ_100Hz_vs_Time 
hold off 
  
%Plotting phase, real, imaginary and absolute relative change in Z 
for 100kHz 
figure 
plot(Time_h,delta_phase(12,:),'b', 'linewidth', 2.0) 
title ('Change in phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 












plot(Time_h,delta_realZ(12,:),'b', 'linewidth', 2.0) 
title ('Change in ReZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 








plot(Time_h,delta_imZ(12,:),'b', 'linewidth', 2.0) 
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 








plot(Time_h,delta_absZ(12,:),'b', 'linewidth', 2.0) 
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{PBS Baseline}) / |Z|_{PBS Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 kHz'); 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Change_absZ_100kHz_vs_Time 
hold off 
  
%Time in hours for each of the three steps of the experiment 
PBSControl_Time = (N-1) * Time_step/(60*60) 
  
%delete the _TRUNC temp files in the TEMP folder 








Biofilm Growth and Treatment 
% THIS CODE IS FOR BIOFILM GROWTH AND BE TREATMENT RUNS ONLY. THE 
RUNS WILL HAVE A LB WITH 
% GENTAMICIN/LB ONLY CONTROL, SEEDING, BIOFILM GROWTH, BIOFILM 
GROWTH-PRETREATMENT AND BIOFILM TREATMENT 
% PHASES 
  
% Set MATLAB work path to folder with CHI data files 
  
%Manually enter values of N, start and end time and date, change the 
name 
% of filename and filename2 to files to be analysed 
filepath = '\'; % Enter your data folder path 
filepath_temp = 'Z:\MSAL User\Sowmya\Biofilm impedance sensing\CHI 
Data\Temp\'; %Enter filepath for temp files 
  
startLB = 1; % start file number of LB 
endLB = 25; % end file number of LB 
startSeed = 1; % start file number of Seeding 
endSeed = 11; % end file number of Seeding 
startGrowth = 1; % start file number of Growth 
endGrowth = 100; % end file number of Growth 
startPreTreat = 1; % start file number of Pre-Treatment 
endPreTreat = 41; % end file number of Pre-Treatment 
startTreat = 1; % start file number of Treatment 
endTreat = 63; % end file number of Treatment 
  
start_date = 3; %enter start date  
start_hour = 15; % enter starting hour in 24 hour format 
start_min = 18; % enter starting minute 
  
end_PreTreat_date = 5; %enter end Pre-Treat date  
end_PreTreat_hour = 10; % enter end Pre-Treat hour in 24 hour format 
end_PreTreat_min = 36; % enter end Pre-Treat minute 
  
end_date = 6; %enter end Treat date  
end_hour = 12; % enter end Treat hour in 24-hour format 
end_min = 18; % enter end Treat minute 
  
M = 60; % M = number of numeric lines in each CHI output text file 
Treatment_buffer = 0 ; % Enter number of hours before completion of 
the 24 hour-growth phase that you start treatment 
  
N1 = endLB - startLB + 1; % N1= number of txt files/runs of the CHI 
for LB control 
N2 = endSeed - startSeed + 1; % N2= number of txt files/runs of the 
CHI for Seeding 
N3 = endGrowth - startGrowth + 1; % N3= number of txt files/runs of 
the CHI for Bioilfm growth 
N4 = endPreTreat - startPreTreat + 1; % N4= number of txt files/runs 
of the CHI for Bioilfm Pre-Treatment 
N5 = endTreat - startTreat + 1; % N5= number of txt files/runs of 






N_sense = N1+N2+N3+N4; % Total number of files with equal times of 
sensing 
N = N1+N2+N3+N4+N5; % Total number of files 
Total_time_sense =  (end_PreTreat_date - start_date) * 24 * 60 * 60 
+ (end_PreTreat_hour - start_hour)* 60 * 60 + (end_PreTreat_min - 
start_min) * 60 ; % Calculate total time in seconds during sensing 
Total_time_treat =  (end_date - end_PreTreat_date) * 24 * 60 * 60 + 
(end_hour - end_PreTreat_hour)* 60 * 60 + (end_min - 
end_PreTreat_min) * 60 ; % Calculate total time in seconds during 
treatment 
  
Time_step_sense = Total_time_sense/(N_sense-1); % average step time 
in seconds between two consecutive runs during sensing 
Time_step_treat = Total_time_treat/(N5-1); % average step time in 
seconds between two consecutive runs during treatment 
  
Time_s_sense = 0: Time_step_sense: Total_time_sense; % create an 
array called time_s_sense 
Time_h_sense = Time_s_sense/(60*60); % row array of time in hours 
during sensing 
Final_time_sense = Time_h_sense'; % column array of time in hours 
during sensing 
  
Time_s_treat = Total_time_sense+Time_step_treat: Time_step_treat: 
Total_time_sense + Total_time_treat+Time_step_treat; % create an 
array called time_s_treat 
Time_h_treat = Time_s_treat/(60*60); % row array of time in hours 
during treatment 
Final_time_treat = Time_h_treat'; % column array of time in hours 
during treatment 
  
Time_h = cat(2, Time_h_sense, Time_h_treat); % Concatenate both time 
arrays to Time_h in one row 
Final_time = Time_h'; % column array of total time in hours 
  
Final_data = zeros(M,5*N); %size of final data array 
Final_realZ = zeros(M,N); %size of final real Z data array 
Final_imZ = zeros(M,N); %size of final im Z data array 
Final_absZ = zeros(M,N); %size of final abs Z data array 
Final_phase = zeros(M,N); %size of final phase of Z data array 
  
j= 1; % counter 
column = 1; % counter for column of final arrays 
  
% Analyze LB control files 
for i = startLB:endLB 
    filename = [filepath 'imp-LB' num2str(i) '.txt']; %give path to 
files you want to analyse 
    fid = fopen(filename, 'r') ;  % Open source file. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 





    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    buffer = fread(fid, Inf) ;  % Read rest of the file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'imp-LB' num2str(i) '_TRUNC.txt']; 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid); 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
    for x=1:M 
        Frequency(x,1) = Transpose_Temp(x,1);  
        x=x+1; 
    end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 







%Analyse seeding files 
for i = startSeed:endSeed 
    filename = [filepath 'imp-Seeding' num2str(i) '.txt']; %give 
path to files you want to analyse 
    fid = fopen(filename, 'r') ;  % Open source file. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    buffer = fread(fid, Inf) ;  % Read rest of the file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'imp-Seeding' num2str(i) 
'_TRUNC.txt']; 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid) ; 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
%     for x=1:M 
%         Frequency(x,1) = Transpose_Temp(x,1);  
%         x=x+1; 
%     end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 





     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 




% Analyze Growth files 
for i = startGrowth:endGrowth 
    filename = [filepath 'imp-Growth' num2str(i) '.txt']; %give path 
to files you want to analyse 
    fid = fopen(filename, 'r') ;  % Open source file. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    buffer = fread(fid, Inf) ;  % Read rest of the file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'imp-Growth' num2str(i) 
'_TRUNC.txt']; 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid) ; 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
%     for x=1:M 





%         x=x+1; 
%     end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 
      column = column+1; 
end 
  
% Analyze Pre-Treatment files 
for i = startPreTreat:endPreTreat 
    filename = [filepath 'imp-GrowthPreTreat' num2str(i) '.txt']; 
%give path to files you want to analyse 
    fid = fopen(filename, 'r') ;  % Open source file. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    buffer = fread(fid, Inf) ;  % Read rest of the file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'imp-GrowthPreTreat' num2str(i) 
'_TRUNC.txt']; 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 






    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
%     for x=1:M 
%         Frequency(x,1) = Transpose_Temp(x,1);  
%         x=x+1; 
%     end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 
      column = column+1; 
end 
  
% Analyze Treatment files 
for i = startTreat:endTreat 
    filename = [filepath 'imp-Treat' num2str(i) '.txt']; %give path 
to files you want to analyse 
    fid = fopen(filename, 'r') ;  % Open source file. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;                    % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 





    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    fgetl(fid) ;     % Read/discard line. 
    buffer = fread(fid, Inf) ;  % Read rest of the file. 
    fclose(fid); 
  
    filename2 = [filepath_temp 'imp-Treat' num2str(i) '_TRUNC.txt']; 
    fid = fopen(filename2, 'w')  ;   % Open destination file. 
    fwrite(fid, buffer) ;            % Save to file without header. 
    fclose(fid) ; 
  
    %copy each file content into a temporary array named Temp 
    fileID = fopen (filename2, 'r'); 
    formatSpec = '%f, %f, %f, %f, %f'; 
    sizeTemp = [5 M]; 
    Temp = fscanf(fileID, formatSpec, sizeTemp); 
    fclose(fileID); 
    Transpose_Temp = Temp'; 
     
    % Array frequency contains a column array of the frequencies at 
which measurements were obtained 
%     for x=1:M 
%         Frequency(x,1) = Transpose_Temp(x,1);  
%         x=x+1; 
%     end 
     
    %append contents of the array Temp to the final data arrays 
    for x=1:M  
        shift_y=j; 
        for y=1:5 
        Final_data(x,shift_y) = Transpose_Temp(x,y); 
        y=y+1; 
        shift_y=shift_y+1; 
        end 
    end 
    j = j+5; % increment counter by 5 columns 
     
    % Write into individual arrays 
    for a=1:M 
        Final_realZ(a,column)= Transpose_Temp(a,2); 
        Final_imZ(a,column)= Transpose_Temp(a,3); 
        Final_absZ(a,column)= Transpose_Temp(a,4); 
        Final_phase(a,column) = Transpose_Temp(a,5); 
        a=a+1; 
    end 
      column = column+1; 
end 
  
% plot figures 
% Real of Z versus frequency on a log log scale 
figure 
loglog(Frequency,Final_realZ(:,1), 'r', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,25),'b', 'LineWidth', 2.0) 
hold on 






loglog(Frequency,Final_realZ(:,75),'k', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,100),'c', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,125),'r--', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,150),'b--', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,175),'g--', 'LineWidth', 2.0) 
hold on 
loglog(Frequency,Final_realZ(:,N),'k--', 'LineWidth', 2.0) 
title('Re Z v. frequency', 'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('Re Z (ohms)', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ReZ_vs_Freq 
hold off 
  
% Im of Z versus frequency on a log log scale 
figure 
loglog(Frequency,Final_imZ(:,1), 'r', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,25),'b', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,50),'g', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,75),'k', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,100),'c', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,125),'r--', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,150),'b--', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,175),'g--', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_imZ(:,N),'k--', 'linewidth', 2.0) 
title('Im Z v. frequency', 'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('Im Z (ohms)', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ImZ_vs_Freq 
hold off 
  
% Abs Z versus frequency on a log log scale 
figure 
loglog(Frequency,Final_absZ(:,1), 'r', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_absZ(:,25),'b', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_absZ(:,50),'g', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_absZ(:,75),'k', 'linewidth', 2.0) 
hold on 






loglog(Frequency,Final_absZ(:,125),'r--', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_absZ(:,150),'b--', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_absZ(:,175),'g--', 'linewidth', 2.0) 
hold on 
loglog(Frequency,Final_absZ(:,N),'k--', 'linewidth', 2.0) 
title('|Z| v. frequency', 'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('|Z| (ohms)', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_vs_Freq 
hold off 
  
% Phase versus frequency on a log log scale 
figure 










% loglog(Frequency,Final_phase(:,125),'r--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_phase(:,150),'b--','LineWidth', 2.0) 
% hold on 
% loglog(Frequency,Final_phase(:,175),'g--','LineWidth', 2.0) 
% hold on 
loglog(Frequency,Final_phase(:,N),'k--','LineWidth', 2.0) 
title('Phase of |Z| v. frequency', 
'FontSize',20,'FontWeight','bold') 
xlabel('frequency (Hz)', 'FontSize',20,'FontWeight','bold') 
ylabel('Phase', 'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Phase_vs_Freq 
hold off 
  
% Real of Z versus time  
figure 
plot(Time_h,Final_realZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_realZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_realZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_realZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_realZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_realZ(60,:),'m', 'linewidth', 2.0) 





xlabel('time (hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Re Z (ohms)', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ReZ_vs_Time 
hold off 
  
% Im of Z versus time(hrs) 
figure 
plot(Time_h,Final_imZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_imZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_imZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_imZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_imZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_imZ(60,:),'m', 'linewidth', 2.0) 
title('Im Z v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Im Z (ohms)', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 ImZ_vs_Time 
hold off 
  
% Abs Z versus time(hrs)  
figure 
plot(Time_h,Final_absZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_absZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_absZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_absZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_absZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,Final_absZ(60,:),'m', 'linewidth', 2.0) 
title('|Z| v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('|Z| (ohms)', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_vs_Time 
hold off 
  
% Phase versus time(hrs)  
figure 















title('Phase v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Phase', 'FontSize',20,'FontWeight','bold') 
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Phase_vs_Time 
hold off 
  
% Abs Z versus time(hrs) Only 100 kHz 
figure 
plot(Time_h,Final_absZ(12,:),'b', 'linewidth', 2.0) 
%hold on 
%plot(Time_h,Final_absZ(24,:),'g') 
title('|Z| v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('|Z| (ohms)', 'FontSize',20,'FontWeight','bold') 
legend( '100 kHz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 AbsZ_100KHz_vs_Time 
hold off 
  





title('Phase v. time(hrs)', 'FontSize',20,'FontWeight','bold') 
xlabel('time(hrs)', 'FontSize',20,'FontWeight','bold') 
ylabel('Phase', 'FontSize',20,'FontWeight','bold') 
legend( '100 kHz') 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Phase_100KHz_vs_Time 
hold off 
  
% Change in Z with respect to baseline obtained using LB 
for i=1:N1 
    LB_absZ(:,i) = Final_absZ(:,i); 
    LB_imZ(:,i) = Final_imZ(:,i); 
    LB_realZ(:,i) = Final_realZ(:,i); 
    LB_phase(:,i) = Final_phase(:,i); 
    i=i+1; 
end 
  
baseline_absZ_LB = mean(LB_absZ, 2); %  average baseline LB absZ 
value for each frequency 
baseline_imZ_LB = mean(LB_imZ,2); %  average baseline LB imZ value 
for each frequency 
baseline_realZ_LB = mean(LB_realZ,2); %  average baseline LB realZ 





baseline_phase_LB = mean(LB_phase,2); %  average baseline LB phase 
value for each frequency 
  
for i =1:N 
    delta_absZ(:,i) = (Final_absZ(:,i) - 
baseline_absZ_LB)./baseline_absZ_LB ; 
    delta_imZ(:,i) = (Final_imZ(:,i) - 
baseline_imZ_LB)./baseline_imZ_LB ; 
    delta_realZ(:,i) = (Final_realZ(:,i) - 
baseline_realZ_LB)./baseline_realZ_LB ; 
    delta_phase(:,i) = (Final_phase(:,i) - 
baseline_phase_LB)./baseline_phase_LB ; 




plot(Time_h,delta_realZ) % plot the change in realZ with respect to  
title ('Change in ReZ with time','FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ReZ-ReZ_{LB}) / ReZ_{LB}', 
'FontSize',20,'FontWeight','bold') 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_realZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_realZ(60,:),'m', 'linewidth', 2.0) 
title ('Change in ReZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ReZ-ReZ_{LB}) / ReZ_{LB}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_imZ) % plot the change in imZ with respect to  
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ImZ-ImZ_{LB}) / ImZ_{LB}', 
'FontSize',20,'FontWeight','bold');  
set(gca,'fontsize',16,'FontWeight','bold') 








plot(Time_h,delta_imZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_imZ(60,:),'m', 'linewidth', 2.0) 
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(ImZ-ImZ_{LB}) / ImZ_{LB}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 





plot(Time_h,delta_absZ) % plot the change in absZ with time  
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{LB}) / |Z|_{LB}', 
'FontSize',20,'FontWeight','bold');  
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_absZ(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_absZ(60,:),'m', 'linewidth', 2.0) 
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{LB}) / |Z|_{LB}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 








plot(Time_h,delta_phase) % plot the change in phase with time  
title ('Change in phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(Phase-Phase_{LB}) / Phase_{LB}', 
'FontSize',20,'FontWeight','bold');  
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_phase(1,:), 'r', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(12,:),'b', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(24,:),'g', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(36,:),'k', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(48,:),'c', 'linewidth', 2.0) 
hold on 
plot(Time_h,delta_phase(60,:),'m', 'linewidth', 2.0) 
title ('Change in phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(phase-phase_{LB}) / phase_{LB}', 
'FontSize',20,'FontWeight','bold');  
legend('825 kHz', '100 kHz', '10 kHz', '1 kHz', '100 Hz', '10 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 
print -dpng -r300 Change_phase_vs_Time_2 
hold off 
  




plot(Time_h,delta_phase(48,:),'c', 'linewidth', 2.0) 
title ('Change in Phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(Phase-Phase_{LB}) / Phase_{LB}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_realZ(48,:),'c', 'linewidth', 2.0) 
title ('Change in ReZ with time', 
'FontSize',20,'FontWeight','bold'); 





ylabel ('(ReZ-ReZ_{LB Baseline}) / ReZ_{LB Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




plot(Time_h,delta_imZ(48,:),'c', 'linewidth', 2.0) 
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 








plot(Time_h,delta_absZ(48,:),'c', 'linewidth', 2.0) 
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{LB Baseline}) / |Z|_{LB Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 Hz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




%Plotting real, imaginary and absolute relative change in Z for 
100kHz 
figure 
plot(Time_h,delta_phase(12,:),'b', 'linewidth', 2.0) 
title ('Change in phase with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 








plot(Time_h,delta_realZ(12,:),'b', 'linewidth', 2.0) 
title ('Change in ReZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 












plot(Time_h,delta_imZ(12,:),'b', 'linewidth', 2.0) 
title ('Change in ImZ with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 








plot(Time_h,delta_absZ(12,:),'b', 'linewidth', 2.0) 
title ('Change in |Z| with time', 
'FontSize',20,'FontWeight','bold'); 
xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
ylabel ('(|Z|-|Z|_{LB Baseline}) / |Z|_{LB Baseline}', 
'FontSize',20,'FontWeight','bold');  
legend( '100 kHz'); 
set(gca,'fontsize',16,'FontWeight','bold') 




%Time in hours for each of the three steps of the experiment 
LBControl_Time = (N1-1) * Time_step_sense/(60*60) 
Seeding_Time = LBControl_Time + N2 * Time_step_sense/(60*60) 
Growth_Time = Seeding_Time + N3 * Time_step_sense/(60*60) + N4 * 
Time_step_sense/(60*60) 
Treat_Time = Growth_Time + (N5-1) * Time_step_treat/(60*60) + 
Time_step_treat/(60*60) 
  
%delete the _TRUNC temp files in the TEMP folder 









Real-time Threshold-activated Sensing-Treatment  
% Last edited on : 2/1/2015 13:00 
% Installation Notes: 
% MUST use 32 bit install of Matlab!! 64 bit WILL NOT WORK! 
% No LabVIEW install necessary! 
  
% Copy folder, including all files, from MSAL server - \MSAL 
User\MSAL Undergrad\Kate\libec.windows 
% Add to Matlab path (when running biofilms_gui2.m) 
  
% Necessary files(must be in same folder): 
% biofilms_gui2.m, biofilms_gui2.fig 
  
% Library files(must be in same folder): 
% libec.dll 
% Qt*.dll  






% Execution Notes: 
% CHANGE num_channels in code! Cannot be changes in GUI 
  
% Output file header(not included in file) 
% ExperimentTime(s) ReZ(Ohm) ImZ(Ohm) |Z|(Ohm) Phase(Rad) Mode(See 
below) 
  
% Data values separated by \t (tab) character 
% 1 file per channel 
  












function varargout = biofilms_gui2(varargin) 
% Initialization of GUI elements - DO NOT EDIT 
gui_Singleton = 1; 
gui_State = struct('gui_Name',       mfilename, ... 
                   'gui_Singleton',  gui_Singleton, ... 
                   'gui_OpeningFcn', @biofilms_gui2_OpeningFcn, ... 
                   'gui_OutputFcn',  @biofilms_gui2_OutputFcn, ... 
                   'gui_LayoutFcn',  [] , ... 
                   'gui_Callback',   []); 









    [varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:}); 
else 
    gui_mainfcn(gui_State, varargin{:}); 
end 
% End initialization code - DO NOT EDIT 
  
% --- Executes just before biofilms_gui2 is made visible. 
function biofilms_gui2_OpeningFcn(hObject, eventdata, handles, 
varargin) 
% Choose default command line output for biofilms_gui2 
handles.output = hObject; 
  
% Update handles structure 
guidata(hObject, handles); 
  
% Load Libec library 
  
if ~libisloaded('libec') 
   loadlibrary('libec.dll', 'labview.h') 
end 
  










































% Initialize default values for experiment parameters 
  
%%%%%%%%%%%%%%%%%%%%% MODIFY NUM CHANNELS HERE 
%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
num_channels = 4; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%% 
% DO NOT USE CHANNEL 1 
channels = 4:(num_channels + 3); % default channel #s 
treat_cycles = zeros(1,num_channels);  
if(num_channels>=2) 
    for ch = num_channels/2+1:num_channels 
        treat_cycles(ch) = 3; % set half of channels to 3 cycles for 
treatment  
    end 
end 
%treat_cycles = [0,0,3,3]; Default treatment cycles 
started = 0; % flag if experiment has started 
filename = 'exp_data_ch_'; 
outlier_thresh = 100; % 1x or 100% percent different from previous 
value 
num_outliers = zeros(num_channels,1); % Stores the number of 
outliers so far 
num_outliers_cond = zeros(num_channels,1); % Stores the number of 
outliers so far 
temp_growth_mode = zeros(num_channels,1); 
  
% Default experiment parameters 
fl_sens =  100; % sensing frequency (Hz) 
fh_sens = fl_sens; 
fh_treat = 1000000; 
fl_treat = fh_treat/10; % treatment frequency (Hz) 
  
  
amp_sens = 0.005; % sensing amplitude (V) 
amp_treat = 0.1; % treatment amplitude (V) 
  
qt = 300; % quiet time between measurments (s) 
qt_growth = 600; 
qt_treat = 60; 
  
sens_thresh = 5; % sensing threshold in % 
treat_thresh = 10; % treatment threshold in % 
growth_hours = 6; 
  
treatment_cycles = 20; % Num of cycles of treatment between every 





exp_cycles_est = 10000; % Max expected num of cycles in experiment - 
pre-allocate storage, more efficient 
  
tech = 14; % impedance sensing is technique #14 for CHI 
ei_sens = 0; % DC bias sensing 
ei_treat = 0; % DC bias treatment 
  
% Preallocate data array 
% 5 values per time point - time, raw |Z|, im, mag, phase, mode, |Z| 
no 
% outlier, |Z| processed 
exp_data = Inf*zeros(num_channels,exp_cycles_est, 8);  
mode= 5*ones(num_channels,1); % Mode for each channel: 1 - control, 
2 - seeding, 3 - growth, 4 - treat 
baseline = zeros(num_channels,1); % Baseline calculated based on 
Control experiment data 
  
cycle = 1; % current cycle 
  
% Set up Raw data figure 
figure(2); 
for ch = 1:num_channels 
    subplot(2,num_channels/2,ch);   
    title(['Ch ' num2str(channels(ch)) ' - Raw |Z|'], 
'FontSize',14,'FontWeight','bold'); 
    xlabel ('Time (hrs)', 'FontSize',10,'FontWeight','bold'); 




% Set up graph for normalized data 
figure(3); 
for ch = 1:num_channels 
    subplot(2,num_channels/2,ch); 
    title(['Ch ' num2str(channels(ch)) ' - Change in |Z|'], 
'FontSize',14,'FontWeight','bold'); 
    xlabel ('Time (hrs)', 'FontSize',10,'FontWeight','bold'); 
    ylabel ('(|Z|-|Z|_{LB Baseline}) / |Z|_{LB Baseline}', 
'FontSize',10,'FontWeight','bold');  
    %line1 = refline([0 sens_thresh/100]); 
    %set(line1,'LineStyle',':', 'Color', 'k', 'LineWidth', 2); 
    %line2 = refline([0 treat_thresh/100]); 
    %set(line2,'LineStyle',':', 'Color', 'k', 'LineWidth', 2); 
end 
  
% filename2 = 'exp1_12032015_4-cond.txt'; 
% M = dlmread(filename2,'\t'); 
  




% --- Outputs from this function are returned to the command line. 






varargout{1} = handles.output; 
  
% Start/stop experiment button 





if (get(hObject,'Value') == get(hObject,'Max')) % if experiment 
started 
    set(hObject,'String','Pause'); 
    set(hObject,'BackgroundColor','yellow'); 
    run_exp = 1; 
    if ~started % set start time 
        started = 1; 
        start_time = clock; 
    end 
    run_Experiment(); % start experiment 
end     
if (get(hObject,'Value') == get(hObject,'Min')) % if experiment 
stopped 
    set(hObject,'String','Start'); 
    set(hObject,'BackgroundColor','green'); 
    run_exp = 0;   
end 
% Hint: get(hObject,'Value') returns toggle state of togglebutton1 
  
  
% get sensing Frequency from text box 
function edit1_Callback(hObject, eventdata, handles) 
global fl_sens; 
global fh_sens; 
fl_sens = str2num(get(hObject,'String')); 
fh_sens = fl_sens; 
  
  
% set sensing frequency text box to default 
function edit1_CreateFcn(hObject, eventdata, handles) 
global fl_sens; 
set(hObject, 'String',num2str(fl_sens))  
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get Treatment Frequency from text box 
function edit2_Callback(hObject, eventdata, handles) 
global fh_treat; 
global fl_treat; 
fh_treat = str2num(get(hObject,'String')); 
fl_treat = fh_treat/10; 
%fh_treat = fl_treat; 
  
% set treatment frequency to default 







if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
%get Sensing Amplitude from text box 
function edit3_Callback(hObject, eventdata, handles) 
global amp_sens; 
amp_sens = str2num(get(hObject,'String')); 
  
%set sensing amplitude to default 
function edit3_CreateFcn(hObject, eventdata, handles) 
global amp_sens; 
set(hObject, 'String',num2str(amp_sens))  
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get Treatment Amplitude from text box 
function edit4_Callback(hObject, eventdata, handles) 
global amp_treat; 
amp_treat = str2num(get(hObject,'String')); 
  
% set treatment amplitude to default 
function edit4_CreateFcn(hObject, eventdata, handles) 
global amp_treat; 
set(hObject, 'String',num2str(amp_treat)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get Quiet Time from text box 
function edit6_Callback(hObject, eventdata, handles) 
global qt; 
qt = str2num(get(hObject,'String')); 
  
  
% set quiet time to text box 
function edit6_CreateFcn(hObject, ~, handles) 
global qt; 
set(hObject, 'String',num2str(qt)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get Treatment Interval from text box, for each channel. 0 for no 
treatment 
function edit7_Callback(hObject, eventdata, handles) 
global treat_cycles; 






% set treatment interval to default 
function edit7_CreateFcn(hObject, eventdata, handles) 
global treat_cycles; 
set(hObject, 'String',num2str(treat_cycles)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get Treatment Threshold from textbox 
function edit8_Callback(hObject, eventdata, handles) 
global treat_thresh; 
treat_thresh = str2num(get(hObject,'String')); 
  
% set treatment threshold to default 
function edit8_CreateFcn(hObject, eventdata, handles) 
global treat_thresh; 
set(hObject, 'String',num2str(treat_thresh)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get Sensing threshold from textbox 
function edit9_Callback(hObject, eventdata, handles) 
global sens_thresh; 
sens_thresh = str2num(get(hObject,'String')); 
  
% set sensing threshold to default 
function edit9_CreateFcn(hObject, eventdata, handles) 
global sens_thresh; 
set(hObject, 'String',num2str(sens_thresh)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get list of Channel numbers from textbox 
function edit10_Callback(hObject, eventdata, handles) 
global channels; 
global num_channels 
channels = str2num(get(hObject,'String')); 
for ch = 1:num_channels % Update plot titles 
    figure(2); 
    subplot(2,num_channels/2,ch); 
    title(['Channel ' num2str(channels(ch))]); 
    figure(3); 
    subplot(2,num_channels/2,ch); 
    title(['Channel ' num2str(channels(ch))]); 
end 
  
% set list of channel numbers to default 







%num_channels = length(channels); 
  
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
% get file name from text box 
function edit11_Callback(hObject, eventdata, handles) 
global filename; 
filename = (get(hObject,'String')); 
  
% set default file name 
function edit11_CreateFcn(hObject, eventdata, handles) 
global filename; 
set(hObject,'String',filename); 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
function edit13_Callback(hObject, eventdata, handles) 
global qt_growth; 
qt_growth = str2num(get(hObject,'String')); 
  
  
% set quiet time to text box 
function edit13_CreateFcn(hObject, ~, handles) 
global qt_growth; 
set(hObject, 'String',num2str(qt_growth)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 





function edit14_Callback(hObject, eventdata, handles) 
global outlier_thresh; 
outlier_thresh = str2num(get(hObject,'String')); 
  
  
% set quiet time to text box 
function edit14_CreateFcn(hObject, ~, handles) 
global outlier_thresh; 
set(hObject, 'String',num2str(outlier_thresh)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 









function checkbox1_Callback(hObject, eventdata, handles) 
  
% Execute mode change based on selection 











curr_mode =  get(hObject,'String'); 
if strcmp(curr_mode,'Control') 
    mode = ones(num_channels,1); 
     
    for ch = 1:num_channels % calculate the baseline for every 
channel 
        baseline_cond = mean(exp_data(ch,(exp_data(ch,:,6) == 
5),7)); 
        if baseline_cond~=0  % If baseline set, replot control data                       
            f = fopen([filename num2str(channels(ch)) '-cond-
proc.txt'],'a'); 
            for c = 1:cycle-1 
                
%fprintf(f,'%d\t%d\t%d\n',exp_data(ch,c,1),exp_data(ch,c,8), 
exp_data(ch,c,6)); 
                
fprintf(f,'%d\t%d\t%d\t%d\n',exp_data(ch,c,1),(exp_data(ch,c,7)-
baseline_cond)/baseline_cond, exp_data(ch,c,6),fh_sens); 
            end 
            fclose(f); 
        end 
    end 
elseif strcmp(curr_mode,'Seeding') % Calculate baseline  
    mode = 2 * ones(num_channels,1); 
    for ch = 1:num_channels % calculate the baseline for every 
channel 
        baseline(ch) = mean(exp_data(ch,(exp_data(ch,:,6) == 1),7)); 
        if baseline (ch)~=0  % If baseline set, replot control data            
            figure(3); 
            subplot(2,num_channels/2,ch); 
            hold on; % control 




            hold off; 
            drawnow 
             
            f = fopen([filename num2str(channels(ch)) '-
proc.txt'],'a'); 






            %start_cycle = max(1,start_cycle); % ensure start cycle 
is at least 1 
             
            for c = start_cycle:cycle-1 
                exp_data(ch,c,8) = (exp_data(ch,c,7)-
baseline(ch))/baseline(ch); 
                
fprintf(f,'%d\t%d\t%d\t%d\n',exp_data(ch,c,1),exp_data(ch,c,8), 
exp_data(ch,c,6),fh_sens); 
                
%fprintf('%d\t%d\t%d\n',exp_data(ch,c,1),(exp_data(ch,c,4)-
baseline(ch))/baseline(ch), exp_data(ch,c,6)); 
            end 
            fclose(f); 
        end 
    end 
     
elseif strcmp(curr_mode, 'Growth/Sensing/BETreatment') 
    temp_growth_mode = ones(num_channels,1);     
    growth_start = clock; 
    mode = 6 * ones(num_channels,1); 
elseif strcmp(curr_mode, 'Conditioning') 
    mode = 5 * ones(num_channels,1); 
elseif strcmp(curr_mode, 'Growth') 





% --- Executes on button press in pushbutton2. ---- %GENERATE 
FIGURES 










% hObject    handle to pushbutton2 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Generate the outlier reports 
    outlier_report = fopen([filename '_outliers.txt'],'w'); % 
Overwrite last report 
    fprintf(outlier_report,'Conditioning Outliers (per channel): '); 
    fprintf(outlier_report,'%d\t',num_outliers_cond); 
    fprintf(outlier_report,'\nControl Outliers (per channel): '); 
    fprintf(outlier_report,'%d\t',num_outliers); 







for ch = 1:num_channels % calculate the baseline for every channel 
     
    %%%%%%%%%%%%%%%%%%%%%  PLOT RAW EXP DATA 
%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    mode = 1; 
    idx = find(exp_data(ch,:,6) == mode,1,'first'); % Find start 
time of experiment 
    if idx > 0 
        exp_start_time = exp_data(ch,idx,1); 
    else 
        exp_start_time = 0; 
    end 
     
    fig = figure(); 
    hold on; 
    mode = 1; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'ok','MarkerSize',4,'MarkerFaceColor','k'); 
    mode = 2; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'om','MarkerSize',4,'MarkerFaceColor','m'); 
    mode = 3; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'ob','MarkerSize',4,'MarkerFaceColor','b'); 
    mode = 4; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'or','MarkerSize',4,'MarkerFaceColor','r'); 
    %mode = 5; % do not plot conditioning data 
    %plot(exp_data(ch,(exp_data(ch,:,6) == 
mode),1),exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'ok','MarkerSize',4,'MarkerFaceColor','k'); 
    mode = 6; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'og','MarkerSize',4,'MarkerFaceColor','g'); 
     
    title(['Ch ' num2str(channels(ch)) ' - Raw |Z|'], 
'FontSize',20,'FontWeight','bold'); 
    xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
    ylabel ('|Z| (ohms)', 'FontSize',20,'FontWeight','bold'); 
    set(gca,'FontSize',16,'FontWeight','bold') 
    graphname = strcat(filename,'_rawZ_',int2str(channels(ch))); 
    print (fig, '-dpng', '-r300',graphname); 
    strcat(graphname,'.fig') 
    savefig(strcat(graphname,'.fig')) 
    hold off;  
  
    %%%%%%%%%%%%%%%%%%%%%  PLOT NOOUTLIER EXP DATA 
%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    fig = figure(); 
    hold on; 





    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'ok','MarkerSize',4,'MarkerFaceColor','k'); 
    mode = 2; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'om','MarkerSize',4,'MarkerFaceColor','m'); 
    mode = 3; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'ob','MarkerSize',4,'MarkerFaceColor','b'); 
    mode = 4; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'or','MarkerSize',4,'MarkerFaceColor','r'); 
    %mode = 5;% do not plot conditioning data 
    %plot(exp_data(ch,(exp_data(ch,:,6) == 
mode),1),exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'ok','MarkerSize',4,'MarkerFaceColor','k'); 
    mode = 6; 
    plot(exp_data(ch,(exp_data(ch,:,6) == mode),1)-
exp_start_time,exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'og','MarkerSize',4,'MarkerFaceColor','g'); 
     
    title(['Ch ' num2str(channels(ch)) ' - |Z| [No Outliers]'], 
'FontSize',20,'FontWeight','bold'); 
    xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
    ylabel ('|Z| (ohms)', 'FontSize',20,'FontWeight','bold'); 
    set(gca,'FontSize',16,'FontWeight','bold') 
    graphname = 
strcat(filename,'_noOutliersZ_',int2str(channels(ch))); 
    print (fig, '-dpng', '-r300',graphname); 
    savefig(strcat(graphname,'.fig')) 
    hold off; 
     
    if baseline (ch)~=0  % If baseline set, replot control data            
        fig = figure(); 
        hold on; 
        mode = 1; 




        mode = 2; 




        mode = 3; 




        mode = 4; 








        %mode = 5; % do not plot exp data 




        mode = 6; 





        title(['Ch ' num2str(channels(ch)) ' - Change in |Z|'], 
'FontSize',20,'FontWeight','bold'); 
        xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
        ylabel ('(|Z|-|Z|_{LB Baseline}) / |Z|_{LB Baseline}', 
'FontSize',20,'FontWeight','bold'); 
        set(gca,'FontSize',16,'FontWeight','bold') 
         
        line1 = refline([0 sens_thresh/100]); 
        set(line1,'LineStyle',':', 'Color', 'k', 'LineWidth', 2); 
        line2 = refline([0 treat_thresh/100]); 
        set(line2,'LineStyle',':', 'Color', 'k', 'LineWidth', 2); 
         
        graphname = 
strcat(filename,'_changeZ_',int2str(channels(ch))); 
        print (fig, '-dpng', '-r300',graphname); 
        savefig(strcat(graphname,'.fig')) 
        hold off; 
        %clf(4)  
    end 
     
    %%%%%%%%%%%%%%%%%%%%%% PLOT BASELINE COND DATA 
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    baseline_cond = mean(exp_data(ch,(exp_data(ch,:,6) == 5),7)); 
    if baseline_cond ~= 0 
        fig = figure(); 
        hold on; 
        mode = 5; 





        title(['Ch ' num2str(channels(ch)) ' - Conditioning - Change 
in |Z|'], 'FontSize',20,'FontWeight','bold'); 
        xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
        ylabel ('(|Z|-|Z|_{LB Baseline}) / |Z|_{LB Baseline}', 
'FontSize',20,'FontWeight','bold'); 
        set(gca,'FontSize',16,'FontWeight','bold') 
        graphname = 
strcat(filename,'_cond_changeZ_',int2str(channels(ch))); 
        print (fig, '-dpng', '-r300',graphname); 
        savefig(strcat(graphname,'.fig')) 





    end 
    
    %%%%%%%%%%%%%%%%%%%%%% PLOT NOOUTLIER COND DATA 
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    fig = figure(); 
    hold on; 
    mode = 5; 
    plot(exp_data(ch,(exp_data(ch,:,6) == 
mode),1),exp_data(ch,(exp_data(ch,:,6) == 
mode),7),'ok','MarkerSize',4,'MarkerFaceColor','w'); 
     
    title(['Ch ' num2str(channels(ch)) ' - Conditioning - |Z| [No 
outliers]'], 'FontSize',20,'FontWeight','bold'); 
    xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
    ylabel ('|Z| (ohms)', 'FontSize',20,'FontWeight','bold'); 
    set(gca,'FontSize',16,'FontWeight','bold') 
    graphname = 
strcat(filename,'_cond_noOutliersZ_',int2str(channels(ch))); 
    print (fig, '-dpng', '-r300',graphname); 
    savefig(strcat(graphname,'.fig')) 
    hold off; 
     
     
        %%%%%%%%%%%%%%%%%%%%%% PLOT RAW COND DATA 
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    fig = figure(); 
    hold on; 
    mode = 5; 
    plot(exp_data(ch,(exp_data(ch,:,6) == 
mode),1),exp_data(ch,(exp_data(ch,:,6) == 
mode),4),'ok','MarkerSize',4,'MarkerFaceColor','w'); 
     
    title(['Ch ' num2str(channels(ch)) ' - Conditioning - Raw |Z| 
'], 'FontSize',20,'FontWeight','bold'); 
    xlabel ('Time (hrs)', 'FontSize',20,'FontWeight','bold'); 
    ylabel ('|Z| (ohms)', 'FontSize',20,'FontWeight','bold'); 
    set(gca,'FontSize',16,'FontWeight','bold') 
    graphname = 
strcat(filename,'_cond_rawZ_',int2str(channels(ch))); 
    print (fig, '-dpng', '-r300',graphname); 
    savefig(strcat(graphname,'.fig')) 
    hold off; 
     
    fprintf('Graphs for channel %d generated.\n', channels(ch)); 
    % save figure 
    % clear figure 
end 
fprintf('Finished generating graphs.\n'); 
  
% Growth (hours) 
function edit12_Callback(hObject, eventdata, handles) 
global growth_hours; 
growth_hours = str2num(get(hObject,'String')); 
  







if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 
    set(hObject,'BackgroundColor','white'); 
end 
  
function edit15_Callback(hObject, eventdata, handles) 
global qt_treat; 
qt_treat = str2num(get(hObject,'String')); 
  
  
% set quiet time to text box 
function edit15_CreateFcn(hObject, ~, handles) 
global qt_treat; 
set(hObject, 'String',num2str(qt_treat)) 
if ispc && isequal(get(hObject,'BackgroundColor'), 
get(0,'defaultUicontrolBackgroundColor')) 











































% Open files for writing 
for ch = 1:num_channels 
    fileID(ch) = fopen([filename num2str(channels(ch)) '.txt'],'a'); 
    fileID_processed(ch) = fopen([filename num2str(channels(ch)) '-
proc.txt'],'a'); 




while (run_exp == 1) 
    for ch = 1:num_channels 
        %Set CHI parameters 
        calllib('libec', 'CHI_set_mch', channels(ch)-1); 
        calllib('libec', 'CHI_setTechnique', tech); % 14 - impedance 
sensing 
         
        if mode (ch)== 4 %treatment 
            n = 50; 
            disp 'treatment' 
            calllib('libec', 'CHI_setParameter', 'm_iP1M', n) 
            calllib('libec', 'CHI_setParameter', 'm_iP100K', n) 
            calllib('libec', 'CHI_setParameter', 'm_iP10K', n) 
  
            calllib('libec', 'CHI_setParameter', 'm_ei', ei_treat); 
            calllib('libec', 'CHI_setParameter', 'm_fl', fl_treat);  
            calllib('libec', 'CHI_setParameter', 'm_fh', fh_treat); 
            calllib('libec', 'CHI_setParameter', 'm_amp', 
amp_treat); 
            calllib('libec', 'CHI_runExperiment'); % non-blocking 
  
            %n = 50; %  
            x = zeros(n, 1); 
            y = zeros(n, 1); 
            y2 = zeros(n, 1); 
            py2 = libpointer('singlePtr',y2); 
  
            px= libpointer('singlePtr', x); 
            py= libpointer('singlePtr', y); 
  
            while calllib('libec', 'CHI_experimentIsRunning') 
               disp 'Treating...' % <- call CHI_getExperimentData() 
in real time 
               pause(5) 
            end 
            calllib('libec', 'CHI_getExperimentData_2channel', px, 
py, py2, n) 
            px.value 
            py.value 
            py2.value 
        end 
  
       % if mode(ch) == 1 || mode(ch) == 2 || mode(ch) == 3 ||  
mode(ch) == 5 ||mode(ch) == 6%sensing 





        disp 'measuring at sensing frequency' 
%         calllib('libec', 'CHI_setParameter', 'm_iP1M', n) 
%         calllib('libec', 'CHI_setParameter', 'm_iP100K', n) 
%         calllib('libec', 'CHI_setParameter', 'm_iP10K', n) 
  
        calllib('libec', 'CHI_setParameter', 'm_ei', ei_sens); 
        calllib('libec', 'CHI_setParameter', 'm_fl', fl_sens);  
        calllib('libec', 'CHI_setParameter', 'm_fh', fh_sens); 
        calllib('libec', 'CHI_setParameter', 'm_amp', amp_sens); 
  
        %Collect data point 
        calllib('libec', 'CHI_runExperiment'); % non-blocking 
  
        %n = 1; % should be a single data point b/c only one 
frequency 
        x = zeros(n, 1); 
        y = zeros(n, 1); 
        y2 = zeros(n, 1); 
        py2 = libpointer('singlePtr',y2); 
  
        px= libpointer('singlePtr', x); 
        py= libpointer('singlePtr', y); 
  
        while calllib('libec', 'CHI_experimentIsRunning') 
           disp 'Sensing...' % <- call CHI_getExperimentData() in 
real time 
           pause(5) 
        end 
        calllib('libec', 'CHI_getExperimentData_2channel', px, py, 
py2, n) 
        px.value 
        py.value 
        py2.value 
        actual_freq = px.value(12); 
        exp_data(ch,cycle,2) = py.value(12); %Re Z 
        exp_data(ch,cycle,3) = py2.value(12); %Im Z 
         
        current_time = clock; 
        exp_data(ch,cycle,1) = etime(current_time, start_time)/3600; 
% time elapsed since start of experiment 
        exp_data(ch,cycle,4) = norm([exp_data(ch,cycle,2) 
exp_data(ch,cycle,3)]); %|Z| 
        if (mode(ch) == 3) 
           exp_data(ch,cycle,4) = exp_data(ch,cycle,4);  
        end 
        exp_data(ch,cycle,5) = 
angle(exp_data(ch,cycle,2)+1i*exp_data(ch,cycle,3)); % Phase 
        exp_data(ch,cycle,6) = mode(ch); % Mode 
        %exp_data(ch,cycle,7) = px.value; 
  
        %%%%%%%%%%%%%%%%%%%%%%% Test Code 
%         measure = M(cycle,2); 
%         if mode(ch) == 3 
%             measure = measure * 1.5; 






%         exp_data(ch,cycle,1) = M(cycle,1); 
%         exp_data(ch,cycle,2) = measure; 
%         exp_data(ch,cycle,3) = measure; 
%         exp_data(ch,cycle,4) = measure; 
%         exp_data(ch,cycle,5) = measure; 
%         exp_data(ch,cycle,6) = mode(ch); 
        %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
        
         
        % Outlier detection - compare |Z| to previous cycle, if same 
mode 
        ref_value = 0; 
        if cycle >= 6 
            ref_value = mean (exp_data(ch,cycle-5:cycle-1,7)); 
        end 
  
        if ref_value > 0 && sum(exp_data(ch,cycle-5:cycle,6)) == 5*6 
&& abs((exp_data(ch,cycle,4)-ref_value)/ref_value*100) > 
outlier_thresh 
            exp_data(ch,cycle,7) = exp_data(ch,cycle-1,7); % outlier 
- replace with last data 
            num_outliers_cond(ch) = num_outliers_cond(ch)+1; 
            fprintf('Outlier Detected. Total number of outliers 
removed for Ch %d: %d\n',channels(ch),num_outliers_cond(ch)); 
        elseif ref_value > 0 && sum(exp_data(ch,cycle-5:cycle,6)) == 
1*6 && abs((exp_data(ch,cycle,4)-ref_value)/ref_value*100) > 
outlier_thresh 
            exp_data(ch,cycle,7) = exp_data(ch,cycle-1,7); % outlier 
- replace with last data 
            num_outliers(ch) = num_outliers(ch)+1; 
            fprintf('Outlier Detected. Total number of outliers 
removed for Ch %d: %d\n',channels(ch),num_outliers(ch)); 
        else  
            exp_data(ch,cycle,7) = exp_data(ch,cycle,4); % Not an 
outlier - current data 
        end  
          
        figure(2);  
        subplot(2,num_channels/2,ch); 
        hold on; 
        % Plot data point in correct color, depending on mode 
        if mode(ch)== 1 
            
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,4),'ok','MarkerSize',4,'
MarkerFaceColor','k'); % Control - black 
        elseif mode (ch) == 2 
            
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,4),'om','MarkerSize',4,'
MarkerFaceColor','m'); % Seeding - blue 
        elseif mode(ch) == 3 
            
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,4),'ob','MarkerSize',4,'
MarkerFaceColor','b'); % Sensing - green 





            
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,4),'or','MarkerSize',4,'
MarkerFaceColor','r'); % Treatment - red 
        elseif mode(ch) == 5 
            
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,4),'ok','MarkerSize',4,'
MarkerFaceColor','w'); % Conditioning 
        elseif mode(ch) == 6 
            
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,4),'og','MarkerSize',4,'
MarkerFaceColor','g'); % Growth 
        end 
        hold off; 
        drawnow  
         
        % If baseline has been set, plot channels relative to 
baseline in 
        % plot 3 
        if baseline(ch) ~= 0 
            exp_data(ch,cycle,8) = (exp_data(ch,cycle,7)-
baseline(ch))/baseline(ch); 
             
            figure(3); 
            subplot(2,num_channels/2,ch); 
  
            hold on; 
            if mode(ch)== 1 
                
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,8),'ok','MarkerSize',4,'
MarkerFaceColor','k'); 
            elseif mode (ch) == 2 
                
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,8),'om','MarkerSize',4,'
MarkerFaceColor','m'); 
            elseif mode(ch) == 3 % sensing 




            elseif mode(ch) == 4 %&& fl_sens == fl_treat 
                
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,8),'or','MarkerSize',4,'
MarkerFaceColor','r'); 
                % do not plot conditioning 
            elseif mode(ch) == 6 
                
plot(exp_data(ch,cycle,1),exp_data(ch,cycle,8),'og','MarkerSize',4,'
MarkerFaceColor','g'); % Growth 
            end 
            hold off; 
             
            if mod(cycle,20) == 0 % Replot baseline every 20 cycles 
                hold on; 
                line1 = refline([0 sens_thresh/100]); 






                line2 = refline([0 treat_thresh/100]); 
                set(line2,'LineStyle',':', 'Color', 'k', 
'LineWidth', 2); 
                hold off; 
            end 
            drawnow  
            % Generate processed file containing: Time, Relative 
Impedance, Mode 
             
            
fprintf(fileID_processed(ch),'%d\t%d\t%d\t%d\n',exp_data(ch,cycle,1)
,exp_data(ch,cycle,8), actual_freq); 
        end 
         
        % Write data to file 
        if mode(ch) == 5 




        else  
            
fprintf(fileID(ch),'%d\t%d\t%d\t%d\t%d\t%d\t%d\t%d\n',exp_data(ch,cy
cle,1:5),exp_data(ch,cycle,7),exp_data(ch,cycle,6),actual_freq); 
        end 
        now = clock; 
        % Logic for changing modes sensing/treatment 
        % if in growth mode & past 5 cycles are also growth 
  
         if treat_cycles(ch)>0 && mode(ch) == 3 && baseline(ch) ~= 0 
&& cycle >= 6 && sum(exp_data(ch,cycle-4:cycle,6)) == 3*5 
             % Use below if only + change threshold range should 
trigger treatment 
             % avg = (double(mean(exp_data(ch,cycle-4:cycle,4))) - 
baseline(ch))/baseline(ch); 
              
             % Use below if both +/- change threshold range should 
trigger treatment  
              avg = abs((double(mean(exp_data(ch,cycle-4:cycle,4))) 
- baseline(ch))/baseline(ch)); 
              
             % Use below if only - change threshold range should 
trigger treatment  
             % avg = -((double(mean(exp_data(ch,cycle-4:cycle,4))) - 
baseline(ch))/baseline(ch)); 
              
             if exp_data(ch,cycle-5,6)== 3 && avg * 100 > 
treat_thresh %if not previously in treatment, must be above 
treat_tresh 
                 mode(ch) = 4 % go to treatment from sensing 
             elseif exp_data(ch,cycle-5,6)== 4 && avg * 100 > 
sens_thresh %if previously in treatment mode (before 5 sensing 
samples), must be above sens_thresh 
                 mode(ch) = 4 % go back to treatment after 5 samples 
in sensing 





         elseif mode(ch) == 4 && cycle >= treat_cycles(ch) && 
sum(exp_data(ch,cycle -(treat_cycles(ch)-1):cycle,6)) == 
4*treat_cycles(ch) 
             mode(ch) = 3 
         elseif mode(ch) == 6 && temp_growth_mode(ch) == 1 && 
abs(etime(growth_start,now))/3600 >= growth_hours % switch from 
growth to treatment 
             mode(ch) = 3 
         end 
  
         if ch == num_channels && (mode(ch) == 6 || mode(ch) == 2) % 
seeding/growth 
             fprintf('Quiet time started\n'); 
             pause(qt_growth); 
         elseif ch == num_channels && (mode(ch) == 3 || mode(ch)== 
4) % at least 1 channel is in treatment 
             fprintf('Quiet time started\n'); 
             pause(qt_treat); 
         elseif ch == num_channels % control/sensing 
            fprintf('Quiet time started\n'); 
            pause(qt); 
         else 
            pause(1); 
         end 
    end 
    cycle = cycle + 1; % increment cycle 




% close data files 
for ch = 1: num_channels 
   fclose(fileID(ch)); 
   fclose(fileID_processed(ch)); 
   fclose(fileID_condition(ch)); 
end 









%THIS CODE EXTRACTS DATA FROM A .FIG FILE AND PERFORMS MOVING 
AVERAGE 
%SMOOTHING WITH THE DEFAULT SPAN OF 5 
filename = exp_data_ch__cond_changeZ_4'; % Enter name (no extension) 
of .fig whose data you want to extract 
filename2 = strcat(filename,'.fig'); 
open(filename2);  
  
% Extract data from .fig file 
h = gcf; %current figure handle 
axesObjs = get(h, 'Children');  %axes handles 
dataObjs = get(axesObjs, 'Children'); %handles to low-level graphics 
objects in axes 
objTypes = get(dataObjs, 'Type');  %type of low-level graphics 
object 
xdata = get(dataObjs, 'XData');  %data from low-level grahics 
objects 
ydata = get(dataObjs, 'YData'); 
zdata = get(dataObjs, 'ZData'); 
  
%Perform moving average smoothing and save as new plot 
yy = smooth(ydata); 
plot(xdata, yy, 'k', 'LineWidth', 2.0) 
graphname = strcat(filename,'_smooth'); 
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